doc_id	relation_id	relation_name	gene_words	hpoterm_words	words	sentences_before	sentences_after	expectation	gene_expectation	hpoterm_expectation	features	weights
SCPDFS_49538.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_49538.pdf_15_15_4_4_7_7_UNSUP	PAX6/HP:0000526|Aniridia	{4}	{7}	{Although,the,association,between,PAX6,mutations,and,aniridia,now,seems,incontrovertible,",",there,is,evidence,that,mutations,at,a,second,human,locus,",",AN2,",",may,be,responsible,for,some,cases,of,aniridia,.}	{"The second , which was detected as an RNA lacking an exon , appeared to be a splicing mutation resulting from an as yet undetected point mutation or very small deletion .","The product of the mutant RNA would lack part of the PAX6 homeodomain ."}	{"It remains to be determined whether","AN2 is a second aniridia gene , or has a more indirect effect on development of the condition ."}	0.982	0.89	0.984	{"WORD_SEQ_[mutation and]",POS_SEQ_[NNS_CC],VERB_DEP_PATH_[seem]_[nn-prep_between|mutation-nsubj|association@cop]_[prep_between-nsubj|association@cop],DEP_PATH_[nn-prep_between|mutation@prep_between],VERB_DEP_PATH_[be]_[nn-prep_between|mutation-nsubj|association-advcl|incontrovertible@]_[prep_between-nsubj|association-advcl|incontrovertible@],VERB_DEP_PATH_POS_[seem]_[nn-prep_between|NNS-nsubj|NN@cop]_[prep_between-nsubj|NN@cop],VERB_DEP_PATH_POS_[be]_[nn-prep_between|NNS-nsubj|NN-advcl|JJ@]_[prep_between-nsubj|NN-advcl|JJ@],DEP_PATH_POS_[nn-prep_between|NNS@prep_between]}	{3.387,-1.06848,0.25427,0.25427,0.25427,0.25427,0.25427,0.131684}
journal.pbio.0020316.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pbio.0020316.pdf_147_147_17_18_3_4_UNSUP	androgen_receptor/HP:0012125|Prostate cancer	{17,18}	{3,4}	{Treatment,for,hormone-dependent,prostate,cancers,focuses,primarily,on,reducing,androgen,levels,by,using,chemicals,that,compete,for,androgen,receptor,docking,rights,in,the,hormone-binding,pocket,of,the,ligand-binding,domain,",",or,LBD,.}	{"Robert Fletterick and colleagues set out to identify the \\" fu | | repertoire \\" of amino acid sequences that might conceivably consort with the androgen receptor .","Their ﬁndings help explain the unusual behavior of the androgen receptor during prostate cancer progression — a ﬁrst step toward developing new anticancer therapies ."}	{"( A ligand is a molecule , like the androgen hormone , that binds to a receptor . )","But cancer cells eventually circumvent these chemical assaults through increased levels of either androgen receptors or their coactivators , or through mutations that make androgen receptors immune to chemotherapy ."}	0.994	1	1	{INV_DEP_PATH_POS_[nn-prep_for|NNS-rcmod|VBP-dobj|NNS-prepc_by|VBG-prepc_on|VBG@prep_for-nsubj|NN],INV_VERB_DEP_PATH_[use]_[nn-prep_for|rights-rcmod|compete-dobj|chemical@]_[prep_for-nsubj|treatment@prepc_by-prepc_on|reduce],INV_DEP_PATH_[nn-prep_for|rights-rcmod|compete-dobj|chemical-prepc_by|use-prepc_on|reduce@prep_for-nsubj|treatment],INV_VERB_DEP_PATH_POS_[use]_[nn-prep_for|NNS-rcmod|VBP-dobj|NNS@]_[prep_for-nsubj|NN@prepc_by-prepc_on|VBG],INV_POS_SEQ_[VBZ_RB_IN_VBG_NN_NNS_IN_VBG_NNS_WDT_VBP_IN],"INV_WORD_SEQ_[focus primarily on reduce androgen level by use chemical that compete for]"}	{0.808558,0.808558,0.808558,0.808558,0.808558,0.808558}
journal.pone.0001931.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0001931.pdf_400_400_21_21_26_27_UNSUP	p63/HP:0000968|Ectodermal dysplasia	{21}	{26,27}	{Kantaputra,PN,",",Hamada,T,",",Kumchai,T,",",McGrath,JA,(,2003,),Heterozygous,mutation,in,the,SAIVI,domain,of,p63,underlies,Rapp,~,Hodgkin,ectodermal,dysplasia,.}	{"Cicero DO , Falconi 1V1 , Candi E , l\\\\/Iele S , Cadot B , et al. ( 2006 ) N1 \\\\ ’ IR structure of the p63 SAIVI domain and dynamical properties of G534V and T5371 ’ pathological mutants , identified in the AEC syndrome .","Cell Biochem Biophys 44 : 475 — 489 ."}	{"J Dent Res 82 : 433 — 437 .","Boccuni P , lV1acGrogan D , Scandura Jl \\\\ ’ I , Nimer SD ( 2003 ) The human L ( 3 ) NIBT polycoml ) group protein is a transcriptional repressor and interacts physically and functionally with TEL ( ETV6 ) ."}	0.956	0.978	1	{"WORD_SEQ_NER_[underlie PERSON ~ PERSON]",VERB_DEP_PATH_POS_[underlie]_[prep_of-prep_in|NN-dep|NN-dep|CD@]_[dobj@],DEP_PATH_POS_[prep_of-prep_in|NN-dep|NN-dep|CD@dobj],POS_SEQ_[VBZ_NNP_NNP_NNP],VERB_DEP_PATH_[underlie]_[prep_of-prep_in|domain-dep|mutation-dep|NUMBER@]_[dobj@],"WORD_SEQ_[underlie Rapp ~ Hodgkin]",DEP_PATH_[prep_of-prep_in|domain-dep|mutation-dep|NUMBER@dobj]}	{0.366974,0.366974,0.366974,0.366974,0.366974,0.366974,0.366974}
journal.pone.0022538.pdf	RELATION_GENEHPOTERM_journal.pone.0022538.pdf_98_98_26_26_30_31	IL-6/HP:0200119|Acute hepatitis	{26}	{30,31}	{This,elevation,of,plasma,IL-6,and,the,acute,phase,response,proteins,",",combined,with,the,increase,in,liver,mass,are,consistent,with,the,known,effects,of,IL-6,in,mediating,the,hepatic,acute,phase,response,[,"13,34,35,36,37",],.}	{"Serum levels of the IL-6 responsive acute phase reactants ﬁbrinogen , haptoglobin and Von Willebrand Factor were also markedly induced in response to the tumor .","Unlike in humans , C Reactive Protein ( CRP ) is not an acute phase protein in mice and was not elevated in cachexia ."}	{"These results in mice with C26 tumors parallel the association of the IL-6 and acute phase response with muscle wasting in cancer patients .","- o - Control 120 - * ~ - Moderate - In Severe"}	0.95	0.292	0.358	{DEP_PATH_[prep_of-prep_with|effect@amod-dobj|response-prepc_in|mediate],DEP_PATH_POS_[prep_of-prep_with|NNS@amod-dobj|NN-prepc_in|VBG],"WORD_SEQ_[in mediate the]",VERB_DEP_PATH_POS_[be]_[prep_of-prep_with|NNS@cop]_[amod-dobj|NN-prepc_in|VBG@cop],VERB_DEP_PATH_POS_[mediate]_[prep_of-prep_with|NNS@prepc_in]_[amod-dobj|NN@],VERB_DEP_PATH_[be]_[prep_of-prep_with|effect@cop]_[amod-dobj|response-prepc_in|mediate@cop],VERB_DEP_PATH_[mediate]_[prep_of-prep_with|effect@prepc_in]_[amod-dobj|response@],POS_SEQ_[IN_VBG_DT]}	{0.374579,0.374579,0.374579,0.374579,0.374579,0.374579,0.374579,0.151366}
journal.pone.0058673.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0058673.pdf_377_377_7_7_24_25_UNSUP	TRPV4/HP:0002652|Skeletal dysplasia	{7}	{24,25}	{Recently,",",it,has,been,reported,that,TRPV4,could,modulate,Ca2,+,inﬂux,and,muscle,fatigue,[,36,],and,is,furthermore,involved,in,skeletal,dysplasia,[,37,],.}	{"Other TRP family members have already been reported as functional channels in skeletal muscle .","Among them , the Transient Receptor Potential Canonical type 1 ( TRPC1 ) could operate as a SR Ca2 + leak channel in skeletal muscle [ 22 ] ."}	{"But unlike TRPV1 or TRPC1 , TRPV4 is localized in the sarcolemma in mouse muscle [ 38 ] .","Adding TRPV1 , we lengthen the list of biologically efficient channels for the muscle"}	0.948	0.442	0.944	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_[involve]_[nsubj-ccomp|modulate@conj_and]_[amod-prep_in|]@],VERB_DEP_PATH_POS_[report]_[nsubj-ccomp|VB@]_[amod-prep_in|NN-conj_and|VBN@],VERB_DEP_PATH_[have]_[nsubj-ccomp|modulate@aux]_[amod-prep_in|]-conj_and|involve@aux],VERB_DEP_PATH_[be]_[nsubj-ccomp|modulate@auxpass-conj_and|involve]_[amod-prep_in|]@auxpass],VERB_DEP_PATH_POS_[modulate]_[nsubj@]_[amod-prep_in|NN-conj_and|VBN@ccomp],DEP_PATH_[nsubj-ccomp|modulate@amod-prep_in|]-conj_and|involve],VERB_DEP_PATH_POS_[have]_[nsubj-ccomp|VB@aux]_[amod-prep_in|NN-conj_and|VBN@aux],VERB_DEP_PATH_POS_[involve]_[nsubj-ccomp|VB@conj_and]_[amod-prep_in|NN@],DEP_PATH_POS_[nsubj-ccomp|VB@amod-prep_in|NN-conj_and|VBN],VERB_DEP_PATH_POS_[be]_[nsubj-ccomp|VB@auxpass-conj_and|VBN]_[amod-prep_in|NN@auxpass],VERB_DEP_PATH_[be]_[nsubj-ccomp|modulate@auxpass]_[amod-prep_in|]-conj_and|involve@auxpass],VERB_DEP_PATH_POS_[be]_[nsubj-ccomp|VB@auxpass]_[amod-prep_in|NN-conj_and|VBN@auxpass],VERB_DEP_PATH_[modulate]_[nsubj@]_[amod-prep_in|]-conj_and|involve@ccomp],VERB_DEP_PATH_[report]_[nsubj-ccomp|modulate@]_[amod-prep_in|]-conj_and|involve@]}	{-3.11955,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516,0.421516}
journal.pone.0022538.pdf	RELATION_GENEHPOTERM_journal.pone.0022538.pdf_607_607_10_10_22_22	SAA1/HP:0004326|Cachexia	{10}	{22}	{C,",",Western,blotting,analysis,demonstrates,signiﬁcantly,increased,fibrinogen,and,SAA1,protein,levels,in,quadriceps,and,gastrocnemius,in,moderate,and,severe,C26,cachexia,.}	{"Data ( means : SEM ) are expressed as ng fibrinogen / pg protein .","* P < 0.05 , ** P < 0.01 , *** P < 0.001 ."}	{"* P < 0.05 , ** P < 0.01 , *** P < 0.001 .","doi :10.1371 / journa | ."}	0.942	0.112	0.194	{POS_SEQ_[NN_NNS_IN_NNS_CC_NNS_IN_JJ_CC_JJ_NN],DEP_PATH_POS_[conj_and-nn|NN-dobj|NNS@prep_in],DEP_PATH_[conj_and-nn|fibrinogen-dobj|level@prep_in],VERB_DEP_PATH_POS_[increase]_[conj_and-nn|NN-dobj|NNS@]_[prep_in@],"WORD_SEQ_[protein level in quadricep and gastrocnemius in moderate and severe c26]",VERB_DEP_PATH_[increase]_[conj_and-nn|fibrinogen-dobj|level@]_[prep_in@]}	{0.448341,0.448341,0.448341,0.448341,0.448341,0.448341}
SCPDFS_40273.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_40273.pdf_18_18_16_16_22_22	WAGR/HP:0000526|Aniridia	{16}	{22}	{The,3-Mb,contig,spans,the,central,region,of,deletions,encompassing,16,chromosomal,breakpoints,in,patients,with,WAGR,syndrome,(,Wilms,tumor,",",aniridia,",",genitourinary,malformation,",",mental,retardation,),",",and,its,construction,is,an,important,step,in,facilitating,functional,analysis,of,these,genes,.}	{"The contig starts from the catalase gene on the centromeric side and reaches beyond the PAX6 gene at the 11p13/p14 .1 boundary .","Additional smaller contigs on either side were identiﬁed , but still have to be linked up ."}	{"© 1998 Academic Press","IN TRO DU CTION"}	0.98	0.33	1	{"POS_SEQ_[NN_CD_NN_NN_,]","WORD_SEQ_[syndrome ( wilm tumor ,]","WORD_SEQ_NER_[syndrome NUMBER PERSON tumor ,]",DEP_PATH_POS_[nn-prep_with|NN-prep_in|NNS@nsubj-dep|NN],DEP_PATH_[nn-prep_with|syndrome-prep_in|patient@nsubj-dep|step],VERB_DEP_PATH_POS_[encompass]_[nn-prep_with|NN-prep_in|NNS@]_[nsubj-dep|NN@],VERB_DEP_PATH_[encompass]_[nn-prep_with|syndrome-prep_in|patient@]_[nsubj-dep|step@]}	{1.36863,1.22314,1.22314,0,0,0,0}
journal.pone.0104486.pdf	RELATION_GENEHPOTERM_journal.pone.0104486.pdf_680_680_22_22_29_30	BDNF/HP:0000819|Diabetes mellitus	{22}	{29,30}	{Han,X,",",Luo,Y,",",Zhang,X,",",Lv,C,",",Sun,X,",",et,al.,(,2013,),Rs4074l34,near,BDNF,gene,is,associated,with,type,2,diabetes,mellitus,in,Chinese,Han,population,independently,of,body,mass,index,.}	{"Dia1 ) eto1ogia 55 : 266042666 .","11 ."}	{"PLoS One 8 : e56898 .","12 ."}	0.918	0.852	1	{VERB_DEP_PATH_POS_[associate]_[nn-prep_near|NN-nsubjpass|NN@]_[prep_with@],DEP_PATH_POS_[nn-prep_near|NN-nsubjpass|NN@prep_with],VERB_DEP_PATH_POS_[be]_[nn-prep_near|NN-nsubjpass|NN@auxpass]_[prep_with@auxpass],POS_SEQ_[NN_VBZ_VBN_IN_NN_CD],"WORD_SEQ_NER_[gene be associate with type NUMBER]",VERB_DEP_PATH_[associate]_[nn-prep_near|gene-nsubjpass|rs4074l34@]_[prep_with@],DEP_PATH_[nn-prep_near|gene-nsubjpass|rs4074l34@prep_with],VERB_DEP_PATH_[be]_[nn-prep_near|gene-nsubjpass|rs4074l34@auxpass]_[prep_with@auxpass],"WORD_SEQ_[gene be associate with type 2]"}	{0.650779,0.650779,0.650779,0.629155,0,0,0,0,0}
journal.pone.0034348.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0034348.pdf_617_617_17_17_6_8_UNSUP	SNRPN/HP:0001508|Failure to thrive	{17}	{6,8}	{Mouse,models,of,"P\\\\/V",S,have,failure,to,thrive,and,is,negatively,regulated,by,the,paternal,expressed,SNRPN,which,results,in,postnatal,lethality,and,growth,retardation,.}	{"The lethality and growth retardation chromosome as a positive regulator for paternal-speciﬁc gene phenotypes seem to correlate with the dual role of the PWS-IC as expression .","the Snrpn promoter and as the IC regulator for imprinted genes at The maternally expressed gene UBE3A / Ube3 ' a is the AS gene the PWS / AS domain ."}	{"sense / UBE3 ' A antisense and Snrpn sense / Ube3a antisense tran - Maternal expression of the Snrpn sense / Ube3a antisense transcripts scripts derived from the SNRPN and Smpn promoters , respectively from the inserted human SNRPJV promoter complements one [ 14,30 ] .","On the wild-type maternal chromosome , silencing of the failure to thrive locus to rescue lethality , but is not able to Snrpn promoter results in expression of Ube3 ' a ( Figure 8A , c ) ."}	0.97	0.81	0.94	{INV_VERB_DEP_PATH_[regulate]_[dobj-partmod|express-agent|paternal@]_[dobj@conj_and],INV_VERB_DEP_PATH_POS_[regulate]_[dobj-partmod|VBN-agent|JJ@]_[dobj@conj_and],INV_VERB_DEP_PATH_[express]_[dobj@]_[dobj@partmod-agent|paternal-conj_and|regulate],"INV_WORD_SEQ_[and be negatively regulate by the paternal express]",INV_POS_SEQ_[CC_VBZ_RB_VBN_IN_DT_JJ_VBN],INV_VERB_DEP_PATH_POS_[express]_[dobj@]_[dobj@partmod-agent|JJ-conj_and|VBN],INV_VERB_DEP_PATH_[be]_[dobj-partmod|express-agent|paternal@auxpass]_[dobj@auxpass-conj_and|regulate],INV_DEP_PATH_[dobj-partmod|express-agent|paternal-conj_and|regulate@dobj],INV_DEP_PATH_POS_[dobj-partmod|VBN-agent|JJ-conj_and|VBN@dobj],INV_VERB_DEP_PATH_POS_[be]_[dobj-partmod|VBN-agent|JJ@auxpass]_[dobj@auxpass-conj_and|VBN],INV_VERB_DEP_PATH_[have]_[dobj-partmod|express-agent|paternal-conj_and|regulate@]_[dobj@],INV_VERB_DEP_PATH_POS_[have]_[dobj-partmod|VBN-agent|JJ-conj_and|VBN@]_[dobj@]}	{0.292166,0.292166,0.292166,0.292166,0.292166,0.292166,0.292166,0.292166,0.292166,0.292166,0.292166,0.292166}
journal.pone.0006161.pdf	RELATION_GENEHPOTERM_journal.pone.0006161.pdf_481_481_23_23_29_30	Dicer/HP:0001644|Dilated cardiomyopathy	{23}	{29,30}	{Chen,JF,",",lylurchison,EP,",",Tang,R,",",Callis,TE,",",Tatsuguchi,NI,",",et,al.,(,2008,),Targeted,deletion,of,Dicer,in,the,heart,leads,to,dilated,cardiomyopathy,and,heart,failure,.}	{"Cell 129 : 3034317 .","15 ."}	{"Proc Natl Acad Sci U S A 105 : 211142116 .","d PLoS ONE | www ."}	0.92	0.886	1	{DEP_PATH_[prep_of-dobj|deletion-partmod|target-nsubj|PERSON@xcomp],DEP_PATH_POS_[prep_of-dobj|NN-partmod|VBN-nsubj|NNP@xcomp],VERB_DEP_PATH_[target]_[prep_of-dobj|deletion@]_[xcomp@partmod-nsubj|PERSON],VERB_DEP_PATH_[lead]_[prep_of-dobj|deletion-partmod|target-nsubj|PERSON@]_[xcomp@],VERB_DEP_PATH_POS_[lead]_[prep_of-dobj|NN-partmod|VBN-nsubj|NNP@]_[xcomp@],POS_SEQ_[IN_DT_NN_VBZ_TO],VERB_DEP_PATH_POS_[target]_[prep_of-dobj|NN@]_[xcomp@partmod-nsubj|NNP],"WORD_SEQ_[in the heart lead to]"}	{0.283025,0.283025,0.283025,0.283025,0.283025,0.283025,0.283025,0.283025}
SCPDFS_42129.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_42129.pdf_638_638_4_4_15_17_UNSUP	RET/HP:0002865|Medullary thyroid carcinoma	{4}	{15,16,17}	{A,mutation,in,the,RET,proto-oncogene,associated,with,multiple,endocrine,neoplasia,type,2B,and,sporadic,medullary,thyroid,carcinoma,.}	{"Science 238 : 1717 - 1720 .","Hofstra , R. M. , Landsvater , R. M. , Ceccherini , I. , Stulp , R. P. , Stelwagen , T. , Luo , Y. , Pasini , B. , Hoppener , J. W. , van Amstel , H. K. , Romeo , G. , et al. ( 1994 ) ."}	{"Nature 367 : 375-376 .","Kaplan , D. R. , Hempstead , B. L. , Martin-Zanca , D. , Chao , M. V. , and Parada , L. F. ( 1991 ) ."}	0.976	0.918	1	{VERB_DEP_PATH_POS_[associate]_[nn-prep_in|NN-nsubj|NN@]_[prep_with@],POS_SEQ_[NN_VBN_IN_JJ_JJ_NN_NN_NN_CC_JJ],"WORD_SEQ_[proto-oncogene associate with multiple endocrine neoplasium type 2b and sporadic]",DEP_PATH_[nn-prep_in|proto-oncogene-nsubj|mutation@prep_with],VERB_DEP_PATH_[associate]_[nn-prep_in|proto-oncogene-nsubj|mutation@]_[prep_with@],DEP_PATH_POS_[nn-prep_in|NN-nsubj|NN@prep_with]}	{1.16666,0.921007,0.921007,0.410951,0.410951,0.258053}
journal.pone.0006097.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0006097.pdf_614_614_18_18_16_16	DAZ/HP:0000027|Azoospermia	{18}	{16}	{moto,1,"\\\\",’,I,(,2000,),Caenorhal,),ditis,elegans,homologue,of,the,human,azoospermia,factor,DAZ,is,required,for,oogenesis,but,not,for,spermatogenesis,.}	{.,"Karashima T , Sugimoto A , Yama ."}	{"Development 127 : 106941079 .",.}	0.912	0.582	0.702	{INV_POS_SEQ_[NN],INV_WORD_SEQ_[factor],INV_VERB_DEP_PATH_[be]_[prep_of-nsubjpass|homologue@auxpass]_[nn-prep_of|DAZ-nsubjpass|homologue@auxpass],INV_VERB_DEP_PATH_POS_[require]_[prep_of-nsubjpass|NN@]_[nn-prep_of|NNP-nsubjpass|NN@],INV_VERB_DEP_PATH_[require]_[prep_of-nsubjpass|homologue@]_[nn-prep_of|DAZ-nsubjpass|homologue@],INV_VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[nn-prep_of|NNP-nsubjpass|NN@auxpass],INV_DEP_PATH_POS_[@nn],INV_DEP_PATH_[@nn]}	{-3.45349,1.34398,1.19937,1.19937,1.19937,1.08917,-0.157586,-0.147349}
journal.pone.0097402.pdf	RELATION_GENEHPOTERM_journal.pone.0097402.pdf_420_420_27_27_23_23	p53/HP:0001059|Pterygium	{27}	{23}	{Perra,IVIT,",",lVIaxia,C,",",Corbu,A,",",lVIinerba,L,",",Demurtas,P,",",et,al.,(,2006,),Oxidative,stress,in,pterygium,:,relationship,between,p53,and,8-hydroxydeoxyguanosine,.}	{"Klebe S , Callahan T , Power ] H ( 2013 ) Peroxiredoxin I and II in Human Eyes : Cellular Distribution and Association with Pterygium and DNA Damage . ]","Histochem Cytochem ."}	{"Mo1Vis 12 : 113641142 .","Tsai YY , Cheng YVV , Lee H , Tsai F ] , Tseng SH , et al. ( 2005 ) Oxidative DNA damage in pterygium ."}	0.912	0.096	0.946	{"INV_WORD_SEQ_[: relationship between]",INV_DEP_PATH_POS_[prep_between-dep|NN@prep_in],INV_DEP_PATH_[prep_between-dep|relationship@prep_in],INV_POS_SEQ_[:_NN_IN]}	{0.968662,0.615648,0.615648,0.177715}
journal.pone.0039240.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0039240.pdf_329_329_2_2_12_12_UNSUP	TBX22/HP:0010296|Ankyloglossia	{2}	{12}	{Mutations,in,TBX22,cause,the,rare,X-linked,syndrome,‘,cleft,palate,with,ankyloglossia,’,(,CPX,",",MIM,303400,),[,47,],.}	{"Mutations in MID ] cause the X-linked Opitz GBBB syndrome ( OSX , MIM 300000 ) , a congenital midline malformation syndrome characterized by clefting of the lip / palate and a variety of other pathologies [ 46 ] .","An association between speciﬁc haplotypes in A / [ ID ] and isolated CL/P was later reported in an Italian population [ 19 ] ."}	{"TBX22 belongs to the T ]","PLoS ONE | www ."}	0.928	0.922	0.998	{DEP_PATH_POS_[prep_in-nsubj|NNS@prep_with-nsubj|NN-xcomp|NN],"WORD_SEQ_NER_[cause the rare MISC syndrome NUMBER cleft palate with]",VERB_DEP_PATH_[cause]_[prep_in-nsubj|mutation@]_[prep_with-nsubj|palate-xcomp|]@],DEP_PATH_[prep_in-nsubj|mutation@prep_with-nsubj|palate-xcomp|]],"WORD_SEQ_[cause the rare x-linked syndrome ‘ cleft palate with]",VERB_DEP_PATH_POS_[cause]_[prep_in-nsubj|NNS@]_[prep_with-nsubj|NN-xcomp|NN@],POS_SEQ_[VBP_DT_JJ_JJ_NN_CD_NN_NN_IN]}	{0.336501,0.336501,0.336501,0.336501,0.336501,0.336501,0.336501}
journal.pgen.1002679.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1002679.pdf_134_134_14_14_15_16_UNSUP	p53/HP:0003003|Colon cancer	{14}	{15,16}	{It,has,also,been,suggested,that,this,latter,mechanism,underlies,wholegenome,duplications,in,faulty,p53,colon,cancer,human,cell,lines,where,telomerase,activity,was,abrogated,[,28,],.}	{"Moreover , deprotection of chromosome ends in TRF2-deﬁcient mouse hepatocytes impedes the onset of anaphase without affecting DNA replication [ 25 ] .","Similarly , persistent telomere deprotection due to deletion of the telomeric DNA-binding protein POTla / b in p53-defective mouse embryonic ﬁbroblasts leads to cell tetraploidization [ 26 ] through endoreduplication [ 27 ] ."}	{"In all these cases , cells skip or exit mitosis without undergoing anaphase or","P PLoS Genetics | www ."}	0.96	0.016	1	{WORD_SEQ_[],POS_SEQ_[],VERB_DEP_PATH_POS_[suggest]_[nn-prep_in|NNS-ccomp|VBZ@]_[nn-prep_in|NNS-ccomp|VBZ@],VERB_DEP_PATH_POS_[be]_[nn-prep_in|NNS@auxpass-advcl|VBN]_[nn-prep_in|NNS@auxpass-advcl|VBN],VERB_DEP_PATH_[be]_[nn-prep_in|line@auxpass-advcl|abrogate]_[nn-prep_in|line@auxpass-advcl|abrogate],VERB_DEP_PATH_[underlie]_[nn-prep_in|line@]_[nn-prep_in|line@],VERB_DEP_PATH_[abrogate]_[nn-prep_in|line@advcl]_[nn-prep_in|line@advcl],VERB_DEP_PATH_[suggest]_[nn-prep_in|line-ccomp|underlie@]_[nn-prep_in|line-ccomp|underlie@],VERB_DEP_PATH_POS_[have]_[nn-prep_in|NNS-ccomp|VBZ@aux]_[nn-prep_in|NNS-ccomp|VBZ@aux],VERB_DEP_PATH_POS_[abrogate]_[nn-prep_in|NNS@advcl]_[nn-prep_in|NNS@advcl],VERB_DEP_PATH_POS_[underlie]_[nn-prep_in|NNS@]_[nn-prep_in|NNS@],VERB_DEP_PATH_[be]_[nn-prep_in|line-ccomp|underlie@auxpass]_[nn-prep_in|line-ccomp|underlie@auxpass],VERB_DEP_PATH_POS_[be]_[nn-prep_in|NNS-ccomp|VBZ@auxpass]_[nn-prep_in|NNS-ccomp|VBZ@auxpass],VERB_DEP_PATH_[have]_[nn-prep_in|line-ccomp|underlie@aux]_[nn-prep_in|line-ccomp|underlie@aux],DEP_PATH_POS_[nn@nn],DEP_PATH_[nn@nn]}	{-1.47483,-1.46457,1.38718,0.817484,0.439416,0.439416,0.439416,0.439416,0.439416,0.439416,0.439416,0.439416,0.439416,0.439416,-0.0245278,0.00991182}
journal.pone.0022667.pdf	RELATION_GENEHPOTERM_journal.pone.0022667.pdf_544_544_33_33_28_28	COPD/HP:0002099|Asthma	{33}	{28}	{In,further,support,of,this,",",IL-6,levels,have,been,shown,to,be,elevated,in,various,pulmonary,disorders,associated,with,ﬁbrosis,",",including,IPF,[,47,],",",asthma,[,48,],and,COPD,[,49,],.}	{"Results from our study also demonstrate that IL-6 contributes to pulmonary ﬁbrosis in ADA-deﬁcient mice .","These are the first studies to demonstrate the ability to halt the progression of ﬁbrosis using IL-6 neutralizing antibodies suggesting IL-6 as a potential therapeutic target for treating pulmonary disorders where ﬁbrosis is abundant ."}	{"Moreover , in vitro studies have demonstrated proﬁbrotic activities of IL-6 on ﬁbroblasts and myoﬁbroblasts [ l7 ,50,5 l ] , which are considered major effector cells in pulmonary ﬁbrosis [ 1 ] .","In addition , IL-6 deﬁciency attenuates ﬁbrosis following intra-tracheal bleomycin exposure [ 21 ] ."}	0.914	0.716	0.284	{"INV_WORD_SEQ_NER_[[ NUMBER ] and]",INV_VERB_DEP_PATH_POS_[have]_[prep_including@aux]_[nn-prep_including|NN@aux],INV_DEP_PATH_POS_[prep_including@nn-prep_including|NN],INV_VERB_DEP_PATH_POS_[include]_[prep_including-_|VBN@ROOT@_]_[nn-prep_including|NN-_|VBN@ROOT@_],INV_VERB_DEP_PATH_POS_[be]_[prep_including@auxpass]_[nn-prep_including|NN@auxpass],"INV_WORD_SEQ_[[ 48 ] and]",INV_POS_SEQ_[NN_CD_NN_CC],INV_VERB_DEP_PATH_POS_[show]_[prep_including@]_[nn-prep_including|NN@],INV_VERB_DEP_PATH_[include]_[prep_including-_|show@ROOT@_]_[nn-prep_including|[-_|show@ROOT@_],INV_DEP_PATH_[prep_including@nn-prep_including|[],INV_VERB_DEP_PATH_[show]_[prep_including@]_[nn-prep_including|[@],INV_VERB_DEP_PATH_[have]_[prep_including@aux]_[nn-prep_including|[@aux],INV_VERB_DEP_PATH_[be]_[prep_including@auxpass]_[nn-prep_including|[@auxpass],INV_VERB_DEP_PATH_POS_[be]_[prep_including@cop-xcomp|JJ]_[nn-prep_including|NN@cop-xcomp|JJ],INV_VERB_DEP_PATH_[be]_[prep_including@cop-xcomp|elevated]_[nn-prep_including|[@cop-xcomp|elevated]}	{0.725415,0.485848,0.455334,0.357141,0.357141,-0.136641,0.106488,0.0522169,0,0,0,0,0,0,0}
journal.pone.0035158.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0035158.pdf_317_317_22_22_26_27_UNSUP	PTEN/HP:0012114|Endometrial carcinoma	{22}	{26,27}	{Tashiro,H,",",Blazes,1VlS,",",VVu,R,",",Cho,KR,",",Bose,S,",",et,al.,(,1997,),Nlutations,in,PTEN,are,frequent,in,endometrial,carcinoma,1,),ut,rare,in,other,common,gynecological,malignancies,.}	{"Cancer Control 16 : 8413 .","4 ."}	{"Cancer Res 57 : 393543940 .","5 ."}	0.948	0.236	0.998	{"WORD_SEQ_[be frequent in]",POS_SEQ_[VBP_JJ_IN],VERB_DEP_PATH_POS_[be]_[prep_in-nsubj|NNS@cop]_[amod-prep_in|NN-amod|JJ@cop],VERB_DEP_PATH_[be]_[prep_in-nsubj|nlutation@cop]_[amod-prep_in|)-amod|frequent@cop],DEP_PATH_[prep_in-nsubj|nlutation@amod-prep_in|)-amod|frequent],DEP_PATH_POS_[prep_in-nsubj|NNS@amod-prep_in|NN-amod|JJ]}	{1.37861,0.531585,0.250261,0.250261,0.250261,0.250261}
journal.pone.0026948.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0026948.pdf_385_385_13_13_17_18_UNSUP	AR/HP:0012125|Prostate cancer	{13}	{17,18}	{In,addition,",",Sam68,is,considered,an,AR,co-activator,as,it,can,modulate,AR,transcriptional,activity,in,prostate,cancers,[,25,],.}	{"Sam68 is a ubiquitous splicing regulator and also a downstream target of the Src signaling pathway [ 28,29 ] .","It is thus far unclear whether or not RBMY either directly regulates AR45 transcription / splicing or via interacting with Sam68 ."}	{"The Src signaling pathway also has been shown to be critical for the HBV X protein-mediated enhancement of AR function [ 30 ] .","Whether RBMY is involved in the Sam68-mediated Src signaling pathway is an interesting issue to be studied in the future ."}	0.918	0.996	1	{"WORD_SEQ_[transcriptional activity in]",POS_SEQ_[JJ_NN_IN],DEP_PATH_[@prep_in-nsubj|activity-rcmod|[],VERB_DEP_PATH_[modulate]_[dobj@]_[prep_in-nsubj|activity-rcmod|[-dobj|ar@],VERB_DEP_PATH_POS_[modulate]_[dobj@]_[prep_in-nsubj|NN-rcmod|VBP-dobj|NNS@],DEP_PATH_POS_[@prep_in-nsubj|NN-rcmod|VBP]}	{1.86089,-1.62691,0.543364,0.543364,0.543364,0.0181145}
journal.pone.0050126.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0050126.pdf_370_370_25_25_29_31_UNSUP	MEF/HP:0001677|Coronary artery disease	{25}	{29,30,31}	{Liu,Y,",",Niu,VV,",",VVu,Z,",",Su,X,",",Chen,Q,",",et,al.,(,2012,),Variants,in,exon,11,of,MEF,2A,gene,and,coronary,artery,disease,:,evidence,from,a,case,—,control,study,",",systematic,review,",",and,meta-analysis,.}	{"CardioloQ ' 119 : 90 — 95 .",.}	{"PLoS One 7 : e31406 .",.}	0.928	0.62	1	{DEP_PATH_POS_[nn-prep_of|NN-prep_in|NN-dep|NNS-dep|FW@conj_and],"WORD_SEQ_[2a gene and]",DEP_PATH_[nn-prep_of|gene-prep_in|exon-dep|variant-dep|(@conj_and],POS_SEQ_[NN_NN_CC]}	{1.06237,1.06237,1.06237,-0.584642}
journal.pone.0039932.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0039932.pdf_511_511_27_27_7_7_UNSUP	CD20/HP:0002665|Lymphoma	{27}	{7}	{Interestingly,",",an,approved,drug,against,nonHodgkin,lymphoma,",",Tositumomab,",",is,known,to,bind,to,F,GRIA,",",although,the,intended,target,is,the,B-lymphocyte,antigen,CD20,.}	{"Immunoglobulirz gamma Fe receptor I ( FCGRIA ) is a receptor protein for immunoglobulin antibodies , which are produced by the innate immune system in response to viral and bacterial infections or cancer cells .","The gene is known to be expressed as part of the immune response signature of follicular lymphoma [ I08 ] and known to be part of a cluster of over-expressed immune system related genes in B-cell lymphoma samples which are rich in T-cells and histiocytes ( immune cells capable of digesting foreign substances ) [ I09 ] ."}	{"The hemoglobin scavenger receptor { Cluster of Dgﬂerentiation 163 , CD163 } protein , encoded by the gene ranked third by BioHEL FR , is a receptor involved in clearance and endocytosis of hemoglobin/haptoglobin complexes by macrophages .","CD163 has been proposed as a marker for tumour-inﬁltrating macrophages in Hodgkin ’s lymphoma , where high CD163 expression has been observed to correlate with adverse outcome [ 1 10 ] ."}	0.964	0.638	0.998	{INV_WORD_SEQ_[TOO_FAR_AWAY],INV_DEP_PATH_POS_[advcl@prep_against-nsubjpass|NN],INV_VERB_DEP_PATH_POS_[bind]_[advcl@xcomp]_[prep_against-nsubjpass|NN@xcomp],INV_VERB_DEP_PATH_[be]_[advcl@auxpass]_[prep_against-nsubjpass|drug@auxpass],INV_VERB_DEP_PATH_POS_[be]_[@cop]_[prep_against-nsubjpass|NN@cop-advcl|NN],INV_VERB_DEP_PATH_POS_[be]_[advcl@auxpass]_[prep_against-nsubjpass|NN@auxpass],INV_VERB_DEP_PATH_[be]_[@cop]_[prep_against-nsubjpass|drug@cop-advcl|cd20],INV_DEP_PATH_[advcl@prep_against-nsubjpass|drug],INV_VERB_DEP_PATH_POS_[know]_[advcl@]_[prep_against-nsubjpass|NN@],INV_VERB_DEP_PATH_[approve]_[advcl@amod-nsubjpass|drug]_[prep_against@amod],INV_VERB_DEP_PATH_[bind]_[advcl@xcomp]_[prep_against-nsubjpass|drug@xcomp],INV_VERB_DEP_PATH_[know]_[advcl@]_[prep_against-nsubjpass|drug@],INV_VERB_DEP_PATH_POS_[approve]_[advcl@amod-nsubjpass|NN]_[prep_against@amod]}	{-2.7069,0.493918,0.493918,0.493918,0.493918,0.493918,0.493918,0.493918,0.493918,0.493918,0.493918,0.493918,0.493918}
journal.pone.0019120.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0019120.pdf_253_253_25_25_19_19_UNSUP	CFTR/HP:0000027|Azoospermia	{25}	{19}	{In,this,regard,",",the,rapid,development,of,drug,targeting,CFTR,may,provide,opportunity,for,the,possible,therapy,of,azoospermia,caused,by,functional,deﬁciency,of,CFTR,in,the,testis,.}	{"Of note , there are more than 1800 mutations of CFTR and most of them may not cause typical CF phenotypes , but may lead to compromised spermatogenesis .","Therefore , the current ﬁndings Call for more clinical studies of CFTR mutations screening , both classic genetic mutations and other variant tracts such as IVS8-Tn locus , in azoospermia and severe oligozoospermia patients ."}	{"Another novel ﬁnding of the present study is the expression of sAC in Sertoli cells and its involvement in the FSH-regulated cAMP cascade .","Although F SH is known to play an essential role in regulating spermatogenesis through the CAMP pathway in Sertoli cells [ 33,42 ] , the present results ﬁnd that full activation of the FSH-stimulated cAMP pathway depends on HCO3 _ , sAC and CFTR , suggesting that the CFTR-HCO3 _ - dependent CAMP pathway is not merely an alternative or redundant pathway ."}	0.92	0.344	1	{INV_VERB_DEP_PATH_POS_[cause]_[prep_of-agent|NN@]_[@partmod],INV_DEP_PATH_[prep_of-agent|deﬁciency-partmod|cause@],INV_VERB_DEP_PATH_[cause]_[prep_of-agent|deﬁciency@]_[@partmod],INV_DEP_PATH_POS_[prep_of-agent|NN-partmod|VBN@],"INV_WORD_SEQ_[cause by functional deﬁciency of]",INV_POS_SEQ_[VBN_IN_JJ_NN_IN]}	{1.2916,0.379528,0.379528,0.35354,0.258313,-0.165441}
journal.pone.0043475.pdf	RELATION_GENEHPOTERM_journal.pone.0043475.pdf_43_43_6_6_20_21	PAPSS2/HP:0002651|Spondyloepimetaphyseal dysplasia	{6}	{20,21}	{A,truncation,mutation,of,the,human,PAPSS2,gene,was,reported,in,a,Pakistani,family,suffering,from,a,novel,form,of,spondyloepimetaphyseal,dysplasia,(,SEMD,),[,"7,8",],.}	{"In humans , PAPS is synthesized from ATP and SO42 _ by two isoforms of PAPS synthetase ( PAPSS ) : PAPSS1 and PAPSS2 .","The PAPSS2 is one of the principal enzymes required for the sulfation of extracellular matrix molecules in bone formation and other tissues [ 4 ~ 6 ] ."}	{"A homozygous PAPSS2 mutation ( S475X ) was identiﬁed in another large Pakistani family affected by SEMD , Pakistani type [ 8,9 ] .","This manifested as disproportionately short stature with short , bowed lower limbs , enlarged knee joints , kyphoscoliosis , and generalized brachydactyly [ 7 ] ."}	0.908	0.968	0.986	{DEP_PATH_[nn-prep_of|gene-nsubjpass|mutation@amod-prep_of|semd-prep_from|form],VERB_DEP_PATH_[report]_[nn-prep_of|gene-nsubjpass|mutation@]_[amod-prep_of|semd-prep_from|form@],VERB_DEP_PATH_POS_[report]_[nn-prep_of|NN-nsubjpass|NN@]_[amod-prep_of|NN-prep_from|NN@],VERB_DEP_PATH_[be]_[nn-prep_of|gene-nsubjpass|mutation@auxpass]_[amod-prep_of|semd-prep_from|form@auxpass],POS_SEQ_[NN_VBD_VBN_IN_DT_JJ_NN_NN_IN_DT_JJ_NN_IN],VERB_DEP_PATH_POS_[be]_[nn-prep_of|NN-nsubjpass|NN@auxpass]_[amod-prep_of|NN-prep_from|NN@auxpass],"WORD_SEQ_[gene be report in a pakistani family suffering from a novel form of]","WORD_SEQ_NER_[gene be report in a MISC family suffering from a novel form of]",DEP_PATH_POS_[nn-prep_of|NN-nsubjpass|NN@amod-prep_of|NN-prep_from|NN]}	{0.263649,0.263649,0.263649,0.263649,0.263649,0.263649,0.263649,0.263649,0.263649}
SCPDFS_39066.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_39066.pdf_35_35_6_6_13_13_UNSUP	APOE/HP:0000726|Dementia	{6}	{13}	{Most,of,the,association,studies,of,APOE,with,PD,and,PD,associated,with,dementia,have,been,negative,in,Caucasians,[,12-15,],.}	{"These commonalities suggest a common etiological link between AD and PD , and APOE may provide the link .","Examination of the variation of APOE in PD populations with and without dementia could be a test of this hypothesis ."}	{"However , one study in a Japanese cohort indicated that the APOE e4 allele frequency was significantly higher in demented patients than in nondemented patients with PD [ 8 ] .","A meta analysis of six PD and APOE studies demonstrated a pooled odds ratio of 0.94 ,"}	0.926	0.108	0.998	{DEP_PATH_POS_[prep_of-prep_of|NNS@prep_with-partmod|VBN],VERB_DEP_PATH_[be]_[prep_of-prep_of|study-nsubj|most@cop]_[prep_with-partmod|associate-nsubj|most@cop],DEP_PATH_[prep_of-prep_of|study@prep_with-partmod|associate],VERB_DEP_PATH_POS_[have]_[prep_of-prep_of|NNS-nsubj|JJS@aux]_[prep_with-partmod|VBN-nsubj|JJS@aux],VERB_DEP_PATH_[associate]_[prep_of-prep_of|study@partmod]_[prep_with@],VERB_DEP_PATH_POS_[be]_[prep_of-prep_of|NNS-nsubj|JJS@cop]_[prep_with-partmod|VBN-nsubj|JJS@cop],POS_SEQ_[IN_NN_CC_NN_VBN_IN],VERB_DEP_PATH_POS_[associate]_[prep_of-prep_of|NNS@partmod]_[prep_with@],VERB_DEP_PATH_[have]_[prep_of-prep_of|study-nsubj|most@aux]_[prep_with-partmod|associate-nsubj|most@aux],"WORD_SEQ_[with pd and pd associate with]"}	{0.264981,0.264981,0.264981,0.264981,0.264981,0.264981,0.264981,0.264981,0.264981,0.264981}
journal.pone.0021858.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0021858.pdf_699_699_30_30_36_37_UNSUP	ABCR/HP:0000608|Macular degeneration	{30}	{36,37}	{Allikmets,R,",",Shroyer,NF,",",Singh,N,",",Seddon,Jl,"\\\\",’,I,",",Lewis,RA,",",et,al.,(,1997,),Mutation,of,the,Stargardt,disease,gene,(,ABCR,),in,age,~,related,macular,degeneration,.}	{"Iyengar SK , Song D , Klein BE , Klein R , SchickJH , et al. ( 2004 ) Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age ~ related macular degeneration .","Am J Hum Genet 74 ( 1 ) : 20439 ."}	{"Science 277 ( 5333 ) : 180547 .","Kuroiwa S , Kojima H , Kikuchi T , Yoshimura N ( 1999 ) ATP binding cassette transporter retina genotypes and age related macular degeneration : an analysis on exudative non-familialJapanese patients ."}	0.936	0.078	1	{POS_SEQ_[NN_IN_NN_NN_JJ],DEP_PATH_POS_[nn-dep|NN-prep_of|NN-dobj|NN@dep-prep_in|NN],DEP_PATH_[nn-dep|)-prep_of|gene-dobj|mutation@dep-prep_in|~],"WORD_SEQ_[) in age ~ related]"}	{1.08492,0.668723,0.668723,0.668723}
journal.pone.0083110.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0083110.pdf_415_415_25_25_40_40_UNSUP	RSPO4/HP:0001798|Anonychia	{25}	{40}	{Blaydon,DC,",",Ishii,Y,",",O'Toole,EA,",",Unsworth,HC,",",Teh,M-T,et,al.,(,2006,),The,gene,encoding,R-spondin,4,(,RSPO4,),",",a,secreted,protein,implicated,in,Wnt,signaling,",",is,mutated,in,inherited,anonychia,.}	{"doi :10.1111 / j. 1742 — 4658.2010.07925 .","x. PubMed : 21078127 ."}	{"Nat Genet 38 : 1245-1247 .","doi :10.1038 / ng1883 ."}	0.912	0.05	0.998	{"POS_SEQ_[NN_,_DT_VBN_NN_VBN_IN_NN_NN_,_VBZ_VBN_IN_VBN]","WORD_SEQ_[) , a secrete protein implicate in wnt signaling , be mutate in inherit]",DEP_PATH_POS_[nn-xcomp|NN-xcomp|VBG-dep|FW-rcmod|NNP-appos|NNP-nsubjpass|NNP@prep_in],DEP_PATH_[nn-xcomp|)-xcomp|encode-dep|(-rcmod|M-T-appos|PERSON-nsubjpass|DC@prep_in]}	{1.09561,0.661198,0.249643,0.249643}
SCPDFS_20474.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_20474.pdf_293_293_13_13_4_5_UNSUP	SPINK1/HP:0006280|Chronic pancreatitis	{13}	{4,5}	{Pathways,to,injury,in,chronic,pancreatitis,:,decoding,the,role,of,the,highrisk,SPINK1,N345,haplotype,using,meta,—,analysis,.}	{"— .","C.H. , Greer , J.B. , Papachristou , G.l. , Barmada , M.M. , Whitcomb , D.C. , 2008 ."}	{"PLoS One 3 , e2003 .","Balog , A. , et al. , 2005 ."}	0.942	0.932	0.992	{INV_POS_SEQ_[:_VBG_DT_NN_IN_DT_JJ],INV_DEP_PATH_POS_[nn-prep_of|NN-dobj|NN@prep_in-pobj|NN-dep|TO],INV_VERB_DEP_PATH_[decode]_[nn-prep_of|haplotype-dobj|role@]_[prep_in-pobj|injury-dep|to@],"INV_WORD_SEQ_[: decode the role of the highrisk]",INV_VERB_DEP_PATH_POS_[decode]_[nn-prep_of|NN-dobj|NN@]_[prep_in-pobj|NN-dep|TO@],INV_DEP_PATH_[nn-prep_of|haplotype-dobj|role@prep_in-pobj|injury-dep|to]}	{1.09048,0.325835,0.325835,0.325835,0.325835,0.325835}
journal.pone.0072344.pdf	RELATION_GENEHPOTERM_journal.pone.0072344.pdf_71_71_15_15_23_23	IL-18/HP:0000093|Proteinuria	{15}	{23}	{This,observation,indicated,that,the,inﬂammasome,activation,characterized,by,the,caspase-1,activation,",",IL-1B,and,IL-18,production,were,correlated,with,the,severity,of,proteinuria,.}	{"As show in Figure 1A , B and C , in patients with mild proteinuria ( less than 5 g/24 h ) , the tubular staining for caspase-1 , IL-1B , and IL-18 was especially obvious .","Shown in Figure 1D , semiquantitative histomorphometric analysis of the immunostaining further conﬁrmed that the relative abundances of inﬂammasome markers caspase-1 , IL-l [ 3 , and IL-18 were significantly higher in the severe proteinuric group than in the mild and moderate proteinuric groups ."}	{"Activation of lnflammasome by Bovine Serum Albumin in NRK — 52E Cells Since the proximal tubule was the major site of reabsorption of ﬁltrated albumin [ 17 ] , we next used NRK-52E cell line as a vitro model to evaluate albuminuria ’s role in regulating inﬂammasome activation .","As shown in Figure 2 ( A through F ) , following bovine serum albumin treatment , NRK-52E cells exhibited caspase-1 activation and maturation of IL-l [ 3 and IL-18 protein in a doseand time-dependent manner , suggesting that bovine serum albumin could induce inﬂammasome activation in vitro ."}	0.954	0.906	0.992	{POS_SEQ_[NN_VBD_VBN_IN_DT_NN_IN],VERB_DEP_PATH_[characterize]_[nn-agent|production@]_[prep_of-prep_with|severity@partmod-nsubjpass|activation],DEP_PATH_POS_[nn-agent|NN-partmod|VBN-nsubjpass|NN@prep_of-prep_with|NN],VERB_DEP_PATH_[correlate]_[nn-agent|production-partmod|characterize-nsubjpass|activation@]_[prep_of-prep_with|severity@],DEP_PATH_[nn-agent|production-partmod|characterize-nsubjpass|activation@prep_of-prep_with|severity],VERB_DEP_PATH_POS_[correlate]_[nn-agent|NN-partmod|VBN-nsubjpass|NN@]_[prep_of-prep_with|NN@],"WORD_SEQ_[production be correlate with the severity of]",VERB_DEP_PATH_POS_[characterize]_[nn-agent|NN@]_[prep_of-prep_with|NN@partmod-nsubjpass|NN]}	{0.676462,0.317879,0.317879,0.317879,0.317879,0.317879,0.317879,0.317879}
journal.pone.0030950.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0030950.pdf_255_255_24_24_39_40_UNSUP	RNASEL/HP:0012125|Prostate cancer	{24}	{39,40}	{Rokman,A,",",Ikonen,T,",",Seppala,EH,",",Nupponen,N,",",Autio,V,",",et,al.,(,2002,),Germline,alterations,of,the,RNASEL,gene,",",a,candidate,HPC1,gene,at,lq25,",",in,patients,and,families,with,prostate,cancer,.}	{"Genomics 64 : l — l4 .","9 ."}	{"AmJ Hum Genet 70 : 129941304 .","10 ."}	0.97	0.24	1	{"WORD_SEQ_NER_[gene , a candidate hpc1 gene at NUMBER , in patient and family with]","POS_SEQ_[NN_,_DT_NN_NN_NN_IN_CD_,_IN_NNS_CC_NNS_IN]",DEP_PATH_[nn-prep_of|gene-dep|alteration@prep_with-prep_in|patient],DEP_PATH_POS_[nn-prep_of|NN-dep|NNS@prep_with-prep_in|NNS],"WORD_SEQ_[gene , a candidate hpc1 gene at lq25 , in patient and family with]"}	{0.872373,0.872373,0.598471,0.598471,0.179327}
journal.pone.0052572.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0052572.pdf_507_507_19_19_12_13_UNSUP	p53/HP:0012125|Prostate cancer	{19}	{12,13}	{In,contrast,",",our,studies,demonstrate,that,GTP,exposure,induces,apoptosis,in,prostate,cancer,cells,with,or,without,functional,p53,",",and,that,two,independent,but,parallel,pathways,mediate,apoptosis,in,prostate,cancer,cells,",",merging,with,one,another,through,the,mitochondrial,death,cascade,.}	{"In addition , other p53independent cellular events such as downregulation of c-IAP and XIAP may be further required for GTP-induced apoptosis .","Most studies indicate that the frequency of p53 mutations is higher in advanced-stage prostate cancers [ 32 ] , and that such cancers are relatively resistant to chemotherapeutically-induced apoptosis [ 56 ] ."}	{"Although some investigators have suggested that the exposure levels to GTP used in cell culture studies could not be realistically achievable in viva because of rapid metabolism and poor absorption [ 57 ] , others have shown that the bioavailability of polyphenols is different in various types of tissue [ 58 ] , indicating the possibility that they may be efficacious in the prevention and / or treatment of cancer .",Conclusions}	0.908	0.05	1	{"INV_WORD_SEQ_[cell with or without functional]",INV_DEP_PATH_[prep_with@nn-prep_in|cell-dobj|apoptosis],INV_POS_SEQ_[NNS_IN_CC_IN_JJ],INV_VERB_DEP_PATH_[induce]_[prep_with@]_[nn-prep_in|cell-dobj|apoptosis@],INV_VERB_DEP_PATH_POS_[induce]_[prep_with@]_[nn-prep_in|NNS-dobj|NN@],INV_DEP_PATH_POS_[prep_with@nn-prep_in|NNS-dobj|NN]}	{0.455442,0.455442,0.455442,0.455442,0.455442,0.0585418}
SCPDFS_23225.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_23225.pdf_405_405_0_0_15_15	POLG/HP:0000602|Ophthalmoplegia	{0}	{15}	{POLG,mutations,presenting,with,sensory,and,ataxic,neuropathy,in,compound,heterozygote,patients,with,progressive,extemal,ophthalmoplegia,.}	{"J .",", Dermaut , B. , et al. , 2003 ."}	{"Neuromuscul .","Disord ."}	0.93	0.892	0.992	{DEP_PATH_POS_[nn@prep_with-prep_in|NNS-partmod|VBG],"WORD_SEQ_[mutation present with sensory and ataxic neuropathy in compound heterozygote patient with progressive extemal]",POS_SEQ_[NNS_VBG_IN_JJ_CC_JJ_NN_IN_NN_NN_NNS_IN_JJ_JJ],VERB_DEP_PATH_[present]_[nn@partmod]_[prep_with-prep_in|patient@],VERB_DEP_PATH_POS_[present]_[nn@partmod]_[prep_with-prep_in|NNS@],DEP_PATH_[nn@prep_with-prep_in|patient-partmod|present]}	{0.72054,0.388863,0.388863,0.388863,0.388863,0.388863}
SCPDFS_46779.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46779.pdf_140_140_12_12_20_20_UNSUP	SCN5A/HP:0011675|Arrhythmia	{12}	{20}	{References,1,Splawski,",",I.,et,al.,(,2002,),Variant,of,SCN5A,sodium,channel,implicated,in,risk,of,cardiac,arrhythmia,.}	{"Genetic testing might assist in guiding such interventions in the future , reduce the need for over — treatment of such groups and reduce the associated expense .","There will always be a limitation in applying a statistical risk derived from population studies to individual patients but at least this risk assessment might be more accurate in the future ."}	{"Science 297 , 1333-1336 2 Chen , Q. et al. ( 1998 ) Genetic basis and molecular mechanism for idiopathic ventricular ﬁbrillation .","Nature 392 , 293-296 3 Wang , Q. et al. ( 1995 ) Cardiac sodium channel mutations in patients with long QT syndrome , an inherited cardiac arrhythmia ."}	0.958	0.46	0.998	{POS_SEQ_[NN_NN_VBN_IN_NN_IN_JJ],"WORD_SEQ_[sodium channel implicate in risk of cardiac]",DEP_PATH_POS_[nn-prep_of|NN-rcmod|FW-dep|NNP-nsubj|NNS@prep_of-prep_in|NN],DEP_PATH_[nn-prep_of|channel-rcmod|(-dep|I.-nsubj|reference@prep_of-prep_in|risk]}	{1.09919,1.09919,0.262994,0.262994}
journal.pone.0045175.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0045175.pdf_695_695_34_34_35_35_UNSUP	DYT1/HP:0001332|Dystonia	{34}	{35}	{Hewett,JVV,",",Tannous,B,",",Niland,BP,",",Nery,FC,",",Zeng,J,",",et,al.,(,2007,),l,"\\\\",’,1utant,torsinA,interferes,with,protein,processing,through,the,secretory,pathway,in,DYT1,dystonia,cells,.}	{"J Biol Chem 283 : 756847579 .","8 ."}	{"Proc Natl Acad Sci U S A 104 : 727147276 .","9 ."}	0.964	0.636	0.986	{VERB_DEP_PATH_POS_[interfere]_[nn-prep_in|NNS-prep_through|NN@]_[nn-prep_in|NNS-prep_through|NN@],VERB_DEP_PATH_[interfere]_[nn-prep_in|cell-prep_through|pathway@]_[nn-prep_in|cell-prep_through|pathway@],WORD_SEQ_[],POS_SEQ_[],DEP_PATH_POS_[nn@nn],DEP_PATH_[nn@nn]}	{2.82264,2.82264,-1.47483,-1.46457,-0.0245278,0.00991182}
SCPDFS_19585.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19585.pdf_267_267_22_22_32_32_UNSUP	BCS1L/HP:0003355|Aminoaciduria	{22}	{32}	{Apart,from,Bjornstad,syndrome,and,complex,lll,deﬁciency,symptoms,(,e.g.,",",encephalopathy,),",",the,most,severe,syndrome,due,to,defective,BCS1L,is,the,GRACILE,syndrome,characterized,by,growth,restriction,",",aminoaciduria,",",cholestasis,",",iron,overload,",",lactic,acidosis,and,early,death,(,Diaz,et,al.,",",2011,;,Moran,et,al.,",",2010,),.}	{"Vizarra et al. , 2007 ; Hinson et al. , 2007 ) .","Missense mutations in BCS IL result in the Bjornstad syndrome characterized by sensorineural HL and pili torti ( Hinson et al. , 2007 ) ."}	{"3.7 .",SUCLA2}	0.998	0.334	0.96	{VERB_DEP_PATH_POS_[be]_[prep_due_to-nsubj|NN@cop]_[agent-partmod|VBN@cop],VERB_DEP_PATH_[be]_[prep_due_to-nsubj|syndrome@cop]_[agent-partmod|characterize@cop],VERB_DEP_PATH_POS_[characterize]_[prep_due_to-nsubj|NN@partmod]_[agent@],DEP_PATH_[prep_due_to-nsubj|syndrome@agent-partmod|characterize],DEP_PATH_POS_[prep_due_to-nsubj|NN@agent-partmod|VBN],VERB_DEP_PATH_[characterize]_[prep_due_to-nsubj|syndrome@partmod]_[agent@],"POS_SEQ_[VBZ_DT_NN_NN_VBN_IN_NN_NN_,]","WORD_SEQ_[be the gracile syndrome characterize by growth restriction ,]"}	{0.797136,0.797136,0.797136,0.797136,0.797136,0.797136,0.0634938,0.0634938}
journal.pone.0097571.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0097571.pdf_64_64_15_15_1_4_UNSUP	CD8/HP:0002843|Abnormality of T cells	{15}	{1,3,4}	{Several,abnormalities,of,T,cells,have,also,been,described,in,CVID,including,oligoclonal,expansion,of,CD8,+,T,cells,",",and,decreased,numbers,of,CD4,+,T,cells,[,7,],.}	{"The typical defect of CVID is the failure of B lymphocytes to differentiate into switched memory B cells and into plasma cells .","Indeed reduced numbers of memory B cells have been associated with CVID , together with loss of isotype switched ( CD27 + IgD_IgM _ ) memory B cells [ 6 ] ."}	{"Moreover , T lymphocytes show an impaired secretion of several soluble mediators [ 8 ] .","As far as the innate immune system concerns , some reports have shown that dendritic cells present a severely altered differentiation , maturation , function and reduced levels of costimulatory molecules that are critical for T cells stimulation [ 9 ] ."}	0.934	0.104	0.374	{"INV_WORD_SEQ_[have also be describe in CVID include oligoclonal expansion of]",INV_VERB_DEP_PATH_[describe]_[prep_of-prep_including|expansion-prep_in|CVID@]_[nsubjpass@],INV_VERB_DEP_PATH_POS_[describe]_[prep_of-prep_including|NN-prep_in|NNP@]_[nsubjpass@],INV_VERB_DEP_PATH_[be]_[prep_of-prep_including|expansion-prep_in|CVID@auxpass]_[nsubjpass@auxpass],INV_VERB_DEP_PATH_[have]_[prep_of-prep_including|expansion-prep_in|CVID@aux]_[nsubjpass@aux],INV_VERB_DEP_PATH_POS_[decrease]_[prep_of-prep_including|NN-prep_in|NNP@conj_and]_[nsubjpass@conj_and],INV_DEP_PATH_POS_[prep_of-prep_including|NN-prep_in|NNP@nsubjpass],INV_VERB_DEP_PATH_POS_[be]_[prep_of-prep_including|NN-prep_in|NNP@auxpass]_[nsubjpass@auxpass],INV_DEP_PATH_[prep_of-prep_including|expansion-prep_in|CVID@nsubjpass],INV_VERB_DEP_PATH_POS_[have]_[prep_of-prep_including|NN-prep_in|NNP@aux]_[nsubjpass@aux],INV_VERB_DEP_PATH_[decrease]_[prep_of-prep_including|expansion-prep_in|CVID@conj_and]_[nsubjpass@conj_and],INV_POS_SEQ_[VBP_RB_VBN_VBN_IN_NNP_VBG_JJ_NN_IN]}	{0.21957,0.21957,0.21957,0.21957,0.21957,0.21957,0.21957,0.21957,0.21957,0.21957,0.21957,0.21957}
SCPDFS_46717.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46717.pdf_17_17_4_4_12_14_UNSUP	HD/HP:0100022|Abnormality of movement	{4}	{12,14}	{As,a,result,",",HD,is,characterized,by,cognitive,defects,",",psychiatric,abnormalities,and,movement,disorders,.}	{"Although all of these disease proteins contain expanded polyQ tracts ( usually > 36 glutamines ) and are widely expressed in the body and brain , they cause distinct neuropathology in particular brain regions .","In HD , the degeneration preferentially occurs in the striatum and the deep layers of the cortex and , during the later stages of the disease , extends to a variety of brain regions , including the hypothalamus and hippocampus [ 3 ] ."}	{"Symptoms usually appear in middle age and become progressively worse during the next 10-15 years until the patient dies .","Apparently , the distinct and selective neurodegeneration that occurs in each polyQ disease is determined by the structure and function of the disease proteins ."}	0.962	0.062	0.994	{DEP_PATH_POS_[nsubjpass@conj_and-agent|NNS],VERB_DEP_PATH_POS_[be]_[nsubjpass@auxpass]_[conj_and-agent|NNS@auxpass],VERB_DEP_PATH_POS_[characterize]_[nsubjpass@]_[conj_and-agent|NNS@],DEP_PATH_[nsubjpass@conj_and-agent|defect],VERB_DEP_PATH_[be]_[nsubjpass@auxpass]_[conj_and-agent|defect@auxpass],"POS_SEQ_[VBZ_VBN_IN_JJ_NNS_,_JJ]",VERB_DEP_PATH_[characterize]_[nsubjpass@]_[conj_and-agent|defect@],"WORD_SEQ_[be characterize by cognitive defect , psychiatric]"}	{0.91063,0.855198,0.653011,0.156228,0.156228,0.156228,0.156228,0.156228}
SCPDFS_18843.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_18843.pdf_15_15_10_10_26_27_UNSUP	MECP2/HP:0001252|Muscular hypotonia	{10}	{26,27}	{Xq28,duplications,encompassing,the,methyl,CpG,binding,protein,2,(,MECP2,),in,males,exhibit,a,distinct,phenotype,",",including,developmental,delay,",",facial,dysmorphism,",",muscular,hypotonia,",",intellectual,disability,",",poor,or,absent,speech,",",recurrent,infections,and,early,death,.}	{"ARTICLE INFO ABSTRACT","Article history : Accepted 1 October 2013 Available online 12 October 2013"}	{"The vast majority of affected males inherit the MECP2 duplication from their usually asymptomatic carrier mothers .","Only a few cases with Xq28 duplication ieggords : originating from de novo unbalanced X/Y translocation have been reported and the paternal origin of the MCIIECPZ duplication aberration has only been validated in three males in the related literature ."}	0.92	0.028	1	{WORD_SEQ_[TOO_FAR_AWAY],DEP_PATH_POS_[nn-nsubj|NN@prep_including-dobj|NN],DEP_PATH_[nn-nsubj|)@prep_including-dobj|phenotype],VERB_DEP_PATH_POS_[encompass]_[nn-nsubj|NN-rcmod|VBP-dobj|NN@]_[prep_including-dobj|NN-rcmod|VBP-dobj|NN@],VERB_DEP_PATH_[encompass]_[nn-nsubj|)-rcmod|exhibit-dobj|protein@]_[prep_including-dobj|phenotype-rcmod|exhibit-dobj|protein@],VERB_DEP_PATH_[exhibit]_[nn-nsubj|)@]_[prep_including-dobj|phenotype@],VERB_DEP_PATH_POS_[exhibit]_[nn-nsubj|NN@]_[prep_including-dobj|NN@]}	{-3.11955,1.98954,0.688457,0.688457,0.688457,0.688457,0.688457}
gb-2008-9-9-232.pdf	RELATION_GENEHPOTERM_SUP_MAP_gb-2008-9-9-232.pdf_110_110_36_36_56_56_UNSUP	ATM/HP:0001009|Telangiectasia	{36}	{56}	{Loss,of,function,of,TRF2,in,a,number,of,mammalian,cell,types,(,tumor,and,primary,cell,lines,),",",and,in,cells,from,conditional,TRF2-knockout,mice,",",elicits,DNA,damage,responses,mediated,mainly,through,the,ATM,pathway,",",whereas,POT1,knockout,triggers,the,DNA,damage,response,pathway,initiated,by,the,protein,kinase,ATR,(,ataxia,telangiectasia,related,),[,84,],.}	{"Xin et al. 232.3","Although both TRF2 and POT1 bind telomere DNA and are required for telomere capping , recent studies indicate that they regulate distinct signaling pathways [ 84,85 ] ."}	{"These results are consistent with the telomere interactome map ( Figure 1 ) , where TRF2 interacts with the MRN complex and DNA-PK , proteins that mediate repair of double-strand breaks , with which ATM is preferentially associated [ 53,54,56,86 ] .","In addition , the repression of ATR activity by POT1 is probably a result of POT1 binding telomere ssDNA and inhibiting ATR activation by blocking access of the single-strand binding protein RPA , by which ATR is recruited , to the telomere [ 84,87 ] ."}	0.906	0.584	0.846	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_POS_[trigger]_[nn-prep_through|NN@advcl]_[agent-partmod|VBN-dobj|NN@],VERB_DEP_PATH_[mediate]_[nn-prep_through|pathway@]_[agent-partmod|initiate-dobj|pathway-advcl|trigger@],VERB_DEP_PATH_[trigger]_[nn-prep_through|pathway@advcl]_[agent-partmod|initiate-dobj|pathway@],VERB_DEP_PATH_POS_[mediate]_[nn-prep_through|NN@]_[agent-partmod|VBN-dobj|NN-advcl|VBZ@],DEP_PATH_[nn-prep_through|pathway@agent-partmod|initiate-dobj|pathway-advcl|trigger],DEP_PATH_POS_[nn-prep_through|NN@agent-partmod|VBN-dobj|NN-advcl|VBZ]}	{-3.11955,0.843626,0.843626,0.843626,0.843626,0.843626,0.843626}
journal.pone.0006936.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0006936.pdf_648_648_22_22_25_25_UNSUP	ESCO2/HP:0009829|Phocomelia	{22}	{25}	{Schule,B,",",Oviedo,A,",",],ohnston,K,",",Pai,S,",",F,rancke,U,(,2005,),Inactivating,mutations,in,ESCO2,cause,SC,phocomelia,and,Roberts,syndrome,:,no,phenotypegenotype,correlation,.}	{"Hou F , Zou H ( 2005 ) Two human orthologues of Eco1 / Ct17 acetyltransferases are both required for proper sister-chromatid cohesion .","N101 Biol Cell 16 : 3908 — 3918 ."}	{"Am ] Hum Genet 77 : 1117 — 1128 .","Sonoda E , Sasaki l \\\\ ’ IS , lVIorrison C , Yamaguchi ~ Iwai Y , Takata l \\\\ ’ I , et al. ( 1999 ) Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells ."}	0.984	0.072	0.916	{"WORD_SEQ_[cause sc]",POS_SEQ_[NN_NN],VERB_DEP_PATH_[inactivate]_[nn-prep_in|phocomelium-dobj|mutation@]_[prep_in-dobj|mutation@],VERB_DEP_PATH_POS_[inactivate]_[nn-prep_in|NN-dobj|NNS@]_[prep_in-dobj|NNS@],DEP_PATH_[nn@],DEP_PATH_POS_[nn@]}	{3.42534,-2.39538,1.77119,1.77119,-0.105105,-0.0901411}
journal.pctr.0020006.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pctr.0020006.pdf_485_485_9_9_1_2_UNSUP	AST/HP:0001392|Abnormality of the liver	{9}	{1,2}	{The,abnormal,liver,function,test,results,(,ALT,",",AST,",",and,alkaline,phosphatase,),in,one,volunteer,at,the,300,mg,dose,may,be,related,to,AQ-13,.}	{"Although AEs involving these and other organs have been reported with AQS previously [ 31 — 34 ] , they have typically been reported in persons treated for prolonged periods of time ( 5-10 y or more ) at doses of 200-400 mg base or higher per day [ 34,38 ] .","The absence of clinically detectable AEs and the normal laboratory tests in 119 volunteers at the 2 and 4 wk follow-up are consistent with previous reports on the safety of short-term CQ treatment [ 3,4,30 — 33 ] ."}	{"However , all the tests were normal one week later and no similar hepatic AEs were observed in any volunteer with","Randomized Controlled Trial of AQ-13"}	0.95	0.054	0.116	{"INV_WORD_SEQ_[function test result ( ALT ,]",INV_DEP_PATH_[appos-tmod|ALT@amod-nsubj|test],INV_VERB_DEP_PATH_[relate]_[appos-tmod|ALT@conj_and]_[amod-nsubj|test@conj_and],"INV_POS_SEQ_[NN_NN_VBZ_CD_NNP_,]",INV_VERB_DEP_PATH_[be]_[appos-tmod|ALT@auxpass-conj_and|relate]_[amod-nsubj|test@auxpass-conj_and|relate],INV_VERB_DEP_PATH_POS_[result]_[appos-tmod|NNP@]_[amod-nsubj|NN@],"INV_WORD_SEQ_NER_[function test result NUMBER ALT ,]",INV_VERB_DEP_PATH_POS_[be]_[appos-tmod|NNP@auxpass-conj_and|VBN]_[amod-nsubj|NN@auxpass-conj_and|VBN],INV_DEP_PATH_POS_[appos-tmod|NNP@amod-nsubj|NN],INV_VERB_DEP_PATH_POS_[relate]_[appos-tmod|NNP@conj_and]_[amod-nsubj|NN@conj_and],INV_VERB_DEP_PATH_[result]_[appos-tmod|ALT@]_[amod-nsubj|test@]}	{0.269846,0.269846,0.269846,0.269846,0.269846,0.269846,0.269846,0.269846,0.269846,0.269846,0.269846}
journal.pone.0001051.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0001051.pdf_24_24_3_3_12_12_UNSUP	ANK2/HP:0011675|Arrhythmia	{3}	{12}	{Loss-of-function,variants,in,ANK2,(,encodes,ankyrin-B,),cause,a,dominantly-inherited,cardiac,arrhythmia,with,increased,risk,for,sudden,cardiac,death,",",initially,termed,type,4,long,QT,syndrome,",",and,more,recently,renamed,sick,sinus,syndrome,with,bradycardia,or,the,“,ankyrin-B,syndrome,”,(,[,l3,—,l5,],;,OMIM,),.}	{"Loss of ankyrin-G function thus would likely have major consequences beginning in early development .","In contrast to ankyrin-G , ankyrin-B has more specialized roles , and is required for postnatal life in mice but not for prenatal survival [ 12 ] ."}	{"Mice heterozygous for a null mutation in ankyrin-B have a similar arrhythmia to humans and exhibit sudden death following administration of catecholamines and / or exercise [ 14 ] .","Studies with ankyrinB ” cardiomyocytes revealed that the basis for sudden death associated with the arrhythmia is elevation of calcium transients in the context of sympathetic stimulation [ 14 ] ."}	0.944	0.174	0.998	{DEP_PATH_POS_[nn-prep_in|NN-nsubj|NNS@dobj-ccomp|VB],VERB_DEP_PATH_POS_[cause]_[nn-prep_in|NN-nsubj|NNS@ccomp]_[dobj@],"WORD_SEQ_[( encode ankyrin-b ) cause a dominantly-inherited cardiac]",POS_SEQ_[NN_VBZ_JJ_NN_VB_DT_JJ_JJ],VERB_DEP_PATH_[cause]_[nn-prep_in|(-nsubj|variant@ccomp]_[dobj@],DEP_PATH_[nn-prep_in|(-nsubj|variant@dobj-ccomp|cause],VERB_DEP_PATH_POS_[encode]_[nn-prep_in|NN-nsubj|NNS@]_[dobj-ccomp|VB@],VERB_DEP_PATH_[encode]_[nn-prep_in|(-nsubj|variant@]_[dobj-ccomp|cause@]}	{0.543831,0.307093,0.307093,0.307093,0.307093,0.307093,0.307093,0.307093}
journal.pgen.1001045.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1001045.pdf_309_309_3_3_13_14_UNSUP	CNNM4/HP:0000548|Cone-rod dystrophy	{3}	{13,14}	{Rare,mutations,in,CNNM4,have,recently,been,reported,as,a,cause,of,autosomal-recessive,cone-rod,dystrophy,with,amelogenesis,imperfecta,[,"37,38",],.}	{"The CNNM2-encoded magnesium transporter , ACDP2 , belongs to the ancient conserved domain proteins ( ACDP ) family [ 35 ] .","It is widely expressed in human tissues with strongest levels in brain , kidney and placenta [ 35 ] , and experimental studies provide evidence for its involvement in magnesium transport [ 29,36 ] ."}	{"A magnesium transport function of the encoded ACDP4 has not yet been shown .","Little is known about ACDP3 encoded by CWNM3 ; due to the close physical proximity of CNNM3 and CZNJVA/I4 , common variants associated with magnesium concentrations in our study may not represent independent signals ."}	0.958	0.8	1	{DEP_PATH_POS_[prep_in-nsubjpass|NNS@prep_of-prep_as|NN],VERB_DEP_PATH_[be]_[prep_in-nsubjpass|mutation@auxpass]_[prep_of-prep_as|cause@auxpass],VERB_DEP_PATH_[have]_[prep_in-nsubjpass|mutation@aux]_[prep_of-prep_as|cause@aux],VERB_DEP_PATH_[report]_[prep_in-nsubjpass|mutation@]_[prep_of-prep_as|cause@],VERB_DEP_PATH_POS_[have]_[prep_in-nsubjpass|NNS@aux]_[prep_of-prep_as|NN@aux],DEP_PATH_[prep_in-nsubjpass|mutation@prep_of-prep_as|cause],VERB_DEP_PATH_POS_[be]_[prep_in-nsubjpass|NNS@auxpass]_[prep_of-prep_as|NN@auxpass],VERB_DEP_PATH_POS_[report]_[prep_in-nsubjpass|NNS@]_[prep_of-prep_as|NN@],"WORD_SEQ_NER_[have DATE be report as a cause of autosomal-recessive]","WORD_SEQ_[have recently be report as a cause of autosomal-recessive]",POS_SEQ_[VBP_RB_VBN_VBN_IN_DT_NN_IN_JJ]}	{0.382828,0.382828,0.382828,0.382828,0.382828,0.382828,0.382828,0.382828,0.206765,0.206765,-0.16835}
SCPDFS_2110.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_2110.pdf_771_771_5_5_10_12_UNSUP	GATA4/HP:0001636|Tetralogy of Fallot	{5}	{10,12}	{A,novel,mutation,in,the,GATA4,gene,in,patients,with,tetralogy,of,Fallot,.}	{"Academic Press .","Nemer , G. , Fadlalah , F. , Usta , J. , Nemer , M. , Dbaibo , G. , Obeid , M. , Bitar , F. , 2006 ."}	{"Hum .","Mutat ."}	0.982	0.782	0.994	{"WORD_SEQ_[gene in patient with]",POS_SEQ_[NN_IN_NNS_IN],DEP_PATH_POS_[nn-prep_in|NN@prep_of],DEP_PATH_[nn-prep_in|gene@prep_of]}	{2.85222,-1.30547,1.26423,1.10574}
journal.pone.0013451.pdf	RELATION_GENEHPOTERM_journal.pone.0013451.pdf_80_80_89_89_101_101	MBD4/HP:0001909|Leukemia	{89}	{101}	{Genes,related,to,apoptosis,:,p,=,0.02,BIN1,bridging,integrator,1,CDK2AP1,CDK2,—,associated,protein,1,CDKN1A,cyclin,—,dependent,kinase,inhibitor,1A,(,p21,",",Cip1,),CFLAR,CASP8,and,FADD,—,|,ike,apoptosis,regulator,CROP,cisplatin,resistance,»,associated,overexpressed,protein,DAPK1,death,—,associated,protein,kinase,1,DUSP5,",6",dual,specificity,phosphatase,"5,6",GLRX,glutaredoxin,(,thioltransferase,),HTRA2,HtrA,serine,peptidase,2,|,ER2,immediate,early,response,2,IER3,immediate,early,response,3,IGFBP3,insulin,—,like,growth,factor,binding,protein,3,MBD4,methy,|,»,CpG,binding,domain,protein,4,MCL1,myeloid,cell,leukemia,sequence,1,(,BCL2,—,re,|,ated,),NDRG1,N,—,myc,downstream,regulated,gene,1,SFN,stratifin,THBD,thrombomodulin}	{"Table 1 .","Genes differentially expressed in cells exposed to albumin ."}	{"Cell growth and proliferation : p = 0.03 ADFP adipose differentiation — re | ated protein CCL20 chemokine ( C » C motif ) ligand 20 DNAJC9 DnaJ ( Hsp40 ) homolog , subfamily C , member 9","HSPB8 heat shock 22kDa protein 8 | RF8 interferon regulatory factor 8 SEMA4D sema domain , immunoglobulin domain ( lg ) , transmembrane domain ( TM ) and short cytoplasmic domain , ( semaphorin ) 4D"}	0.916	0.918	1	{VERB_DEP_PATH_[ate]_[dep@dep]_[dep@dep],VERB_DEP_PATH_POS_[ate]_[dep@dep]_[dep@dep],VERB_DEP_PATH_[relate]_[dep@dep]_[dep@dep],VERB_DEP_PATH_POS_[relate]_[dep@dep]_[dep@dep],DEP_PATH_POS_[dep@dep],DEP_PATH_[dep@dep],VERB_DEP_PATH_POS_[regulate]_[dep@dep]_[dep@dep],VERB_DEP_PATH_[regulate]_[dep@dep]_[dep@dep],VERB_DEP_PATH_[associate]_[dep@dep]_[dep@dep],VERB_DEP_PATH_POS_[associate]_[dep@dep]_[dep@dep],VERB_DEP_PATH_POS_[bridge]_[dep@dep]_[dep@dep],VERB_DEP_PATH_[bridge]_[dep@dep]_[dep@dep],POS_SEQ_[NN_CD_CD_NN_NN_NN_NN_CD_NN_JJ_NN],"WORD_SEQ_NER_[methy NUMBER NUMBER cpg binding domain protein NUMBER mcl1 myeloid cell]","WORD_SEQ_[methy | » cpg binding domain protein 4 mcl1 myeloid cell]"}	{0.944105,0.944105,0.81234,0.81234,-0.594234,-0.581269,0.175204,0.175204,-0.134258,-0.134258,-0.00976075,-0.00976075,0,0,0}
journal.pone.0033548.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0033548.pdf_398_398_1_1_17_19_UNSUP	POMC/HP:0004324|Increased body weight	{1}	{17,18,19}	{As,POMC,is,an,important,anorexigenic,peptide,",",its,prolonged,inhibition,during,olanzapine,treatment,may,lead,to,increased,body,weight,and,adiposity,side,—,effects,.}	{"p | osone.org 8","may contribute to the suppression of POMC ( 7 ) ."}	{"doi :10.1371 / journa | .","pone ."}	0.904	0.82	0.996	{WORD_SEQ_[TOO_FAR_AWAY],DEP_PATH_[nsubj-advcl|peptide@prep_to],VERB_DEP_PATH_[be]_[nsubj@cop]_[prep_to@cop-advcl|peptide],VERB_DEP_PATH_[increase]_[nsubj-advcl|peptide@amod-prep_to|weight]_[@],VERB_DEP_PATH_POS_[lead]_[nsubj-advcl|NN@]_[prep_to@],VERB_DEP_PATH_POS_[increase]_[nsubj-advcl|NN@amod-prep_to|NN]_[@],VERB_DEP_PATH_[lead]_[nsubj-advcl|peptide@]_[prep_to@],DEP_PATH_POS_[nsubj-advcl|NN@prep_to],VERB_DEP_PATH_POS_[be]_[nsubj@cop]_[prep_to@cop-advcl|NN]}	{-3.11955,0.74558,0.74558,0.74558,0.74558,0.74558,0.74558,0.3509,0.3509}
journal.pone.0059791.pdf	RELATION_GENEHPOTERM_journal.pone.0059791.pdf_259_259_24_24_36_36	AK2/HP:0002664|Neoplasm	{24}	{36}	{Anand,S,",",Stedham,F,",",Beer,P,",",Gudgin,E,",",Ortmann,CA,",",et,al.,(,2011,),Effects,of,the,],AK2,mutation,on,the,hematopoietic,stem,and,progenitor,compartment,in,human,myeloproliferative,neoplasms,.}	{"Am ] Hematol 86:974 — 979 .","23 ."}	{"Blood 118:177 — 181 .","24 ."}	0.904	0.716	1	{DEP_PATH_[nn-prep_of|mutation-dobj|effect@prep_in-prep_on|stem],POS_SEQ_[NN_IN_DT_JJ_NN_CC_NN_NN_IN_JJ_JJ],DEP_PATH_POS_[nn-prep_of|NN-dobj|NNS@prep_in-prep_on|NN],"WORD_SEQ_[mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative]"}	{0.558934,0.558934,0.558934,0.558934}
SCPDFS_39218.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_39218.pdf_440_440_0_0_11_11_UNSUP	PAX6/HP:0000526|Aniridia	{0}	{11}	{PAX6,gene,dosage,effect,in,a,family,with,congenital,cataracts,",",aniridia,",",anophthalmia,and,central,nervous,system,defects,.}	{"18 : 262-265 .","Glaser , T. , Jepeal , L. , Edwards , J. G. , Young , S. R. , Favor , J. , and Maas , R. L. ( 1994 ) ."}	{"Nat .","Genet ."}	0.99	0.884	1	{"WORD_SEQ_[gene dosage effect in a family with congenital cataract ,]","POS_SEQ_[NN_NN_NN_IN_DT_NN_IN_JJ_NNS_,]",DEP_PATH_POS_[nn@nn-nn|NN-appos|NNS-prep_with|NNS],DEP_PATH_[nn@nn-nn|anophthalmium-appos|defect-prep_with|cataract]}	{2.16722,1.95334,0.0776574,0.0776574}
journal.pbio.1001679.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pbio.1001679.pdf_515_515_11_11_25_25_UNSUP	MEF2C/HP:0000717|Autism	{11}	{25}	{It,will,be,interesting,to,determine,whether,translational,regulation,of,human,MEF2C,is,also,important,in,the,nervous,system,",",where,MEFQC,is,associated,with,autism,and,synaptic,regulation,[,97,],.}	{"The TORC1-4EBP-Mef2 pathway might be involved in other musclewasting conditions that affect TOR activity , such as fasting , ageing , and cachexia .","By showing that Mef ‘ 2c regulates muscle ﬁber growth regardless of any earlier role in myoblast terminal differentiation , our data support the View of Mef2 as a muscle homeostatic regulator [ 95,96 ] ."}	{"In the heart , Mef2c is required for cardiomyocyte differentiation and expression persists in differentiated cardiomyocytes [ 44,98 ] .","Our ﬁnding of activity-dependent accumulation of Mef2 in skeletal muscle suggests a mechanism that could regulate heart muscle cell size and / or function ."}	0.934	0.45	0.984	{DEP_PATH_[prep_of-nsubj|regulation@nn-prep_with|[-rcmod|associate-prep_in|system],VERB_DEP_PATH_[associate]_[prep_of-nsubj|regulation@rcmod-prep_in|system]_[nn-prep_with|[@],VERB_DEP_PATH_POS_[associate]_[prep_of-nsubj|NN@rcmod-prep_in|NN]_[nn-prep_with|NN@],"WORD_SEQ_[be also important in the nervous system , where mefqc be associate with]",DEP_PATH_POS_[prep_of-nsubj|NN@nn-prep_with|NN-rcmod|VBN-prep_in|NN],"POS_SEQ_[VBZ_RB_JJ_IN_DT_JJ_NN_,_WRB_NN_VBZ_VBN_IN]"}	{0.415054,0.415054,0.415054,0.415054,0.415054,0.415054}
journal.pone.0072934.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0072934.pdf_285_285_9_9_17_17_UNSUP	FGF23/HP:0002905|Hyperphosphatemia	{9}	{17}	{Although,numerous,studies,in,man,and,rodents,support,that,FGF23,is,stimulated,by,dietary,phosphate,intake,and,hyperphosphatemia,[,"56,5","7,58",],",",we,observed,higher,levels,of,circulating,FGF23,during,hibernation,",",despite,the,presence,of,hypophosphatemia,.}	{"Low winter phosphate levels may also reﬂect bonepreserving mechanisms ; i.e. no excess phosphate is released from bone .","As renal and intestinal phosphate transport is modulated by amino acids and glucose it is possible that also other metabolic changes will off-set downstream alterations in phosphate metabolism ."}	{"Similarly , there is a gradual increase in FGF23 that parallels the decline in kidney function in patients with CKD [ 56,59 ] .","Thus , these data are consistent with the hypothesis that GFR per se is a strong regulator of FGF23 , independent of serum inorganic phosphorous level or dietary phosphate intake ."}	0.928	0.074	0.988	{POS_SEQ_[VBZ_VBN_IN_JJ_NN_NN_CC],VERB_DEP_PATH_POS_[stimulate]_[nsubjpass@]_[conj_and-agent|NN@],"WORD_SEQ_[be stimulate by dietary phosphate intake and]",VERB_DEP_PATH_[support]_[nsubjpass-ccomp|stimulate@]_[conj_and-agent|intake-ccomp|stimulate@],VERB_DEP_PATH_[be]_[nsubjpass@auxpass]_[conj_and-agent|intake@auxpass],VERB_DEP_PATH_[observe]_[nsubjpass-ccomp|stimulate-advcl|support@]_[conj_and-agent|intake-ccomp|stimulate-advcl|support@],VERB_DEP_PATH_POS_[support]_[nsubjpass-ccomp|VBN@]_[conj_and-agent|NN-ccomp|VBN@],VERB_DEP_PATH_[stimulate]_[nsubjpass@]_[conj_and-agent|intake@],DEP_PATH_[nsubjpass@conj_and-agent|intake],VERB_DEP_PATH_POS_[observe]_[nsubjpass-ccomp|VBN-advcl|VBP@]_[conj_and-agent|NN-ccomp|VBN-advcl|VBP@],VERB_DEP_PATH_POS_[be]_[nsubjpass@auxpass]_[conj_and-agent|NN@auxpass],DEP_PATH_POS_[nsubjpass@conj_and-agent|NN]}	{0.505657,0.26735,0.26735,0.26735,0.26735,0.26735,0.26735,0.26735,0.26735,0.26735,-0.157741,-0.157741}
journal.pone.0029767.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0029767.pdf_36_36_2_2_11_12_UNSUP	GPR56/HP:0007095|Frontoparietal polymicrogyria	{2}	{11,12}	{Mutations,in,GPR56,cause,a,speciﬁc,human,brain,malformation,called,bilateral,frontoparietal,polymicrogyria,(,BFPP,),[,3,—,6,],.}	{"WWS is the most severe form of congenital muscular dystrophy , with the vast majority of patients dying in utero or in early infancy .","The genetic cause for MEB , FCMD , and some WWS cases is aberrant glycosylation of OI-dystroglycan , a receptor for laminin GPR56 is a member of the adhesion G protein-coupled receptor ( GPCR ) family ."}	{"The magnetic resonance images of BFPP brains revealed a thickened cerebral cortex with coarse gyri , shallow sulci , and a “ scalloped ” appearance at the grey-white matter junction — much like the radiological features of other polymicrogyria malformations .","Histological analysis of Gpr56 knockout mouse brains and postmortem human BFPP brains revealed the histopathology of BFPP to be cobblestone lissencephaly [ 7,8 ] ."}	0.92	0.934	0.994	{VERB_DEP_PATH_[call]_[prep_in-nsubj|mutation@partmod-dobj|malformation]_[amod-xcomp|]@],POS_SEQ_[VBP_DT_NN_JJ_NN_NN_VBN_JJ],DEP_PATH_POS_[prep_in-nsubj|NNS@amod-xcomp|NN-partmod|VBN-dobj|NN],VERB_DEP_PATH_[cause]_[prep_in-nsubj|mutation@]_[amod-xcomp|]-partmod|call-dobj|malformation@],DEP_PATH_[prep_in-nsubj|mutation@amod-xcomp|]-partmod|call-dobj|malformation],VERB_DEP_PATH_POS_[call]_[prep_in-nsubj|NNS@partmod-dobj|NN]_[amod-xcomp|NN@],VERB_DEP_PATH_POS_[cause]_[prep_in-nsubj|NNS@]_[amod-xcomp|NN-partmod|VBN-dobj|NN@],"WORD_SEQ_[cause a speciﬁc human brain malformation call bilateral]"}	{0.377099,0.377099,0.377099,0.377099,0.377099,0.377099,0.377099,0.0468319}
journal.pone.0001609.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0001609.pdf_708_708_23_23_33_34_UNSUP	GNE/HP:0003805|Rimmed vacuoles	{23}	{33,34}	{Nlalicdan,RIC,",",Noguchi,S,",",Nonaka,I,",",Hayashi,YK,",",Nishino,I,(,2007,),A,Gne,knockout,mouse,expressing,human,GNE,D176V,mutation,develops,features,similar,to,distal,myopathy,with,rimmed,vacuoles,or,hereditary,inclusion,body,myopathy,.}	{"Younger ] l \\\\ ’ I , Chen L , Ren HY , Rosser l\\\\/IF , Turnbull EL , et al. ( 2006 ) Sequential quality-control checkpoints triage misfolded cystic ﬁbrosis transmembrane conductance regulator .","Cell 126 : 5714582 ."}	{"Hum l \\\\ ’ Iol Genet 16 : 266942682 .","VViekowski l \\\\ ’ IT , Chen SC , Zalamea P , VVilburn BP , Kinsley D ] , et al. ( 2001 ) Disruption of neutrophil migration in a conditional transgenic model : evidence for CXCR2 desensitization in vivo . ]"}	0.96	0.974	1	{POS_SEQ_[NN_NN_VBZ_NNS_JJ_TO_JJ_NN_IN],DEP_PATH_[TOO_FAR_AWAY],"WORD_SEQ_[d176v mutation develop feature similar to distal myopathy with]"}	{1.68673,0.889952,0.8505}
journal.pone.0057856.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0057856.pdf_6_6_26_26_11_12_UNSUP	JAK2/HP:0005547|Myeloproliferative disorder	{26}	{11,12}	{Background,:,Non,—,reactive,platelet,counts,elevation,occurs,mainly,in,myeloproliferative,disorders,(,MPDs,),",",which,have,been,reported,to,be,closely,associated,with,JAK2,V617F,mutation,.}	{"Juan Zhou , Yuanxin Ye , Shugen Zeng , Yi Zhou , Zhigang Mao , Xingbo Song , Binwu Ying * , Xiaojun Lu * , Hong Jiang * , Lanlan Wang * Department of Laboratory Medicine , West China Hospital , Sichuan University , Chengdu , Sichuan Province , China",Abstract}	{"Complete blood cell count ( CBC ) is essential in diagnosis of MPDs , however , the impact of JAK2 V617F mutation on the patients ’ hemogram variation remains not clear .","Methods : JAK2 V617F mutation was detected by allele speciﬁc real — time quantitative fluorescence PCR ( AS — qPCR ) ."}	0.926	1	1	{INV_VERB_DEP_PATH_[report]_[nn-prep_with|mutation-xcomp|associate@]_[prep_in-dep|occur@rcmod-nsubj|NUMBER],INV_DEP_PATH_POS_[nn-prep_with|NN-xcomp|VBN-rcmod|VBN-nsubj|CD@prep_in-dep|VBZ],"INV_POS_SEQ_[VBP_NNS_CD_,_WDT_VBP_VBN_VBN_TO_VB_RB_VBN_IN]",INV_VERB_DEP_PATH_POS_[report]_[nn-prep_with|NN-xcomp|VBN@]_[prep_in-dep|VBZ@rcmod-nsubj|CD],"INV_WORD_SEQ_[( mpd ) , which have be report to be closely associate with]","INV_WORD_SEQ_NER_[( mpd NUMBER , which have be report to be closely associate with]",INV_DEP_PATH_[nn-prep_with|mutation-xcomp|associate-rcmod|report-nsubj|NUMBER@prep_in-dep|occur]}	{0.376264,0.376264,0.376264,0.376264,0.376264,0.376264,0.376264}
SCPDFS_46000.pdf	RELATION_GENEHPOTERM_SCPDFS_46000.pdf_40_40_17_17_41_43	COL9A1/HP:0005562|Multiple renal cysts	{17}	{41,42,43}	{Stickler,syndrome,:,a,group,of,disorders,caused,by,mutations,in,COL2A1,",",COL11A1,",",COL11A2,or,COL9A1,and,characterized,by,craniofacial,defects,including,flat,mala,",",hearing,loss,",",myopia,or,other,eye,problems,polydipsia,",",proteinuria,and,characterized,by,multiple,renal,cysts,and,fibrosis,.}	{"The disease is characterized by skeletal and craniofacial defects and hearing loss .","Polycystic kidney disease ( PKD ) : a disorder that can be autosomal recessive or autosomal dominant ( the majority of cases ) and characterized by the presence and growth of multiple cysts in the kidneys ."}	{"168 0168-9525 / 55 — see front matter © 2010 Elsevier Ltd. .","All rights reserved ."}	0.918	0.702	1	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_[characterize]_[conj_or-prep_in|col2a1-prep_by|mutation@conj_and]_[prep_by-conj_and|characterize@conj_and],VERB_DEP_PATH_POS_[characterize]_[conj_or-prep_in|NN-prep_by|NNS@conj_and]_[prep_by@],DEP_PATH_POS_[conj_or-prep_in|NN-prep_by|NNS@prep_by-conj_and|VBN],VERB_DEP_PATH_[cause]_[conj_or-prep_in|col2a1-prep_by|mutation@]_[prep_by-conj_and|characterize@],VERB_DEP_PATH_[characterize]_[conj_or-prep_in|col2a1-prep_by|mutation@conj_and]_[prep_by@],VERB_DEP_PATH_POS_[characterize]_[conj_or-prep_in|NN-prep_by|NNS@conj_and]_[prep_by-conj_and|VBN@conj_and],DEP_PATH_[conj_or-prep_in|col2a1-prep_by|mutation@prep_by-conj_and|characterize],VERB_DEP_PATH_POS_[cause]_[conj_or-prep_in|NN-prep_by|NNS@]_[prep_by-conj_and|VBN@]}	{-3.11955,0.68304,0.68304,0.68304,0.68304,0.68304,0.68304,0.68304,0.68304}
SCPDFS_3707.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_3707.pdf_771_771_9_9_17_18_UNSUP	IRF6/HP:0000202|Oral cleft	{9}	{17,18}	{Genomic,",",cDNA,and,embryonic,expression,analysis,of,zebraﬁsh,IRF6,",",the,gene,mutated,in,the,human,oral,clefting,disorders,Van,der,Woude,and,popliteal,pterygium,syndromes,.}	{"Ben .","J. , Jabs , E.W. , Chong , S.S. , 2005 ."}	{"Gene Expr .","Patterns 5 , 629-638 ."}	0.902	0.914	1	{"WORD_SEQ_[, the gene mutate in the human]","POS_SEQ_[,_DT_NN_VBN_IN_DT_JJ]",VERB_DEP_PATH_[mutate]_[prep_of-nsubj|analysis@]_[amod-prep_in|disorder@],VERB_DEP_PATH_POS_[mutate]_[prep_of-nsubj|NN@]_[amod-prep_in|NNS@],DEP_PATH_[prep_of-nsubj|analysis@amod-prep_in|disorder],DEP_PATH_POS_[prep_of-nsubj|NN@amod-prep_in|NNS]}	{0.660754,0.660754,0.311946,0.311946,0.311946,-0.07703}
journal.pone.0097174.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0097174.pdf_42_42_38_38_33_33_UNSUP	ATR/HP:0001009|Telangiectasia	{38}	{33}	{NBSl,(,MRN,),complex,",",which,is,followed,by,the,activation,of,the,phosphatidylinositol,3-kinase-like,protein,kinase,(,PIKKS,),family,members,:,ataxia,telangiectasia,mutated,protein,(,ATM,),",",ataxia,telangiectasia,and,Rad3-related,protein,(,ATR,),and,DNA,dependent,protein,kinase,(,DNA-PK,),[,2,—,4,],.}	{"RAD50 .","— ."}	{"These kinases phosphorylate and activate a variety of substrates to execute various cellular functions such as DNA repair , cell cycle arrest and cell death .","One substrate is the histone variant H2AX , which can be phosphorylated at Ser-139 ( termed YHQAX ) and is directly involved in DNA repair [ 5,6 ] ."}	0.904	0.136	0.968	{"INV_WORD_SEQ_[and rad3-related protein (]",INV_DEP_PATH_POS_[nn-dep|NN-dep|NN@dep],INV_VERB_DEP_PATH_[mutate]_[nn-dep|)-dep|[-dobj|protein@]_[dep-dobj|protein@],INV_VERB_DEP_PATH_POS_[mutate]_[nn-dep|NN-dep|NN-dobj|NN@]_[dep-dobj|NN@],INV_DEP_PATH_[nn-dep|)-dep|[@dep],INV_POS_SEQ_[CC_JJ_NN_NN]}	{1.38411,-0.942568,0.568639,0.568639,0.568639,-0.216701}
journal.pone.0062807.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0062807.pdf_473_473_25_25_32_32	frataxin/HP:0001251|Ataxia	{25}	{32}	{Greene,E,",",Mahishi,L,",",Entezam,A,",",Kumari,D,",",Usdin,K,(,2007,),Repeat-induced,epigenetic,changes,in,intron,1,of,the,frataxin,gene,and,its,consequences,in,Friedreich,ataxia,.}	{"PLoS ONE 4 : e7914 .","35 ."}	{"Nucleic Acids Res 35 : 338343390 .","36 ."}	0.988	0.644	1	{DEP_PATH_[nn-prep_of|gene-prep_in|intron@prep_in],"WORD_SEQ_[gene and its consequence in Friedreich]",POS_SEQ_[NN_CC_PRP$_NNS_IN_NNP],DEP_PATH_POS_[nn-prep_of|NN-prep_in|NN@prep_in]}	{1.06396,1.06396,1.06396,0.87512}
SCPDFS_43304.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_43304.pdf_13_13_1_1_22_22_UNSUP	PAX6/HP:0000526|Aniridia	{1}	{22}	{The,PAX6,gene,is,expressed,at,high,levels,in,the,developing,eye,and,cerebellum,and,is,mutated,in,patients,with,autosomal,dominant,aniridia,.}	{"The Queen 's University of Belfast , Belfast , Northern lreland BT9 7 AB","Received June 16 , 1993 ; revised October 12 , 1993"}	{"We have tested the role of PAX 6 mutations in three families with Gillespie syndrome , a rare autosomal recessive condition consisting of partial aniridia , cerebellar ataxia , and mental retardation .","Single-strand conformational polymorphism analysis of affected individuals revealed no alteration of PAX6 sequences ."}	0.922	0.53	1	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_POS_[express]_[nn-nsubjpass|NN@]_[prep_with-prep_in|NNS-conj_and|VBN@],VERB_DEP_PATH_[mutate]_[nn-nsubjpass|gene@conj_and]_[prep_with-prep_in|patient@],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass-conj_and|VBN]_[prep_with-prep_in|NNS@auxpass],VERB_DEP_PATH_[be]_[nn-nsubjpass|gene@auxpass-conj_and|mutate]_[prep_with-prep_in|patient@auxpass],VERB_DEP_PATH_[express]_[nn-nsubjpass|gene@]_[prep_with-prep_in|patient-conj_and|mutate@],DEP_PATH_POS_[nn-nsubjpass|NN@prep_with-prep_in|NNS-conj_and|VBN],VERB_DEP_PATH_[be]_[nn-nsubjpass|gene@auxpass]_[prep_with-prep_in|patient-conj_and|mutate@auxpass],DEP_PATH_[nn-nsubjpass|gene@prep_with-prep_in|patient-conj_and|mutate],VERB_DEP_PATH_POS_[mutate]_[nn-nsubjpass|NN@conj_and]_[prep_with-prep_in|NNS@],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[prep_with-prep_in|NNS-conj_and|VBN@auxpass]}	{-3.11955,0.580562,0.580562,0.580562,0.580562,0.580562,0.580562,0.580562,0.580562,0.580562,0.580562}
journal.pone.0026183.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0026183.pdf_228_228_28_28_24_24_UNSUP	DYT5/HP:0001332|Dystonia	{28}	{24}	{The,human,orthologs,of,these,two,genes,underlie,DYT5,and,DYTI4,(,Dopa-responsive,),dystonia,[,1,],which,is,phenotypically,similar,to,DYTI,dystonia,",",except,that,DYT5,and,DYTI4,patients,respond,very,well,to,the,administration,of,L-dopa,[,"36,37",],whereas,DYTl,patients,do,not,.}	{"Pu and pie loss-of-function mutants show similar phenotypes to each other [ 34 ] , as Pu mutants exhibit reductions in dopamine pools due to limiting BH4 levels [ 35 ] .","Homozygous Pu lossoffunction mutants die during late embryogenesis with completely unpigmented and weak cuticles [ 32 ] ."}	{"Most DYTI4 patients have dominantly inherited loss of function mutations in the GCH1 gene , while mutations in the TH gene are responsible for a rare recessive form [ 36 ] .","The third gene involved in dopamine metabolism , DAT , was found to be mutated in a hyperactive ﬂy line , ﬁmzin ."}	0.93	0.08	0.512	{"INV_POS_SEQ_[,_IN_DT]",INV_DEP_PATH_POS_[nn-nsubj|NNS-advcl|VBP@prep_to-rcmod|JJ-xcomp|NN],INV_VERB_DEP_PATH_[respond]_[nn-nsubj|patient@]_[prep_to-rcmod|similar-xcomp|]@advcl],INV_VERB_DEP_PATH_[underlie]_[nn-nsubj|patient-advcl|respond@]_[prep_to-rcmod|similar-xcomp|]@],INV_VERB_DEP_PATH_POS_[underlie]_[nn-nsubj|NNS-advcl|VBP@]_[prep_to-rcmod|JJ-xcomp|NN@],INV_VERB_DEP_PATH_POS_[respond]_[nn-nsubj|NNS@]_[prep_to-rcmod|JJ-xcomp|NN@advcl],"INV_WORD_SEQ_[, except that]",INV_DEP_PATH_[nn-nsubj|patient-advcl|respond@prep_to-rcmod|similar-xcomp|]]}	{-0.718427,0.48384,0.48384,0.48384,0.48384,0.48384,0.48384,0.48384}
journal.pone.0069714.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0069714.pdf_61_61_3_3_9_10_UNSUP	EWS/HP:0012254|Ewing's sarcoma	{3}	{9,10}	{Rearrangement,of,the,EWS,locus,was,veriﬁed,in,all,Ewing,sarcoma,cell,lines,by,split,probe,ﬂuorescence,in,situ,hybridization,(,FISH,),at,Genzyme,.}	{"Materials and Methods","Cell lines and Materials All Ewing sarcoma cell lines were obtained from American Type Culture Collection ( ATCC ) and cultured in DMEM with 10 % FCS or RPMI-1640 with 15 % FCS ( Life Technologies ) ."}	{"CellTiter 96 non-radioactive cell proliferation assay ( MTT ) was purchased from Promega .","Absolutely RNA microprep kit was obtained from Stratagene ."}	0.924	0.266	0.998	{POS_SEQ_[NN_VBD_VBN_IN_DT],DEP_PATH_POS_[nn-prep_of|NN-nsubjpass|NN@nn-prep_in|NNS],VERB_DEP_PATH_POS_[be]_[nn-prep_of|NN-nsubjpass|NN@auxpass]_[nn-prep_in|NNS@auxpass],DEP_PATH_[nn-prep_of|locus-nsubjpass|rearrangement@nn-prep_in|line],"WORD_SEQ_[locus be veriﬁed in all]",VERB_DEP_PATH_[veriﬁed]_[nn-prep_of|locus-nsubjpass|rearrangement@]_[nn-prep_in|line@],VERB_DEP_PATH_POS_[veriﬁed]_[nn-prep_of|NN-nsubjpass|NN@]_[nn-prep_in|NNS@],VERB_DEP_PATH_[be]_[nn-prep_of|locus-nsubjpass|rearrangement@auxpass]_[nn-prep_in|line@auxpass]}	{-0.945325,0.714458,0.714458,0.382427,0.382427,0.382427,0.382427,0.382427}
SCPDFS_39607.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_39607.pdf_590_590_3_3_8_9_UNSUP	RP17/HP:0000510|Retinitis pigmentosa	{3}	{8,9}	{Reﬁnement,of,the,RP17,locus,for,autosomal,dominant,retinitis,pigmentosa,",",construction,of,a,YAC,contig,and,investigation,of,the,candidate,gene,retinal,fascin,.}	{", Tubb , B. , Bryan , J .",", Queimado , L. , Lovett , M. , and Ramesar , R. S. ( 1999 ) ."}	{"Eur .","J. Hum ."}	0.988	0.246	0.918	{"WORD_SEQ_[locus for autosomal dominant]",DEP_PATH_POS_[nn-prep_of|NN@prep_for],POS_SEQ_[NN_IN_JJ_JJ],DEP_PATH_[nn-prep_of|locus@prep_for]}	{2.04375,1.23004,0.749829,0.651206}
journal.pone.0026021.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0026021.pdf_806_806_28_28_33_33_UNSUP	DHDPSL/HP:0003159|Hyperoxaluria	{28}	{33}	{Belostotsky,R,",",Seboun,E,",",Idelson,GH,",",l,"\\\\",’,Iilliner,DS,",",Becker-Cohen,R,",",et,al.,(,2010,),l,"\\\\",’,Iutations,in,DHDPSL,Are,Responsible,For,Primary,Hyperoxaluria,Type,III,.}	{"Ki1igl1tJ , Jiang ] , Assimos DG , Holmes RP ( 2006 ) Hydroxyproline ingestion and urinary oxalate and glycolate excretion .","Kidney Int 70 : l929 — 1934 ."}	{"Amj Hum Genet 87 : 392 — 399 .","Nlonico CG , Rossetti S , Belostotsky R , Cogal AG , Herges R , et al. ( 201 1 ) Primary hyperoxaluria type III gene HOGAI ( formerly DHDPSL ) as a possible risk factor for idiopathic calcium oxalate urolithiasis ."}	0.944	0.092	0.992	{POS_SEQ_[VBP_JJ_IN_JJ],VERB_DEP_PATH_[be]_[prep_in-dep|iutation@cop]_[nn-prep_for|type@cop],DEP_PATH_POS_[prep_in-dep|NNS@nn-prep_for|NN],"WORD_SEQ_[be responsible for primary]",DEP_PATH_[prep_in-dep|iutation@nn-prep_for|type],VERB_DEP_PATH_POS_[be]_[prep_in-dep|NNS@cop]_[nn-prep_for|NN@cop]}	{1.064,0.331706,0.331706,0.331706,0.331706,0.331706}
SCPDFS_49538.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_49538.pdf_15_15_23_23_7_7_UNSUP	AN2/HP:0000526|Aniridia	{23}	{7}	{Although,the,association,between,PAX6,mutations,and,aniridia,now,seems,incontrovertible,",",there,is,evidence,that,mutations,at,a,second,human,locus,",",AN2,",",may,be,responsible,for,some,cases,of,aniridia,.}	{"The second , which was detected as an RNA lacking an exon , appeared to be a splicing mutation resulting from an as yet undetected point mutation or very small deletion .","The product of the mutant RNA would lack part of the PAX6 homeodomain ."}	{"It remains to be determined whether","AN2 is a second aniridia gene , or has a more indirect effect on development of the condition ."}	0.904	0.228	0.984	{INV_WORD_SEQ_[TOO_FAR_AWAY],INV_VERB_DEP_PATH_[be]_[appos-prep_at|locus-nsubj|mutation-ccomp|responsible@]_[prep_between-nsubj|association-advcl|incontrovertible@],INV_DEP_PATH_[appos-prep_at|locus-nsubj|mutation-ccomp|responsible@prep_between-nsubj|association-advcl|incontrovertible],INV_VERB_DEP_PATH_POS_[be]_[appos-prep_at|NN-nsubj|NNS-ccomp|JJ@]_[prep_between-nsubj|NN-advcl|JJ@],INV_DEP_PATH_POS_[appos-prep_at|NN-nsubj|NNS-ccomp|JJ@prep_between-nsubj|NN-advcl|JJ]}	{-2.7069,1.2385,1.2385,1.2385,1.2385}
SCPDFS_20043.pdf	RELATION_GENEHPOTERM_SCPDFS_20043.pdf_271_271_0_0_3_4	CDKL5/HP:0012469|Infantile spasms	{0}	{3,4}	{CDKL5,mutations,cause,infantile,spasms,",",early,onset,seizures,","}	{References,"Archer , H. L , et al. , 2006 ."}	{"and severe mental retardation in female patients .","J. Med ."}	0.928	0.962	1	{VERB_DEP_PATH_POS_[cause]_[nn-nsubj|NNS@]_[dobj@],"WORD_SEQ_[mutation cause]",DEP_PATH_POS_[nn-nsubj|NNS@dobj],POS_SEQ_[NNS_VBP],DEP_PATH_[nn-nsubj|mutation@dobj],VERB_DEP_PATH_[cause]_[nn-nsubj|mutation@]_[dobj@]}	{3.00607,2.6572,-2.09121,-1.56085,1.21768,-0.465917}
journal.pone.0088140.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0088140.pdf_91_91_0_0_10_10_UNSUP	ATM/HP:0001009|Telangiectasia	{0}	{10}	{ATM,(,Ataxia,telangiectasia,mutated,),and,ATR,(,Ataxia,telangiectasia,and,Rad3,related,),",",two,important,transducer,proteins,",",play,critical,roles,in,DNA,damage,response,by,controlling,the,damage,response,through,phosphorylation,of,effector,proteins,[,"19,20",],.}	{"the oxidative injury of DNA [ 16 ] , which can via checkpoint activation induce cell cycle arrest [ 17 ] .","In the DNA damage response , activation of DNA damage checkpoints is ﬁrstly recognized by sensors proteins , followed by activation of a series effector kinases which target the major cell cycle control machinery [ 18 ] ."}	{"Following their activation and phosphorylation , the downstream effectors such as Chkl , Chk2 , p53 were phosphorylated and activated , leading to further transmission of the checkpoint signals [ 21,22 ] .","By the interaction between the cyclin-dependent kinases ( Cdks ) and the cyclins , cells transit between different phases of cycle ."}	0.946	0.602	0.994	{"WORD_SEQ_[( Ataxia telangiectasium mutate ) and atr ( Ataxia]",VERB_DEP_PATH_POS_[play]_[nn@rcmod]_[dobj-partmod|VBN-nsubj|NN@],POS_SEQ_[NNP_NNP_NN_VBN_NN_CC_NN_CD_NNP],VERB_DEP_PATH_[control]_[nn@prepc_by-rcmod|play]_[dobj-partmod|mutate-nsubj|telangiectasium@prepc_by],"WORD_SEQ_NER_[( Ataxia telangiectasium mutate ) and atr NUMBER Ataxia]",VERB_DEP_PATH_[mutate]_[nn@partmod-nsubj|telangiectasium-rcmod|play]_[dobj@],DEP_PATH_[nn@dobj-partmod|mutate-nsubj|telangiectasium-rcmod|play],VERB_DEP_PATH_POS_[mutate]_[nn@partmod-nsubj|NN-rcmod|VBP]_[dobj@],VERB_DEP_PATH_POS_[control]_[nn@prepc_by-rcmod|VBP]_[dobj-partmod|VBN-nsubj|NN@prepc_by],VERB_DEP_PATH_[play]_[nn@rcmod]_[dobj-partmod|mutate-nsubj|telangiectasium@],DEP_PATH_POS_[nn@dobj-partmod|VBN-nsubj|NN-rcmod|VBP]}	{0.58198,0.288106,0.288106,0.288106,0.288106,0.288106,0.288106,0.288106,0.288106,0.288106,-0.161716}
journal.pone.0031021.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0031021.pdf_97_97_5_5_20_20_UNSUP	CFHR5/HP:0000790|Hematuria	{5}	{20}	{For,both,",",TBMN,and,CFHR5,cohorts,",",“,mildly,”,affected,patients,are,those,having,only,microscopic,or,macroscopic,hematuria,episodes,(,but,no,CKD,),or,hematuria,plus,low,grade,proteinuria,(,<,400,mg/24,hrs,",",but,no,CKD,),.}	{"The CFHR5 nephropathy group was comprised of 45 male and 33 female patients ( born before January 1975 ) , all sharing a common exons 2 — 3 heterozygous duplication in CFHR5 gene [ 5 ] .","Pedigrees and analytical clinical data have been published in detail elsewhere [ 26,27 ] ."}	{"“ Severely ” affected patients are those having hematuria plus proteinuria > 500 mg / 24 hrs or hematuria plus proteinuria plus CKD or ESKD .","CKD was deﬁned as an elevated serum creatinine over 1.5 mg/dl ."}	0.912	0.014	1	{DEP_PATH_POS_[nn-nsubj|NNS@nn-dobj|NNS-partmod|VBG],"WORD_SEQ_[cohort , “ mildly ” affect patient be those have only microscopic or macroscopic]",VERB_DEP_PATH_[be]_[nn-nsubj|cohort@cop]_[nn-dobj|episode-partmod|have@cop],VERB_DEP_PATH_[have]_[nn-nsubj|cohort@partmod]_[nn-dobj|episode@],VERB_DEP_PATH_POS_[have]_[nn-nsubj|NNS@partmod]_[nn-dobj|NNS@],"POS_SEQ_[NNS_,_NN_RB_RB_VBN_NNS_VBP_DT_VBG_RB_JJ_CC_JJ]",DEP_PATH_[nn-nsubj|cohort@nn-dobj|episode-partmod|have],VERB_DEP_PATH_POS_[be]_[nn-nsubj|NNS@cop]_[nn-dobj|NNS-partmod|VBG@cop]}	{0.312949,0.312949,0.312949,0.312949,0.312949,0.312949,0.312949,0.312949}
journal.pone.0046934.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0046934.pdf_518_518_22_22_30_30_UNSUP	PAX6/HP:0000526|Aniridia	{22}	{30}	{Yasuda,T,",",Kajimoto,Y,",",Fujitani,Y,",","\\\\",/,Vatada,H,",",Yamamoto,S,",",et,al.,(,2002,),PAX6,mutation,as,a,genetic,factor,common,to,aniridia,and,glucose,intolerance,.}	{"Bioessays 24 : l041 — 105l .","6 ."}	{"Diabetes 51 : 224 ~ 230 .","7 ."}	0.954	0.966	0.998	{"WORD_SEQ_[mutation as a genetic factor common to]",POS_SEQ_[NN_IN_DT_JJ_NN_JJ_TO],DEP_PATH_[nn@nn-prep_to|intolerance-amod|common],DEP_PATH_POS_[nn@nn-prep_to|NN-amod|JJ]}	{1.03991,1.03991,1.03991,0.270548}
journal.pone.0071374.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0071374.pdf_604_604_20_20_28_33_UNSUP	p53/HP:0006740|Transitional cell carcinoma of the bladder	{20}	{28,29,30,33}	{Dekairelle,AF,",",Tombal,B,",",Cosyns,JP,",",Gala,JL,(,200.5,),Assessment,of,the,transcriptional,activity,of,p53,improves,the,prediction,of,recurrence,in,superficial,transitional,cell,carcinoma,of,the,bladder,.}	{"Oncogene 28 : 168241693 .",.}	{"Clin Cancer Res 11 : 4724 — 4732 .",.}	0.918	0.44	1	{"WORD_SEQ_[improve the prediction of recurrence in superficial]",VERB_DEP_PATH_[improve]_[prep_of-prep_of|activity-dep|Assessment-dep|NUMBER@]_[prep_in@],DEP_PATH_POS_[prep_of-prep_of|NN-dep|NNP-dep|CD@prep_in],DEP_PATH_[prep_of-prep_of|activity-dep|Assessment-dep|NUMBER@prep_in],POS_SEQ_[VBZ_DT_NN_IN_NN_IN_JJ],VERB_DEP_PATH_POS_[improve]_[prep_of-prep_of|NN-dep|NNP-dep|CD@]_[prep_in@]}	{0.434366,0.434366,0.434366,0.434366,0.434366,0.434366}
journal.pbio.0050234.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pbio.0050234.pdf_147_147_26_26_15_15_UNSUP	WAGR/HP:0000526|Aniridia	{26}	{15}	{Mutations,in,humans,in,WT,],and,PAX6,respectively,cause,Wilms,tumor,and,type,2,aniridia,",",while,chromosomal,deletions,encompassing,all,four,genes,lead,to,WAGR,syndrome,.}	{"# PLoS Biology | www .","p | osbio | ogy.org and paired box 6 ( PAX6 ) ( Figure 1B ) ."}	{"Mouse knockouts generated for Wtl and Pax6 have a variety of phenotypes , the most notable being kidney and eye abnormalities , respectively .","Detailed pathological analysis of the kidneys and eyes of the uc329 null mice revealed no signiﬁcant differences compared to the wild-type littermates ( Table S1 ) , other than the ~ 2 % unilateral renal agenesis discussed above ."}	0.948	0.54	0.998	{INV_DEP_PATH_[nn-prep_to|syndrome-advcl|lead@conj_and-dobj|tumor],INV_VERB_DEP_PATH_POS_[cause]_[nn-prep_to|NN-advcl|VBP@]_[conj_and-dobj|NN@],"INV_WORD_SEQ_NER_[, while chromosomal deletion encompass all NUMBER gene lead to]",INV_DEP_PATH_POS_[nn-prep_to|NN-advcl|VBP@conj_and-dobj|NN],"INV_POS_SEQ_[,_IN_JJ_NNS_VBG_DT_CD_NNS_VBP_TO]",INV_VERB_DEP_PATH_POS_[lead]_[nn-prep_to|NN@]_[conj_and-dobj|NN@advcl],INV_VERB_DEP_PATH_[cause]_[nn-prep_to|syndrome-advcl|lead@]_[conj_and-dobj|tumor@],INV_VERB_DEP_PATH_[lead]_[nn-prep_to|syndrome@]_[conj_and-dobj|tumor@advcl],"INV_WORD_SEQ_[, while chromosomal deletion encompass all four gene lead to]"}	{0.324027,0.324027,0.324027,0.324027,0.324027,0.324027,0.324027,0.324027,0.324027}
journal.pgen.0030096.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.0030096.pdf_869_869_28_28_31_35_UNSUP	HNF4A/HP:0004904|Maturity-onset diabetes of the young	{28}	{31,32,35}	{Ellard,S,",",Colclough,K,(,2006,),Mutations,in,the,genes,encoding,the,transcription,factors,hepatocyte,nuclear,factor,1,alpha,(,HNFIA,),and,4,alpha,(,HNF4A,),in,maturity-onset,diabetes,of,the,young,.}	{"Kara ( ) z U , Murali TM , Letovsky S , Zheng Y , Ding C , et al. ( 2004 ) Wholegenome annotation by using evidence integration in functional-linkage networks .","Proc Natl Acad Sci U S A 101 : 2888 — 2893 ."}	{"Hum Mutat 27 : 854 — 869 .","h & + PLoS Genetics | www ."}	0.904	0.114	0.916	{POS_SEQ_[NN_IN],"WORD_SEQ_[) in]",VERB_DEP_PATH_POS_[encode]_[nn-dobj|NN@]_[prep_in-dobj|NN@],VERB_DEP_PATH_[encode]_[nn-dobj|)@]_[prep_in-dobj|)@],DEP_PATH_POS_[nn@prep_in],DEP_PATH_[nn@prep_in]}	{-1.27044,1.05278,0.863826,0.863826,0.317543,0.315909}
SCPDFS_24466.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_24466.pdf_314_314_18_18_14_15_UNSUP	RP3/HP:0000510|Retinitis pigmentosa	{18}	{14,15}	{Mapping,of,Xlinked,progressive,retinal,atrophy,(,XLPRA,),",",the,canine,homolog,of,retinitis,pigmentosa,3,(,RP3,),.}	{"25 , 462 — 466 .","Zeiss , C.J. , Ray , K. , Acland , G.M. , Aguirre , G.D. , 2000 ."}	{"Hum .","Mol ."}	0.902	0.022	0.76	{"INV_WORD_SEQ_[3 (]","INV_WORD_SEQ_NER_[NUMBER (]",INV_POS_SEQ_[CD_NN],INV_DEP_PATH_[nn-dep|)@prep_of],INV_DEP_PATH_POS_[nn-dep|NN@prep_of]}	{3.33781,3.26134,-3.19263,-1.63617,0.490961}
SCPDFS_48085.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_48085.pdf_41_41_12_12_7_7_UNSUP	ATM/HP:0001009|Telangiectasia	{12}	{7}	{Indeed,",",the,cancerprone,disorder,ataxia,—,telangiectasia,results,from,mutation,of,ATM,",",a,gene,involved,in,a,checkpoint,that,responds,to,DNA,damage,.}	{"Checkpoints are control mechanisms that prevent the occurrence of later events in the cell cycle until earlier events are successfully completed .","It has been postulated that disruption of such control pathways could be important in tumourigenesis ."}	{"These papers implicate disruption of a checkpoint that monitors spindle assembly in cancer development ; cells derived from certain colorectal tumours have defects in this response ( Cahill et ( 11 ) , and a component of this checkpoint is targeted by a viral oncoprotein ( jin et oil ) .","The mitotic spindle checkpoint prevents anaphase if the spindle is incorrectly assembled ; in budding yeast this is dependent on the products of the BUB and M4D groups of genes ."}	0.922	0.936	0.998	{"INV_WORD_SEQ_[result from mutation of]",INV_VERB_DEP_PATH_[result]_[prep_of-prep_from|mutation@]_[dep-nsubj|ataxia@],INV_DEP_PATH_[prep_of-prep_from|mutation@dep-nsubj|ataxia],INV_DEP_PATH_POS_[prep_of-prep_from|NN@dep-nsubj|NN],INV_VERB_DEP_PATH_POS_[result]_[prep_of-prep_from|NN@]_[dep-nsubj|NN@],INV_POS_SEQ_[VBZ_IN_NN_IN]}	{0.66232,0.66232,0.66232,0.165664,0.165664,0.101327}
journal.pone.0068203.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0068203.pdf_425_425_32_32_21_22_UNSUP	p53/HP:0001402|Hepatocellular carcinoma	{32}	{21,22}	{Kawate,S,",",Fukusato,T,",",Ohwada,S,",",Watanuki,A,",",Morishita,Y,(,1999,),Amplification,of,c-myc,in,hepatocellular,carcinoma,:,correlation,with,clinicopathologic,features,",",proliferative,activity,and,p53,overexpression,.}	{"CAN-09-1089 .","PubMed : 19723656 ."}	{"Oncology 57 : 157-163 .","doi :10.1159 / 000012024 ."}	0.932	0.882	1	{"INV_POS_SEQ_[:_NN_IN_JJ_NNS_,_JJ_NN_CC]","INV_WORD_SEQ_[: correlation with clinicopathologic feature , proliferative activity and]",INV_DEP_PATH_POS_[nn-conj_and|NN-prep_with|NNS@prep_in-prep_of|NN-dep|NN],INV_DEP_PATH_[nn-conj_and|overexpression-prep_with|feature@prep_in-prep_of|c-myc-dep|amplification]}	{0.957652,0.957652,0.732755,0.242844}
journal.pone.0047595.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0047595.pdf_566_566_39_39_35_35_UNSUP	PTEN/HP:0010566|Hamartoma	{39}	{35}	{Nlarsh,DJ,",",Coulon,V,",",Lunetta,KL,",",Rocca-Serra,P,",",Dahia,PL,",",et,al.,(,1998,),Nlutation,spectrum,and,genotype,—,phenotype,analyses,in,Cowden,disease,and,Bannayan-Zonana,syndrome,",",two,hamartoma,syndromes,with,germline,PTEN,mutation,.}	{"Alimonti A , Carracedo A , ClohessyJG , Trotman LC , Nardella C , et al. ( 2010 ) Subtle variations in Pten dose determine cancer susceptibility .","Nat Genet 42 : 4544458 ."}	{"Hum NIo1 Genet 7 : 5074515 .","Nleng F , Henson R , \\\\ / Vehbe - \\\\ ] anek H , Ghoshal K , Jacob ST , et al. ( 2007 ) NIicroRNA ~ 2l regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer ."}	0.964	0.918	1	{INV_DEP_PATH_[nn-prep_with|mutation@nn],INV_POS_SEQ_[NNS_IN_NN],"INV_WORD_SEQ_[syndrome with germline]",INV_DEP_PATH_POS_[nn-prep_with|NN@nn]}	{2.82388,-1.14204,0.808389,0.528164}
journal.pone.0083777.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0083777.pdf_45_45_3_3_13_13_UNSUP	DM2/HP:0002486|Myotonia	{3}	{13}	{Both,DMl,and,DM2,are,progressive,multisystemic,disorders,characterized,by,muscle,weakness,",",myotonia,",",cataracts,",",cardiac,conduction,defects,",",cerebral,involvement,and,endocrinological,disturbances,such,as,increased,insulin,resistance,and,male,hypogonadism,.}	{"DM type 1 ( DMl ) is caused by the expansion of an unstable CTG trinucleotide repeat in the 3 ' untranslated region of the DM protein kinase ( DMPK ) gene [ 2,3 ] .","The DM type 2 ( DM2 ) mutation consists in the expansion of an unstable CCTG tetranucleotide within the ﬁrst intron of the CCHC-type zinc ﬁnger , nucleic acid-binding protein ( CNBB gene ( previously named Zinc Finger Protein 9 , ZNF9 gene ) [ 4 ] ."}	{"Experimental evidence supports an RNA gain-of-function mechanism of expanded transcripts in both DMl and DM2 in which repeat containing transcripts from the expanded allele accumulate in nuclei as foci and alter the functions of RNA binding proteins involved in regulating alternative splicing and mRNA translation [ 5,6 ] .","The alteration of pre-mRNA processing strengthens the"}	0.968	0.148	1	{VERB_DEP_PATH_POS_[be]_[conj_and-nsubj|NN@cop]_[agent-partmod|VBN@cop],VERB_DEP_PATH_[be]_[conj_and-nsubj|dml@cop]_[agent-partmod|characterize@cop],VERB_DEP_PATH_POS_[increase]_[conj_and-nsubj|NN@amod-prep_such_as|NN]_[agent-partmod|VBN@amod-prep_such_as|NN],DEP_PATH_POS_[conj_and-nsubj|NN@agent-partmod|VBN],VERB_DEP_PATH_POS_[characterize]_[conj_and-nsubj|NN@partmod]_[agent@],DEP_PATH_[conj_and-nsubj|dml@agent-partmod|characterize],VERB_DEP_PATH_[characterize]_[conj_and-nsubj|dml@partmod]_[agent@],VERB_DEP_PATH_[increase]_[conj_and-nsubj|dml@amod-prep_such_as|resistance]_[agent-partmod|characterize@amod-prep_such_as|resistance],"POS_SEQ_[VBP_JJ_JJ_NNS_VBN_IN_NN_NN_,]","WORD_SEQ_[be progressive multisystemic disorder characterize by muscle weakness ,]"}	{0.38255,0.38255,0.38255,0.38255,0.38255,0.38255,0.38255,0.38255,0.192172,0.192172}
SCPDFS_42721.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_42721.pdf_18_18_50_50_55_55_UNSUP	SLC3A1/HP:0003131|Cystinuria	{50}	{55}	{Since,all,three,homologous,cDNAs,(,D2,",",D2H,",",and,rBAT,),induce,high-aiﬁnity,transport,of,cystine,",",dibasic,",",and,neutral,amino,acids,and,are,highly,expressed,in,small,intestine,and,kidney,(,4,),",",it,has,been,proposed,that,a,defect,in,the,transporter,encoded,by,SLC3A1,might,be,involved,in,cystinuria,or,Hartnup,disease,.}	{"All rights of reproduction in any form reserved .","Similar expression cloning strategies were used to isolate the rabbit kidney cDNA ( rBAT ) by Bertran et al. ( 2 ) and its human homologue , also called rBAT ( 1 ) , encoded by the gene SLC3A1 ."}	{"Recently , Calonge et al. ( 3 ) identiﬁed six mutations in the rBAT gene in their study of ﬁve patients affected with cystin — uria .","One of the mutations nearly abolished the amino acid transport activity induced by this gene in Xenopus oocytes ."}	0.918	0.588	0.99	{VERB_DEP_PATH_[involve]_[agent-partmod|encode-prep_in|transporter-nsubjpass|defect@]_[nn-prep_in|disease@],DEP_PATH_[agent-partmod|encode-prep_in|transporter-nsubjpass|defect@nn-prep_in|disease],VERB_DEP_PATH_POS_[involve]_[agent-partmod|VBN-prep_in|NN-nsubjpass|NN@]_[nn-prep_in|NN@],DEP_PATH_POS_[agent-partmod|VBN-prep_in|NN-nsubjpass|NN@nn-prep_in|NN],"WORD_SEQ_[might be involve in]",POS_SEQ_[MD_VB_VBN_IN]}	{0.532327,0.532327,0.532327,0.532327,0.1021,0.00560196}
SCPDFS_41730.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_41730.pdf_180_180_17_17_3_3_UNSUP	KCNA1/HP:0002411|Myokymia	{17}	{3}	{Episodic,ataxia,],myokymia,syndrome,is,associated,with,point,mutations,in,the,human,potassium,channel,gene,",",KCNA1,.}	{"2 .","Browne , D. L. , Gancher , S. T. , Nutt , T. G. , Brunt , E. R. P. , Smith , E. A. , Kramer , P. , and Litt , M. ( 1994 ) ."}	{"Nature Genet .","8 : 136140 ."}	0.938	0.674	0.988	{"INV_POS_SEQ_[NN_VBZ_VBN_IN_NN_NNS_IN_DT_JJ_NN_NN_NN_,]","INV_WORD_SEQ_[syndrome be associate with point mutation in the human potassium channel gene ,]",INV_DEP_PATH_[appos-prep_in|gene-prep_with|mutation@nn-dep|syndrome-nsubjpass|]],INV_VERB_DEP_PATH_POS_[associate]_[appos-prep_in|NN-prep_with|NNS@]_[nn-dep|NN-nsubjpass|NN@],INV_VERB_DEP_PATH_[be]_[appos-prep_in|gene-prep_with|mutation@auxpass]_[nn-dep|syndrome-nsubjpass|]@auxpass],INV_DEP_PATH_POS_[appos-prep_in|NN-prep_with|NNS@nn-dep|NN-nsubjpass|NN],INV_VERB_DEP_PATH_POS_[be]_[appos-prep_in|NN-prep_with|NNS@auxpass]_[nn-dep|NN-nsubjpass|NN@auxpass],INV_VERB_DEP_PATH_[associate]_[appos-prep_in|gene-prep_with|mutation@]_[nn-dep|syndrome-nsubjpass|]@]}	{0.65107,0.65107,0.291706,0.291706,0.291706,0.291706,0.291706,0.291706}
SCPDFS_42809.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_42809.pdf_31_31_44_44_50_51_UNSUP	FBN2/HP:0002803|Congenital contracture	{44}	{50,51}	{One,located,on,chromosome,15q15,—,q21,(,FBN1,),has,been,linked,to,Marian,syndrome,(,Lee,et,al.,",",1991,;,Maslen,et,ol.,",",1991,;,Pereira,et,al.,",",1993,),and,the,other,on,chromosome,5q23,—,q31,(,FBN2,),has,been,linked,to,congenital,contractural,arachnodactyly,(,Lee,et,ai,.,'}	{"Subsequent molecular cloning studies have indicated that the 340 — kDa protein corresponds to the 350 — kDa protein , named ﬁbrillin , identiﬁed in culture media of human ﬁbroblasts ( Sakai et al. , 1986 ) .","Two different human ﬁbrillin genes have been identiﬁed ."}	{.,", 1991 ) ."}	0.962	0.044	0.936	{"WORD_SEQ_[) have be link to]",DEP_PATH_POS_[nn-nsubjpass|NN@amod-prep_to|NN],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[amod-prep_to|NN@auxpass],VERB_DEP_PATH_[link]_[nn-nsubjpass|)@]_[amod-prep_to|arachnodactyly@],VERB_DEP_PATH_POS_[link]_[nn-nsubjpass|NN@]_[amod-prep_to|NN@],DEP_PATH_[nn-nsubjpass|)@amod-prep_to|arachnodactyly],VERB_DEP_PATH_[be]_[nn-nsubjpass|)-parataxis|link@]_[amod-prep_to|arachnodactyly-parataxis|link@],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN-parataxis|VBN@]_[amod-prep_to|NN-parataxis|VBN@],VERB_DEP_PATH_[have]_[nn-nsubjpass|)@aux]_[amod-prep_to|arachnodactyly@aux],VERB_DEP_PATH_[be]_[nn-nsubjpass|)@auxpass]_[amod-prep_to|arachnodactyly@auxpass],POS_SEQ_[NN_VBZ_VBN_VBN_TO],VERB_DEP_PATH_POS_[have]_[nn-nsubjpass|NN@aux]_[amod-prep_to|NN@aux]}	{0.51642,0.366776,0.366776,0.257972,0.257972,0.257972,0.257972,0.257972,0.257972,0.257972,-0.0846982,0.0776651}
journal.pone.0072491.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0072491.pdf_422_422_38_38_39_39_UNSUP	DYT1/HP:0001332|Dystonia	{38}	{39}	{Napolitano,F,",",Pasqualetti,l,"\\\\",’,I,",",Usiello,A,",",Santini,E,",",Pacini,G,",",et,al.,(,2010,),Dopamine,D2,receptor,dysfunction,is,rescued,by,adenosine,A2A,receptor,antagonism,in,a,model,of,DYT1,dystonia,.}	{"1487 — l521 p. Nlartella G , Tassone A , Scia_manna G , Platania P , Cuomo D , et al. ( 2009 ) Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia : role of endogenous acetylcholine .","Brain 132 : 2336 ~ 2349 ."}	{"Neuro1 ) io1 Dis 38 : 434 — 445 .","Dang l \\\\ ’ IT , Yokoi F , Cheetham CC , LuJ , Vo V , et al. ( 2012 ) An anticholinergic reverses motor control and corticostriatal LTD deficits in Dytl De1taGAG knock-in mice ."}	0.934	0.856	0.76	{VERB_DEP_PATH_POS_[rescue]_[nn-prep_of|NN-prep_in|NN@]_[prep_of-prep_in|NN@],VERB_DEP_PATH_[rescue]_[nn-prep_of|dystonium-prep_in|model@]_[prep_of-prep_in|model@],VERB_DEP_PATH_[be]_[nn-prep_of|dystonium-prep_in|model@auxpass]_[prep_of-prep_in|model@auxpass],WORD_SEQ_[],POS_SEQ_[],VERB_DEP_PATH_POS_[be]_[nn-prep_of|NN-prep_in|NN@auxpass]_[prep_of-prep_in|NN@auxpass],DEP_PATH_[nn@],DEP_PATH_POS_[nn@]}	{1.75273,1.75273,1.75273,-1.47483,-1.46457,0.669979,-0.105105,-0.0901411}
journal.pone.0019169.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0019169.pdf_44_44_5_5_20_22_UNSUP	FLT3/HP:0004808|Acute myeloid leukemia	{5}	{20,21,22}	{In,human,acute,leukemia,",",FLT3,is,expressed,on,the,surface,of,the,leukemic,cells,in,70,—,90,%,acute,myeloid,leukemia,(,AML,),patients,and,most,B-acute,lymphoblastic,leukemia,(,B-ALL,),[,"1,2,3",],.}	{"Type III RTKS share a common structure consisting of 5 extracellular immunoglobulinlike domains , a single transmembrane domain , a cytoplasmic juxtamembrane region , and a cytoplasmic kinase domain interrupted by the kinase insert .","FLT3 is primarily expressed in early myeloid and lymphoid progenitors and plays an important role in their proliferation and differentiation ."}	{"Overexpression and activating mutations of receptor tyrosine kinases ( RTKS ) are known to be involved in the pathogenesis of many types of cancer .","Mutations in F LT3 are commonly detected in patients with AML ."}	0.936	0.962	1	{DEP_PATH_POS_[nsubjpass@prep_in-prep_of|NNS-prep_on|NN],"WORD_SEQ_NER_[be express on the surface of the leukemic cell in PERCENT PERCENT PERCENT PERCENT]",VERB_DEP_PATH_POS_[express]_[nsubjpass@]_[prep_in-prep_of|NNS-prep_on|NN@],"WORD_SEQ_[be express on the surface of the leukemic cell in 70 — 90 %]",VERB_DEP_PATH_[express]_[nsubjpass@]_[prep_in-prep_of|cell-prep_on|surface@],POS_SEQ_[VBZ_VBN_IN_DT_NN_IN_DT_JJ_NNS_IN_CD_CD_CD_NN],VERB_DEP_PATH_POS_[be]_[nsubjpass@auxpass]_[prep_in-prep_of|NNS-prep_on|NN@auxpass],VERB_DEP_PATH_[be]_[nsubjpass@auxpass]_[prep_in-prep_of|cell-prep_on|surface@auxpass],DEP_PATH_[nsubjpass@prep_in-prep_of|cell-prep_on|surface]}	{0.277187,0.277187,0.277187,0.277187,0.277187,0.277187,0.277187,0.277187,0.277187}
SCPDFS_20654.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_20654.pdf_295_295_26_26_30_32_UNSUP	POLG/HP:0000590|Progressive external ophthalmoplegia	{26}	{30,31,32}	{Van,Goethem,",",G.,",",Dermaut,",",B.,",",Lofgren,",",A.,",",Martin,",",J.J.,",",Van,Broeckhoven,",",C.,",",2001,",",Mutation,of,POLG,is,associated,with,progressive,external,ophthalmoplegia,characterized,by,mtDNA,deletions,.}	{"W748S POLG mutations : a study of 26 cases .","Brain 129 , 1685-1692 ."}	{"Nat .","Genet ."}	0.988	0.754	1	{"WORD_SEQ_[be associate with]",POS_SEQ_[VBZ_VBN_IN],VERB_DEP_PATH_POS_[be]_[prep_of-appos|NN-nsubjpass|NNP@auxpass]_[prep_with@auxpass],VERB_DEP_PATH_[associate]_[prep_of-appos|mutation-nsubjpass|PERSON@]_[prep_with@],VERB_DEP_PATH_POS_[associate]_[prep_of-appos|NN-nsubjpass|NNP@]_[prep_with@],DEP_PATH_[prep_of-appos|mutation-nsubjpass|PERSON@prep_with],DEP_PATH_POS_[prep_of-appos|NN-nsubjpass|NNP@prep_with],VERB_DEP_PATH_[be]_[prep_of-appos|mutation-nsubjpass|PERSON@auxpass]_[prep_with@auxpass]}	{2.44981,-1.20118,0.464158,0.464158,0.464158,0.464158,0.464158,0.464158}
journal.pone.0089410.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0089410.pdf_249_249_40_40_28_28_UNSUP	SCA2/HP:0001251|Ataxia	{40}	{28}	{Burk,K,",",Abele,1,"\\\\",’,I,",",Fetter,IVI,",",Dichgans,J,",",Skalej,IVI,",",et,al.,(,1996,),Autosomal,dominant,cerel,),ellar,ataxia,type,I,clinical,features,and,IVIRI,in,families,with,SCA1,",",SCA2,and,SCA3,.}	{"Neuroreport 14 : 1799 — 1802 .","5 ."}	{"Brain 119 ( Pt 5 ) : 1497 — 1505 .","6 ."}	0.958	0.894	0.998	{INV_DEP_PATH_[prep_with@nn-dep|type-dobj|autosomal],INV_DEP_PATH_POS_[prep_with@nn-dep|NN-dobj|NN],"INV_POS_SEQ_[NN_CD_JJ_NNS_CC_NNP_IN_NNS_IN_NN_,]","INV_WORD_SEQ_[type i clinical feature and IVIRI in family with sca1 ,]","INV_WORD_SEQ_NER_[type NUMBER clinical feature and IVIRI in family with sca1 ,]"}	{0.909024,0.909024,0.640831,0.27559,0.27559}
journal.pone.0070617.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0070617.pdf_560_560_22_22_29_29_UNSUP	DHDPSL/HP:0003159|Hyperoxaluria	{22}	{29}	{Belostotsky,R,",",Seboun,E,",",Idelson,GH,",",Nlilliner,DS,",",Becker-Cohen,R,",",et,al.,(,2010,),lVlutations,in,DHDPSL,are,responsil,),le,for,primary,hyperoxaluria,type,III,.}	{"Am Soc Nephrol 12 : 198641993 .","3 ."}	{"Am ] Hum Gen 87 : 3924399 .","4 ."}	0.926	0.068	0.996	{DEP_PATH_POS_[prep_in-nsubj|NNS@nn-prep_for|NN-dep|DT],"WORD_SEQ_[be responsil ) le for primary]",DEP_PATH_[prep_in-nsubj|lvlutation@nn-prep_for|type-dep|le],VERB_DEP_PATH_[be]_[prep_in-nsubj|lvlutation@cop]_[nn-prep_for|type-dep|le@cop],POS_SEQ_[VBP_JJ_NN_DT_IN_JJ],VERB_DEP_PATH_POS_[be]_[prep_in-nsubj|NNS@cop]_[nn-prep_for|NN-dep|DT@cop]}	{0.401731,0.401731,0.401731,0.401731,0.401731,0.401731}
SCPDFS_19274.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19274.pdf_28_28_46_46_31_31_UNSUP	WNT7A/HP:0009829|Phocomelia	{46}	{31}	{In,this,paper,",",we,present,two,new,cases,of,AARRS,from,two,different,Saudi,Arabian,tribes,:,one,case,with,R292C,mutation,of,WNT,7A,with,bilateral,“,apparent,“,phocomelia,and,a,second,case,with,a,novel,c.,814G,>,T,mutation,of,the,WNT7A,gene,(,resulting,in,wnt7a,protein,truncation,at,position,272,),with,unilateral,“,apparent,"\\"",phocomelia,.}	{"“ Apparent “ phocomelia describes the most severe form of ulnar ray deﬁciency in A1_Awadi_Raa5_R0th5chi1d Syndrome which there is absent ulna with radio — humeral synostosis .","“ Apparent \\" phocomelia is diagnosed radiologically Wmm by three radiological features : the apparently single bone occupying the arm/forearm appears relatively long , the area of radio — humeral synostosis will have thicker cortex with or without slight angulation , and the lower end of the bone resembles the lower end of a radius and not a humerus ."}	{"We reviewed previously reported cases of AARRS and SP5 to further delineate the differences between these two syndromes .","We make the argument that these two syndromes are two different entities and hence require two different MIM entries ."}	0.928	0.526	0.976	{INV_VERB_DEP_PATH_[present]_[nn-prep_of|(-parataxis|mutation@]_[prep_with-prep_with|mutation-nsubj|case-parataxis|mutation@],INV_DEP_PATH_[nn-prep_of|(@prep_with-prep_with|mutation-nsubj|case],"INV_WORD_SEQ_NER_[and DURATION DURATION case with a novel c. 814g > t mutation of the]","INV_WORD_SEQ_[and a second case with a novel c. 814g > t mutation of the]",INV_POS_SEQ_[CC_DT_JJ_NN_IN_DT_JJ_NN_NN_JJR_NN_NN_IN_DT],INV_VERB_DEP_PATH_POS_[present]_[nn-prep_of|NN-parataxis|NN@]_[prep_with-prep_with|NN-nsubj|NN-parataxis|NN@],INV_DEP_PATH_POS_[nn-prep_of|NN@prep_with-prep_with|NN-nsubj|NN]}	{0.401532,0.401532,0.401532,0.401532,0.401532,0.401532,0.401532}
journal.pone.0028895.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0028895.pdf_46_46_12_12_21_21_UNSUP	PAX6/HP:0000526|Aniridia	{12}	{21}	{Eye,development,is,highly,sensitive,to,Pax6,dose,and,haploinsufﬁciency,in,human,PAX6,',[,/,_,heterozygotes,is,characterised,by,aniridia,and,other,ocular,abnormalities,[,26,—,28,],.}	{"Pax6 is widely expressed during eye development [ 23 ] and continues in several adult tissues , including the corneal , limbal and conjunctival epithelia [ 24 ] .","Absence of Pax6 causes anophthalmia in both mice [ 1 ] and humans [ 25 ] ."}	{"Heterozygosity for mouse Pax6 _ null mutations , such as Pax6Se “ v [ 1,29,30 ] , Pux6 * W \\" \\" [ 131 ] and Paxélmz [ 32 ] , causes similar abnormalities and small-eyes .","Ocular phenotypes produced by hypomorphic Pax6 alleles showed that surface ectoderm derivatives are more sensitive to Pax6 levels than optic vesicle derivatives [ 6 ] ."}	0.946	0.624	1	{"WORD_SEQ_[' [ / _ heterozygote be characterise by]",VERB_DEP_PATH_POS_[be]_[@auxpass-dep|VBN-dep|CD]_[nn-agent|NNS@auxpass],VERB_DEP_PATH_[characterise]_[@dep-dep|NUMBER]_[nn-agent|abnormality@],POS_SEQ_[''_CD_:_CD_NNS_VBZ_VBN_IN],VERB_DEP_PATH_[be]_[@auxpass-dep|characterise-dep|NUMBER]_[nn-agent|abnormality@auxpass],VERB_DEP_PATH_POS_[characterise]_[@dep-dep|CD]_[nn-agent|NNS@],DEP_PATH_POS_[@nn-agent|NNS-dep|VBN-dep|CD],DEP_PATH_[@nn-agent|abnormality-dep|characterise-dep|NUMBER],"WORD_SEQ_NER_[' NUMBER / NUMBER heterozygote be characterise by]"}	{0.28404,0.28404,0.28404,0.28404,0.28404,0.28404,0.28404,0.28404,0.28404}
SCPDFS_44363.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_44363.pdf_37_37_18_18_21_25_UNSUP	LQT/HP:0001657|Prolonged QT interval	{18}	{21,24,25}	{Like,their,counterparts,who,have,inherited,this,disorder,because,of,a,single,mutant,gene,",",individuals,with,acquired,LQT,frequently,have,prolongation,of,the,QT,interval,on,electrocardiogram,and,may,develop,cardiac,arrhythmias,(,Moss,and,Schwartz,",",1979,),.}	{"Two circumstantial pieces of evidence have implicated K + channels in the pathogenesis of LQT .","First , pharmacological agents that block K + channels ( for example , type-1 antiarrhythmic agents like quinidine , tricyclic antidepressant agents , cesium ) and certain metabolic abnormalities ( particularly hypokalemia ) can induce a phenotype that is similar to LQT in purportedly normal individuals ."}	{"Second , K + channels activators , like pinacidil , have been shown to reduce the incidence of repolarization — related ventricular arrhythmias in animal models ( Davidenko et al. , 1989 ) .","These data support the hypothesis that LQT is caused by mutations in a cardiac K + channel gene ."}	0.968	0.036	0.996	{"WORD_SEQ_[frequently have]",VERB_DEP_PATH_[develop]_[prep_with-nsubj|individual@]_[dobj@conj_and],DEP_PATH_[prep_with-nsubj|individual-conj_and|develop@dobj],DEP_PATH_POS_[prep_with-nsubj|NNS-conj_and|VB@dobj],VERB_DEP_PATH_POS_[have]_[prep_with-nsubj|NNS-conj_and|VB@]_[dobj@],VERB_DEP_PATH_[have]_[prep_with-nsubj|individual-conj_and|develop@]_[dobj@],VERB_DEP_PATH_POS_[develop]_[prep_with-nsubj|NNS@]_[dobj@conj_and],POS_SEQ_[RB_VBP]}	{0.467526,0.467526,0.467526,0.467526,0.467526,0.467526,0.268234,-0.199296}
SCPDFS_41217.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_41217.pdf_875_875_15_15_12_12_UNSUP	CPX/HP:0010296|Ankyloglossia	{15}	{12}	{Reﬁned,mapping,and,YAC,contig,construction,of,the,X-linked,cleft,palate,and,ankyloglossia,locus,(,CPX,),including,the,proximal,X-Y,homology,breakpoint,within,Xq21,.3,.}	{"SALA ET AL. .","Gregory , S. G. , Bentley , D. R. , Mumm , S. , Moore , G. E. , and Stanier , P. ( 1996 ) ."}	{"Genomics 31 : 36-43 .","Gyapay , G. , Morisette , J. , Vignal , A. , Dib , C. , Fizames , C. , Millaseau , P. , Marc , S. , Bernardi , G. , Lathrop , M. , and Weissenbach , J. ( 1994 ) ."}	0.96	0.032	0.99	{"INV_WORD_SEQ_[locus (]",INV_POS_SEQ_[NN_NN],INV_DEP_PATH_POS_[@nn-prep_of|NN-nsubj|NN],INV_VERB_DEP_PATH_POS_[reﬁned]_[xcomp@]_[nn-prep_of|NN-nsubj|NN-xcomp|NN@],INV_VERB_DEP_PATH_[reﬁned]_[xcomp@]_[nn-prep_of|(-nsubj|construction-xcomp|cpx@],INV_DEP_PATH_[@nn-prep_of|(-nsubj|construction]}	{5.28975,-1.71457,-0.694248,0.174238,0.174238,0.174238}
SCPDFS_18635.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_18635.pdf_655_655_12_12_10_10_UNSUP	HERG/HP:0011675|Arrhythmia	{12}	{10}	{A,mechanistic,link,between,an,inherited,and,an,acquired,cardiac,arrhythmia,:,HERG,encodes,the,II,(,r,potassium,channel,.}	{"J. 91 , 4381-4391 .","Sanguinetti , M.C. , et al. , 1995 ."}	{"Cell 81 , 299-307 .","Sanguinetti , M.C. , et al. , 1996 ."}	0.98	0.01	0.962	{INV_POS_SEQ_[:],INV_WORD_SEQ_[:],INV_DEP_PATH_[nsubj-dep|encode@conj_and],INV_VERB_DEP_PATH_POS_[acquire]_[nsubj-dep|VBZ@amod-conj_and|NN]_[@amod],INV_DEP_PATH_POS_[nsubj-dep|VBZ@conj_and],INV_VERB_DEP_PATH_[inherit]_[nsubj-dep|encode@amod-prep_between|a]_[conj_and@amod-prep_between|a],INV_VERB_DEP_PATH_POS_[inherit]_[nsubj-dep|VBZ@amod-prep_between|DT]_[conj_and@amod-prep_between|DT],INV_VERB_DEP_PATH_POS_[encode]_[nsubj@]_[conj_and@dep],INV_VERB_DEP_PATH_[acquire]_[nsubj-dep|encode@amod-conj_and|arrhythmium]_[@amod],INV_VERB_DEP_PATH_[encode]_[nsubj@]_[conj_and@dep]}	{-1.90287,0.935103,0.607489,0.607489,0.607489,0.607489,0.607489,0.607489,0.607489,0.607489}
journal.pone.0003088.pdf	RELATION_GENEHPOTERM_journal.pone.0003088.pdf_161_161_4_4_14_14	OTX2/HP:0002885|Medulloblastoma	{4}	{14}	{Interestingly,",",the,oncogene,OTX2,",",which,is,ampliﬁed,in,a,low,percentage,of,medulloblastomas,",",but,highly,expressed,in,about,75,%,of,medulloblastomas,[,26,—,28,],",",is,not,or,hardly,expressed,in,group,B,tumors,(,Figure,3B,),.}	{"Activation of the SHH signaling pathway in medulloblastoma can occur by mutations in PTCH ] [ 19,39,40 ] .","Sequencing of all 23 exons of the PTCH ] gene indeed identiﬁed frameshift mutations in 4 tumors of cluster B , but not in any of the remaining tumors ( P = 0.009 ) ( Figure 1A and Table S1 for mutation details ) ."}	{"Clusters A and B share increased expression of genes involved in protein biosynthesis , cell cycle , NOTCH and PDGF pathways Although tumors from cluster A and B were very distinct from each other , they also share certain characteristics ( Figure 2 ) .","IIIIIIIIIIIIII til I IIIII II IIIIIIIII"}	0.902	0.94	0.956	{VERB_DEP_PATH_POS_[be]_[@auxpass-rcmod|VBN]_[prep_of-prep_in|NN@auxpass],DEP_PATH_POS_[@prep_of-prep_in|NN-rcmod|VBN],"POS_SEQ_[,_WDT_VBZ_VBN_IN_DT_JJ_NN_IN]",VERB_DEP_PATH_[express]_[nsubj@]_[prep_of-prep_in|percentage-rcmod|ampliﬁed-nsubj|otx2@],"WORD_SEQ_[, which be ampliﬁed in a low percentage of]",DEP_PATH_[@prep_of-prep_in|percentage-rcmod|ampliﬁed],VERB_DEP_PATH_[be]_[@auxpass-rcmod|ampliﬁed]_[prep_of-prep_in|percentage@auxpass],VERB_DEP_PATH_[ampliﬁed]_[@rcmod]_[prep_of-prep_in|percentage@],VERB_DEP_PATH_POS_[express]_[nsubj@]_[prep_of-prep_in|NN-rcmod|VBN-nsubj|NN@],VERB_DEP_PATH_POS_[ampliﬁed]_[@rcmod]_[prep_of-prep_in|NN@]}	{1.11928,0.964557,0,0,0,0,0,0,0,0}
journal.pone.0069466.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0069466.pdf_559_559_22_22_30_30_UNSUP	CDK4/HP:0100242|Sarcoma	{22}	{30}	{Khatib,ZA,",",Matsushime,H,",",Valentine,M,",",Shapiro,DN,",",Sherr,CJ,et,al.,(,1993,),Coamplification,of,the,CDK4,gene,with,MDM2,and,GLI,in,human,sarcomas,.}	{"Cancer Res 49 : 5407-5413 .","PubMed : 2766305 ."}	{"Cancer Res 53 : 5535-5541 .","PubMed : 8221695 ."}	0.95	0.344	0.994	{DEP_PATH_POS_[nn-prep_of|NN-dobj|NN@prep_in],"WORD_SEQ_[gene with mdm2 and glus in human]",POS_SEQ_[NN_IN_NN_CC_NN_IN_JJ],DEP_PATH_[nn-prep_of|gene-dobj|coamplification@prep_in],"WORD_SEQ_NER_[gene with mdm2 and MISC in human]"}	{1.31261,0.727098,0.727098,0.211981,0.211981}
journal.pone.0026183.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0026183.pdf_427_427_5_5_28_28_UNSUP	TH/HP:0001332|Dystonia	{5}	{28}	{Notably,",",human,GTPCH,and,TH,are,defective,in,two,forms,of,dopa-responsive,dystonia,(,DYTI4,and,DYT5,",",respectively,),",",while,torsinA,is,altered,in,DYTl,dystonia,.}	{"OO26183 .",gO10}	{"Deﬁcits in dopamine neurotransmission have been implicated in all these forms of dystonia that have a similar clinical appearance , manifesting as early onset generalized dystonia [ 37,40 ] .","DYT5 and DYT14 dystonia results from mutations in genes needed for biosynthesis of dopamine , and symptoms can be alleviated with L-DOPA [ 36 ] ."}	0.936	0.12	0.29	{WORD_SEQ_[TOO_FAR_AWAY],DEP_PATH_POS_[conj_and-nsubj|NN@prep_in-advcl|VBN],VERB_DEP_PATH_POS_[be]_[conj_and-nsubj|NN@auxpass-advcl|VBN]_[prep_in@auxpass],VERB_DEP_PATH_POS_[alter]_[conj_and-nsubj|NN@advcl]_[prep_in@],VERB_DEP_PATH_[be]_[conj_and-nsubj|gtpch@cop]_[prep_in-advcl|alter@cop],VERB_DEP_PATH_[be]_[conj_and-nsubj|gtpch@auxpass-advcl|alter]_[prep_in@auxpass],VERB_DEP_PATH_POS_[be]_[conj_and-nsubj|NN@cop]_[prep_in-advcl|VBN@cop],DEP_PATH_[conj_and-nsubj|gtpch@prep_in-advcl|alter],VERB_DEP_PATH_[alter]_[conj_and-nsubj|gtpch@advcl]_[prep_in@]}	{-3.11955,0.68498,0.68498,0.68498,0.68498,0.68498,0.68498,0.68498,0.68498}
journal.pone.0059067.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0059067.pdf_36_36_9_9_23_23_UNSUP	PLCE1/HP:0000093|Proteinuria	{9}	{23}	{[,6,],Rare,mutations,of,high,penetrance,within,PLCE1,are,associated,with,nephrotic,syndrome,",",a,condition,characterised,by,oedema,secondary,to,proteinuria,and,reduced,vascular,oncotic,pressure,.}	{"| nt | - oduction might result in impaired induction of anti-viral effector functions in NK cells with the consequence being a greater DENV-infected cell mass in vivo [ 6 ] , a recognised risk factor for severe dengue .","[ 7 ] The identiﬁcation ofvariants of PLCE1 as being associated with severe dengue is intriguing ."}	{"[ 8 ] Since plasma leak , proteinuria and hypovolemia are also characteristic features of severe dengue , it ’s plausible that nephrotic syndrome and severe dengue share some common underlying pathophysiological processes .","Furthermore , there are data implicating PLCE1 in the homeostatic regulation of blood pressure ."}	0.912	0.216	1	{DEP_PATH_POS_[prep_within-prep_of|NN-nsubjpass|NNS@prep_to-partmod|VBN-appos|NN-prep_with|NN],"WORD_SEQ_[be associate with nephrotic syndrome , a condition characterise by oedema secondary to]","POS_SEQ_[VBP_VBN_IN_JJ_NN_,_DT_NN_VBN_IN_NN_JJ_TO]",VERB_DEP_PATH_[associate]_[prep_within-prep_of|penetrance-nsubjpass|mutation@]_[prep_to-partmod|characterise-appos|condition-prep_with|syndrome@],DEP_PATH_[prep_within-prep_of|penetrance-nsubjpass|mutation@prep_to-partmod|characterise-appos|condition-prep_with|syndrome],VERB_DEP_PATH_POS_[associate]_[prep_within-prep_of|NN-nsubjpass|NNS@]_[prep_to-partmod|VBN-appos|NN-prep_with|NN@]}	{0.395606,0.395606,0.395606,0.395606,0.395606,0.395606}
journal.pone.0005555.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0005555.pdf_61_61_57_57_67_67_UNSUP	HI/HP:0003074|Hyperglycemia	{57}	{67}	{Furthermore,",",we,correlated,the,PSA-NCAM,labeling,to,the,functional,[,3-cell,mass,in,animal,models,where,it,is,either,decreased,or,increased,:,(,i,),the,Zucker,Diabetic,Fatty,(,ZDF,),rat,",",a,model,of,type,2,diabetes,[,16,],and,(,ii,),the,48,h,glucoseinfused,rat,(,HG,/,HI,),",",a,model,in,which,a,long-term,imposed,hyperglycemia,leads,to,pancreatic,overactivity,and,to,an,impressive,increase,of,functional,B-cell,mass,[,17,],.}	{"According to the level of surface PSA-NCAM , B-cells were divided in two subpopulations with different glucose responsiveness in rats [ 13 ] .","Our present study aimed to characterize these two groups of Bcells and to investigate the basis supporting their different insulin secretory capacities ."}	{"Taken together , our data ( i ) conﬁrm that PSA-NCAM is a prominent marker of functional B-cells , ( ii ) provide proof of concept that a functional heterogeneity of [ 3-cells exists in vivo and ( iii ) explore mechanistic insights of heterogeneity .","Moreover , they support the idea that an alteration of pancreatic B-cell plasticity , i.e. an inability to recruit fully functional B-cells , could contribute to the impairment of insulin secretion in type 2 diabetes ."}	0.944	0.068	0.252	{VERB_DEP_PATH_POS_[correlate]_[nn-dep|NN-dep|NNP@]_[nsubj-prepc_in|VBZ-dep|NNP@],VERB_DEP_PATH_POS_[lead]_[nn-dep|NN@prepc_in]_[nsubj@],VERB_DEP_PATH_[decrease]_[nn-dep|)-dep|HG@advcl]_[nsubj-prepc_in|lead-dep|HG@advcl],VERB_DEP_PATH_POS_[decrease]_[nn-dep|NN-dep|NNP@advcl]_[nsubj-prepc_in|VBZ-dep|NNP@advcl],"POS_SEQ_[NN_,_DT_NN_IN_WDT_DT_JJ_VBN]",DEP_PATH_POS_[nn-dep|NN@nsubj-prepc_in|VBZ],"WORD_SEQ_[) , a model in which a long-term impose]",VERB_DEP_PATH_[correlate]_[nn-dep|)-dep|HG@]_[nsubj-prepc_in|lead-dep|HG@],VERB_DEP_PATH_[lead]_[nn-dep|)@prepc_in]_[nsubj@],DEP_PATH_[nn-dep|)@nsubj-prepc_in|lead]}	{0.290012,0.290012,0.290012,0.290012,0.290012,0.290012,0.290012,0.290012,0.290012,0.290012}
journal.pone.0005526.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0005526.pdf_430_430_20_20_33_36_UNSUP	FBN1/HP:0001519|Disproportionate tall stature	{20}	{33,34,36}	{O,Mendelian,disorder,:,Marfan,syndrome,(,MFS,",",OMIM,#,154700,),o,Disease,gene,:,ﬁbrillin-1,precursor,(,FBN1,",",OMIM,*,134797,),o,Phenotype,:,variable,skeletal,abnormalities,",",tall,stature,",",disproportionately,long,limbs,and,digits,",",joint,laxity,",",eye,anomalies,and,progressive,cardiovascular,problems,.}	{"Platform : Agilent-012391 Whole Human Genome Oligo Microarray G4112A","o MFS"}	{"o Expression data : Tao et al. ( 2007 ) [ 12 ] ( GEO accession number GDS2960 ) .","Fibroblast cultures from patients with conﬁrmed FBN1 missense ( 9 ) and nonsense ( 7 ) mutations as"}	0.932	0.016	1	{DEP_PATH_[dep-_|disorder@ROOT@_],DEP_PATH_POS_[dep-_|NN@ROOT@_],"WORD_SEQ_[, omim * 134797 ) o phenotype : variable skeletal abnormality ,]","POS_SEQ_[,_NN_CD_CD_NN_NN_NN_:_JJ_JJ_NNS_,]","WORD_SEQ_NER_[, omim NUMBER NUMBER ) o phenotype : variable skeletal abnormality ,]"}	{2.64518,-2.59797,0.786883,0.786883,0.786883}
journal.pone.0097162.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0097162.pdf_7_7_21_21_25_27_UNSUP	FTO/HP:0004324|Increased body weight	{21}	{25,26,27}	{Single,nucleotide,polymorphisms,in,the,first,intron,of,the,fat,—,mass,—,and,—,obesity,—,re,|,ated,gene,FTO,are,associated,with,increased,body,weight,and,adiposity,.}	{"1 Henry Wellcome Centre for Gene Function , Department of Physiology , Anatomy ; and Genetics , University of Oxford , Parks Road , Oxford , United Kingdom , 2 Medical Research Council Harwell , Mammalian Genetics Unit , Harwell Science and Innovation Campus , Harwell , Oxford , United Kingdom",Abstract}	{"Increased expression of FTO is likely underlying this obesity phenotype , as mice with two additional copies of Fto ( FTO — 4 mice ) exhibit increased adiposity and are hyperphagic .","FTO is a demethylase of single stranded DNA and RNA , and one of its targets is the m6A modification in RNA , which might play a role in the regulation of gene expression ."}	0.946	0.484	0.998	{"WORD_SEQ_[be associate with]",DEP_PATH_[dobj-partmod|ate-tmod||-prep_in|intron-nsubjpass|polymorphism@prep_with],DEP_PATH_POS_[dobj-partmod|VBN-tmod|NN-prep_in|NN-nsubjpass|NNS@prep_with],POS_SEQ_[VBP_VBN_IN]}	{2.44981,0.296332,0.296332,-0.2401}
journal.pone.0081437.pdf	RELATION_GENEHPOTERM_journal.pone.0081437.pdf_114_114_9_9_13_13	CEACAMP8/HP:0100602|Preeclampsia	{9}	{13}	{These,data,indicated,that,LOC391533,",",LOC284100,",",and,CEACAMP8,were,up-regulated,in,preeclampsia,samples,compared,with,NT,samples,(,Figure,2,",",Table,88,),.}	{"( cc .","5 j e , j ° ‘ \\" \\" $ E j 15 ' j matched control placenta tissues using qPCR ( p < 0.05 for each lncRNAs ) ."}	{Discussion,"Preeclampsia is a systemic complication of pregnancy , which presents with hypertension , proteinuria and pathologic edema ."}	0.92	0.466	1	{POS_SEQ_[VBD_VBN_IN],DEP_PATH_POS_[conj_and-nsubjpass|NN@nn-prep_in|NNS],VERB_DEP_PATH_POS_[be]_[conj_and-nsubjpass|NN@auxpass]_[nn-prep_in|NNS@auxpass],VERB_DEP_PATH_POS_[indicate]_[conj_and-nsubjpass|NN-ccomp|VBN@]_[nn-prep_in|NNS-ccomp|VBN@],"WORD_SEQ_[be up-regulate in]",DEP_PATH_[conj_and-nsubjpass|loc391533@nn-prep_in|sample],VERB_DEP_PATH_[indicate]_[conj_and-nsubjpass|loc391533-ccomp|up-regulate@]_[nn-prep_in|sample-ccomp|up-regulate@],VERB_DEP_PATH_[be]_[conj_and-nsubjpass|loc391533@auxpass]_[nn-prep_in|sample@auxpass]}	{-2.52524,0.899429,0.899429,0.591011,0.591011,0.591011,0.591011,0.591011}
SCPDFS_38559.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_38559.pdf_473_473_8_8_15_15_UNSUP	SCN5A/HP:0011675|Arrhythmia	{8}	{15}	{[,3,W.,Wang,",",et,al.,",",SCN5A,mutations,associated,with,an,inherited,cardiac,arrhythmia,",",long,QT,syndrome,",",Cell,80,(,1995,),805-811,.}	{"112 ( 2003 ) 8105 .","[ 2 M. Keating , M. Sanguinetti , Molecular and cellular mechanisms of cardiac arrhythmias , Cell 104 ( 2001 ) 569-580 ."}	{"[ 4 I. Splawski , M. Tristani-Firouzi , M. Lehmann , M. Sanguinetti , M. Keating , Mutations in the hminK gene cause long QT syndrome and suppress IKs function , Nat .","Genet ."}	0.956	0.82	1	{DEP_PATH_POS_[nn@prep_with-partmod|VBN],"WORD_SEQ_[mutation associate with a inherit cardiac]",POS_SEQ_[NNS_VBN_IN_DT_VBN_JJ],VERB_DEP_PATH_POS_[associate]_[nn@partmod]_[prep_with@],VERB_DEP_PATH_[associate]_[nn@partmod]_[prep_with@],DEP_PATH_[nn@prep_with-partmod|associate],VERB_DEP_PATH_POS_[inherit]_[nn@amod-prep_with|NN-partmod|VBN]_[@amod],VERB_DEP_PATH_[inherit]_[nn@amod-prep_with|arrhythmium-partmod|associate]_[@amod]}	{-1.53458,1.40363,1.40363,0.878004,0.878004,0.878004,-0.441328,-0.441328}
journal.pone.0064189.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0064189.pdf_38_38_13_13_21_22_UNSUP	p53/HP:0012125|Prostate cancer	{13}	{21,22}	{Most,recently,",",our,lab,reported,that,sGCoil,can,block,the,activity,of,p53,in,and,thus,enhance,the,survival,of,prostate,cancer,cells,[,10,],.}	{"Dysregulation of this balance between cell proliferation and cell death is undoubtedly critical to the development of prostate cancer .","expression is barely detectable in normal prostate tissues and is markedly elevated in prostate cancer tissues , with expression levels increasing with increasing stage of disease and the highest levels observed in hormone — refractory prostate cancer [ 7 ] ."}	{"PLOS ONE | www .","p | osone.org 1 May 2013 | Volume 8 | Issue 5 | e64189"}	0.93	0.21	1	{DEP_PATH_[prep_of@nn-prep_of|cell-nsubj|survival-ccomp|[-dep|enhance-dep|in],VERB_DEP_PATH_[enhance]_[prep_of@dep-dep|in]_[nn-prep_of|cell-nsubj|survival-ccomp|[@],VERB_DEP_PATH_POS_[enhance]_[prep_of@dep-dep|IN]_[nn-prep_of|NNS-nsubj|NN-ccomp|VBP@],"WORD_SEQ_[in and thus enhance the survival of]",DEP_PATH_POS_[prep_of@nn-prep_of|NNS-nsubj|NN-ccomp|VBP-dep|VBP-dep|IN],POS_SEQ_[IN_CC_RB_VBP_DT_NN_IN]}	{0.446361,0.446361,0.446361,0.446361,0.446361,0.446361}
SCPDFS_41023.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_41023.pdf_163_163_34_34_27_27_UNSUP	PAX6/HP:0000526|Aniridia	{34}	{27}	{Conversely,",",all,members,of,the,contig,were,within,the,deletions,of,WESMI,and,TAK,",",who,are,not,deleted,for,the,WT1,gene,but,who,have,aniridia,and,are,missing,one,copy,of,PAX6,.}	{"The distal DAR deletion breakpoint is known to be within the 375-kb NotI fragment ( Fig .","1 ) ."}	{"An individual , THOPH , with triphasic Wilms ’ tumor and hypospadias but no aniridia , was deleted for WT1 but not for cSRL9a9 .","FISH signal with H11148 was strong on the normal chromosome 11 from THOPH but weak on the deletion-bearing chromosome , suggesting that this cosmid spans the distal THOPH breakpoint ( Fig ."}	0.934	0.05	0.938	{INV_VERB_DEP_PATH_[be]_[prep_of-dobj|copy@aux]_[dobj@aux-conj_and|miss],"INV_WORD_SEQ_NER_[and be miss NUMBER copy of]",INV_VERB_DEP_PATH_POS_[have]_[prep_of-dobj|NN-conj_and|VBG@]_[dobj@],INV_POS_SEQ_[CC_VBP_VBG_CD_NN_IN],INV_DEP_PATH_[prep_of-dobj|copy-conj_and|miss@dobj],INV_VERB_DEP_PATH_POS_[miss]_[prep_of-dobj|NN@]_[dobj@conj_and],INV_VERB_DEP_PATH_POS_[delete]_[prep_of-dobj|NN-conj_and|VBG-conj_but|VBP@]_[dobj-conj_but|VBP@],INV_VERB_DEP_PATH_[delete]_[prep_of-dobj|copy-conj_and|miss-conj_but|have@]_[dobj-conj_but|have@],"INV_WORD_SEQ_[and be miss one copy of]",INV_VERB_DEP_PATH_[have]_[prep_of-dobj|copy-conj_and|miss@]_[dobj@],INV_VERB_DEP_PATH_[miss]_[prep_of-dobj|copy@]_[dobj@conj_and],INV_DEP_PATH_POS_[prep_of-dobj|NN-conj_and|VBG@dobj],INV_VERB_DEP_PATH_POS_[be]_[prep_of-dobj|NN@aux]_[dobj@aux-conj_and|VBG]}	{0.227957,0.227957,0.227957,0.227957,0.227957,0.227957,0.227957,0.227957,0.227957,0.227957,0.227957,0.227957,0.227957}
journal.pone.0081281.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0081281.pdf_28_28_15_15_34_36_UNSUP	FBN/HP:0001634|Mitral valve prolapse	{15}	{34,35,36}	{Moreover,",",defective,ﬁbrillin-1,alters,transforming,growth,factor-B,(,TGF-B,),signaling,",",which,in,FBN,],deﬁcient,mice,has,been,shown,to,account,for,manifestations,of,Marfan,syndrome,such,as,pulmonary,emphysema,",",mitral,valve,prolapse,",",skeletal,muscle,myopathy,and,aortic,root,dilatation,[,3,—,6,],.}	{Introduction,"Marfan syndrome is an autosomal-dominantly inherited disease of the connective tissue that is caused by mutations of the ﬁbrillin-1 ( FBNI ) gene , which encodes ﬁbrillin-l monomers of the extracellular microﬁbrils 5 - Defective ﬁbrillin-l may cause Marfan syndrome phenotype by disrupting the structure of the connective tissue elastic ﬁbres [ 2 ] ."}	{"In untreated Marfan syndrome dissection and rupture of the proximal aorta are major causes of premature death , but current medical and surgical therapy prevents most of these fatalities [ 7,8 ] .","There is mounting evidence , that Marfan syndrome also carries a risk for ventricular arrhythmia and sudden cardiac death ( SCD ) [ 9 — l2 ] ."}	0.964	0.042	0.992	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_POS_[account]_[prep_in@xcomp]_[prep_such_as-prep_of|NN-prep_for|NNS@],VERB_DEP_PATH_POS_[show]_[prep_in@]_[prep_such_as-prep_of|NN-prep_for|NNS-xcomp|VB@],DEP_PATH_POS_[prep_in@prep_such_as-prep_of|NN-prep_for|NNS-xcomp|VB],VERB_DEP_PATH_[show]_[prep_in@]_[prep_such_as-prep_of|syndrome-prep_for|manifestation-xcomp|account@],DEP_PATH_[prep_in@prep_such_as-prep_of|syndrome-prep_for|manifestation-xcomp|account],VERB_DEP_PATH_[account]_[prep_in@xcomp]_[prep_such_as-prep_of|syndrome-prep_for|manifestation@]}	{-3.11955,1.03768,1.03768,1.03768,1.03768,1.03768,1.03768}
journal.pone.0086340.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0086340.pdf_404_404_35_35_19_21_UNSUP	OPA1/HP:0000590|Progressive external ophthalmoplegia	{35}	{19,20,21}	{Ferraris,S,",",Clark,S,",",Garelli,E,",",Davidzon,G,",",Moore,SA,et,al.,(,2008,),Progressive,external,ophthalmoplegia,and,vision,and,hearing,loss,in,a,patient,with,mutations,in,POLG2,and,OPA1,.}	{"Van Goethem G , Dermaut B , Lofgren A , l \\\\ ’ IartinJJ , Van BC ( 2001 ) l \\\\ ’ Iutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions .","Nat Genet 28 : 211-212 ."}	{"Arch Neurol 65 : 125-131 .","Spelbrink JN , Li FY , Tiranti V , Nikali K , Yuan QP et al. ( 2001 ) Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle , a phage T7 gene 4-like protein localized in mitochondria ."}	0.918	0.976	0.98	{INV_DEP_PATH_[prep_in-prep_with|mutation@dep-dobj|NUMBER],INV_DEP_PATH_POS_[prep_in-prep_with|NNS@dep-dobj|CD],"INV_WORD_SEQ_[and vision and hearing loss in a patient with mutation in polg2 and]",INV_POS_SEQ_[CC_NN_CC_NN_NN_IN_DT_NN_IN_NNS_IN_NN_CC]}	{1.21235,0.640577,0.295119,0.295119}
SCPDFS_1357.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_1357.pdf_44_44_0_0_6_6_UNSUP	SOX2/HP:0000528|Anophthalmia	{0}	{6}	{SOX2,haploinsufﬁciency,has,been,associated,with,anophthalmia,",",microphthalmia,",",and,septo,—,optic,dysplasia,(,SOD,),which,is,a,congenital,brain,malformation,with,pituitary,",",optic,nerve,",",and,midline,forebrain,defects,(,Kelberman,et,al.,",",2006,;,Fantes,et,al.,",",2003,;,Kelberrnan,and,Dattani,",",2007,;,Williamson,et,al.,",",2006,),.}	{"The neural retina and hypothalamus are more sensitive than other regions of the neuroepithelium to Sox2 dosage , likely because the other SoxB1 members , Sox1 and Sox3 , are not expressed in the neural retina , and Sox1 is excluded from the ventral diencephalon .","Normal dosage of SOX2 is also critical for human development ."}	{"Despite the recognition of critical roles of Sox2 in central nervous system ( CNS ) development , little is known about mechanisms of how Sox2 deﬁciency leads to different outcomes in dose — and context — dependent manners .","This is partly due to the limited number of known Sox2 targets during the progress of CNS development ."}	0.984	0.414	0.99	{VERB_DEP_PATH_POS_[have]_[nn-nsubjpass|NN@aux]_[prep_with@aux],VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NN@]_[prep_with@],DEP_PATH_[nn-nsubjpass|haploinsufﬁciency@prep_with],VERB_DEP_PATH_[associate]_[nn-nsubjpass|haploinsufﬁciency@]_[prep_with@],VERB_DEP_PATH_[be]_[nn-nsubjpass|haploinsufﬁciency@auxpass]_[prep_with@auxpass],DEP_PATH_POS_[nn-nsubjpass|NN@prep_with],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[prep_with@auxpass],VERB_DEP_PATH_[have]_[nn-nsubjpass|haploinsufﬁciency@aux]_[prep_with@aux],"WORD_SEQ_[haploinsufﬁciency have be associate with]",POS_SEQ_[NN_VBZ_VBN_VBN_IN]}	{1.47358,1.06947,0.458499,0.458499,0.458499,-0.453996,-0.453996,0.231987,0.231987,0.20609}
journal.pone.0089095.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0089095.pdf_420_420_14_14_26_27_UNSUP	PC/HP:0100543|Cognitive impairment	{14}	{26,27}	{Kantarci,K,",",jack,CR,jr.,",",Xu,YC,",",Campeau,NG,",",O’Brien,PC,",",et,al.,(,2000,),Regional,metabolic,patterns,in,mild,cognitive,impairment,and,Alzheimer,’s,disease,:,A,1H,l,"\\\\",’,IRS,study,.}	{"l metabolic and cognitive decline in persons at genetic risk for Alzheimer ’s disease .","PNAS 97 : 6037 — 6042 ."}	{"Neurology 55 : 210 * 217 .","Drzezga A , Lautenschlager N , Siebner H , Riemenschneider IVI , VVil1och F , et al. ( 2003 ) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer ’s disease : a PET follow-up study ."}	0.93	0.034	1	{DEP_PATH_POS_[appos@prep_in-dep|NNS-dep|FW],"POS_SEQ_[,_FW_FW_FW_CD_CD_NNP_JJ_NNS_IN_JJ]","WORD_SEQ_NER_[, et al. ( DATE NUMBER Regional metabolic pattern in mild]","WORD_SEQ_[, et al. ( 2000 ) Regional metabolic pattern in mild]",DEP_PATH_[appos@prep_in-dep|pattern-dep|(]}	{-1.12368,0.997773,0.997773,0.997773,0.676632}
journal.pone.0075793.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0075793.pdf_427_427_14_14_20_21_UNSUP	ACTG1/HP:0000365|Hearing impairment	{14}	{20,21}	{(,2009,),In,vivo,and,in,vitro,effects,of,two,novel,gamma-actin,(,ACTG1,),mutations,that,cause,DFNA20/26,hearing,impairment,.}	{"MP5 Finds Causative Mutations in CI/EAS Patients","Nlorin 1 \\\\ ’ I , Bryan KE , 1VIayo ~ 1 \\\\ ’ Ierino F , Goodyear R , 1VIencia A , et a1 ."}	{"Hum 1VIo1 Genet .","18 : 307545089 ."}	0.954	0.116	1	{"WORD_SEQ_[) mutation that cause dfna20/26]",POS_SEQ_[NN_NNS_WDT_VBP_NN],VERB_DEP_PATH_POS_[cause]_[nn-dep|NNS-prep_of|NN-nsubj|NNS@]_[dobj@],VERB_DEP_PATH_[cause]_[nn-dep|mutation-prep_of|gamma-actin-nsubj|effect@]_[dobj@],DEP_PATH_[nn-dep|mutation-prep_of|gamma-actin-nsubj|effect@dobj],DEP_PATH_POS_[nn-dep|NNS-prep_of|NN-nsubj|NNS@dobj]}	{0.716814,0.44775,0.343862,0.343862,0.343862,0.343862}
journal.pone.0012262.pdf	RELATION_GENEHPOTERM_journal.pone.0012262.pdf_2025_2025_28_28_39_40	PKP1/HP:0000968|Ectodermal dysplasia	{28}	{39,40}	{Sprecher,E,",",l,"\\\\",’,Iolho-Pessach,V,",",Ingber,A,",",Sagi,E,",",Indelman,NI,",",et,al.,(,2004,),Homozygous,splice,site,mutations,in,PKP1,result,in,loss,of,epidermal,plakophilin,1,expression,and,underlie,ectodermal,dysplasia,/,skin,fragility,syndrome,in,two,consanguineous,families,.}	{"Boralevi F , Haftek NI , Vabres P , Lepreux S , Goizet C , et al. ( 2005 ) Hereditary mucoepithelial dysplasia : clinical , ultrastructural and genetic study of eight patients and literature review .","BrJ Dermatol 153 : 3104318 ."}	{"J Invest Dermatol 122 : 6474651 .","Cheng X , l \\\\ ’ Iihindukulasuriya K , Den Z , Kowalczyk AP , Calkins CC , et al. ( 2004 ) Assessment of splice variant-specific functions of desmocollin 1 in the skin ."}	0.918	0.894	1	{VERB_DEP_PATH_POS_[underlie]_[nn-prep_in|NN-dep|NNS@dep]_[dobj@],"WORD_SEQ_NER_[result in loss of epidermal plakophilin NUMBER expression and underlie]",DEP_PATH_[nn-prep_in|result-dep|mutation@dobj-dep|underlie],"WORD_SEQ_[result in loss of epidermal plakophilin 1 expression and underlie]",DEP_PATH_POS_[nn-prep_in|NN-dep|NNS@dobj-dep|VB],POS_SEQ_[NN_IN_NN_IN_JJ_NN_CD_NN_CC_VB],VERB_DEP_PATH_[underlie]_[nn-prep_in|result-dep|mutation@dep]_[dobj@]}	{0.334394,0.334394,0.334394,0.334394,0.334394,0.334394,0.334394}
journal.pgen.1002708.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1002708.pdf_565_565_13_13_30_31_UNSUP	ENPP1/HP:0004912|Hypophosphatemic rickets	{13}	{30,31}	{Mutations,in,four,genes,",",FGF23,itself,",",PHEX,",",DMP,],and,ENPP1,",",have,been,reported,to,remarkably,increase,the,plasma,levels,of,FGF23,",",leading,to,hereditary,hypophosphatemic,rickets,[,9,—,"11,13",—,15,],.}	{"As in the cases of PHEX - and DMP ] - deficiency , FGF 23 was overexpressed in the bones of the Fam20c cKO mice ( Figure 8K and 8L , Table 2 ) .","The overproduction of FGF 23 by the bone cells is likely to be responsible for the elevation of this protein in the serum ."}	{"Dm / ) 1 - , P/zex - and Fam20c-deﬁcient mice shared similarities in osteomalacia , hypophosphatemia and the remarkable elevation of F GF23 in the circulation and skeleton .","Interestingly , an alteration of Fam20c expression was not observed in the Dmpl KO mice or Hyp mice , while remarkable downregulation of Dmpl ( but not P/zex ) was observed in the Fam20c cKO mice ."}	0.94	0.116	1	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_[increase]_[conj_and-appos|]-nsubjpass|mutation@xcomp]_[prep_to-xcomp|lead@xcomp],VERB_DEP_PATH_[have]_[conj_and-appos|]-nsubjpass|mutation@aux]_[prep_to-xcomp|lead@aux],VERB_DEP_PATH_[lead]_[conj_and-appos|]-nsubjpass|mutation@xcomp]_[prep_to@],VERB_DEP_PATH_POS_[have]_[conj_and-appos|NN-nsubjpass|NNS@aux]_[prep_to-xcomp|VBG@aux],VERB_DEP_PATH_POS_[increase]_[conj_and-appos|NN-nsubjpass|NNS@xcomp]_[prep_to-xcomp|VBG@xcomp],VERB_DEP_PATH_POS_[be]_[conj_and-appos|NN-nsubjpass|NNS@auxpass]_[prep_to-xcomp|VBG@auxpass],VERB_DEP_PATH_[report]_[conj_and-appos|]-nsubjpass|mutation@]_[prep_to-xcomp|lead@],DEP_PATH_[conj_and-appos|]-nsubjpass|mutation@prep_to-xcomp|lead],VERB_DEP_PATH_POS_[lead]_[conj_and-appos|NN-nsubjpass|NNS@xcomp]_[prep_to@],VERB_DEP_PATH_POS_[report]_[conj_and-appos|NN-nsubjpass|NNS@]_[prep_to-xcomp|VBG@],VERB_DEP_PATH_[be]_[conj_and-appos|]-nsubjpass|mutation@auxpass]_[prep_to-xcomp|lead@auxpass],DEP_PATH_POS_[conj_and-appos|NN-nsubjpass|NNS@prep_to-xcomp|VBG]}	{-3.11955,0.491761,0.491761,0.491761,0.491761,0.491761,0.491761,0.491761,0.491761,0.491761,0.491761,0.491761,0.491761}
journal.pone.0061054.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0061054.pdf_340_340_30_30_27_27_UNSUP	BCL2/HP:0002665|Lymphoma	{30}	{27}	{Other,targets,of,miR34a,involved,in,cell,cycle,",",cell,growth,",",invasion,and,apoptosis,including,Cyclin,D1,",",Cyclin,E2,",",E2F,",",B-cell,CLL,/,lymphoma,2,(,BCL2,),",",CCNE2,",",CCND1,",",microtubule,actin,cross-linking,factor,1,(,MACF1,),",",cyclin-dependent,kinase,6,(,CDK6,),",",CDK4,",",LaminA,/,C,",",microtubuleactin,cross-linking,factor,",",tubulin,a-1B,chain,",",Glial,ﬁbrillary,acidic,protein,(,GFAP,),",",Tropomyosin,oi-4,chain,(,TPM4,),",",chaperone,protein,Endoplasmin,(,HSP90B1,),",",Lamin-A,/,C,(,LMNA,),",",Aldehyde,dehydrogenase,(,ALDH2,),",",Leucine-rich,repeat-containing,protein,(,LOClOO129335,),",",Cathepsin,D,",",baculoviral,IAP,repeat-containing,3,(,BIRC3,),",",decoy,receptor,3,(,DCR3,also,known,as,TNFRSF6B,),and,c-MET,[,"14,20,21",],.}	{"When p53 was induced , it alters the expression of a large set of target genes leading to cell-cycle arrest , apoptosis , increased DNA repair , and / or inhibition of angiogenesis .","miR — 34a is suggested to be an important component of the p53 tumor suppressor network [ 21 ] ."}	{"Further exploration is needed to investigate target genes of miR — 34a of HCC cells .","Higher expression of c-MET in tumor tissue can lead to scattering , angiogenesis , proliferation , enhanced cell motility , invasion , and eventually , metastasis [ 22,23,24,25,26 ] ."}	0.918	0.964	1	{"INV_WORD_SEQ_[2 (]",INV_POS_SEQ_[CD_CD],INV_DEP_PATH_POS_[dep@dep],INV_DEP_PATH_[dep@dep],INV_VERB_DEP_PATH_[involve]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[involve]_[dep@dep]_[dep@dep],"INV_WORD_SEQ_NER_[NUMBER NUMBER]",INV_VERB_DEP_PATH_POS_[include]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[include]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[know]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[know]_[dep@dep]_[dep@dep]}	{3.93688,-1.21389,-0.366141,-0.339995,0.182174,0.182174,0.15378,-0.0942341,-0.0942341,-0.0303663,-0.0303663}
journal.pone.0062046.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0062046.pdf_57_57_2_2_11_12_UNSUP	GATA3/HP:0000110|Renal dysplasia	{2}	{11,12}	{Haploinsufﬁciency,of,GATA3,causes,human,hypoparathyroidism,",",sensorineural,deafness,",",and,renal,dysplasia,(,HDR,),syndrome,[,36,],.}	{"Gata3 expression continues in the organ of Corti and spiral ganglion neurons from speciﬁcation through late postnatal stages [ 17,32 — 34 ] .","However , levels of Gata3 protein expression in the hair cells of the organ of Corti seems to decrease over time , [ 35 ] but remains in the supporting cells [ 17,34 ] ."}	{"While patients have different combinations of the three central phenotypes which characterize HDR syndrome , all patients studied thus far have some form of sensorineural deafness [ 3 7 ] , indicating GATA3 has a particularly profound role in cochlear neurosensory development .","Despite its apparent absolute necessity for early neurosensory formation in the cochlea [ 38,39 ] , the role of Gata3 in cochlear neurosensory speciﬁcation , differentiation , and maintenance as well as the relationship of Gata3 to other pro-neurosensory genes and their cascades remains unclear due to limited viability of the mouse Gata3 null mutant ."}	0.924	0.558	1	{VERB_DEP_PATH_POS_[cause]_[prep_of-nsubj|NN@]_[dobj@],DEP_PATH_POS_[prep_of-nsubj|NN@dobj],DEP_PATH_[prep_of-nsubj|haploinsufﬁciency@dobj],VERB_DEP_PATH_[cause]_[prep_of-nsubj|haploinsufﬁciency@]_[dobj@],"POS_SEQ_[VBZ_JJ_NN_,_JJ_NN_,_CC]","WORD_SEQ_[cause human hypoparathyroidism , sensorineural deafness , and]"}	{1.56131,-0.981214,0.677698,0.677698,0.223059,0.223059}
SCPDFS_45549.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_45549.pdf_439_439_23_23_11_11_UNSUP	WAGR/HP:0000526|Aniridia	{23}	{11}	{The,),3-subunit,of,follicle-stimulating,hormone,is,deleted,in,patients,with,aniridia,and,Wilms,’,tumor,",",allowing,a,further,deﬁnition,of,the,WAGR,locus,.}	{"M. , SIMOLA , K. o. J .",", AND HOUSMAN , D. E. ( 1986 ) ."}	{"Nature ( London ) 321 : 882-887 .","GLUECKSOHN-WAELSCH , S. ( 1979 ) ."}	0.998	0.29	1	{INV_VERB_DEP_PATH_POS_[delete]_[nn-prep_of|NN-dobj|NN-xcomp|VBG@]_[prep_with@],INV_VERB_DEP_PATH_POS_[allow]_[nn-prep_of|NN-dobj|NN@]_[prep_with@xcomp],INV_DEP_PATH_POS_[nn-prep_of|NN-dobj|NN-xcomp|VBG@prep_with],"INV_POS_SEQ_[CC_NN_CD_NN_,_VBG_DT_JJ_NN_IN_DT]","INV_WORD_SEQ_[and wilm ’ tumor , allow a further deﬁnition of the]","INV_WORD_SEQ_NER_[and PERSON NUMBER tumor , allow a further deﬁnition of the]",INV_DEP_PATH_[nn-prep_of|locus-dobj|deﬁnition-xcomp|allow@prep_with],INV_VERB_DEP_PATH_[allow]_[nn-prep_of|locus-dobj|deﬁnition@]_[prep_with@xcomp],INV_VERB_DEP_PATH_[delete]_[nn-prep_of|locus-dobj|deﬁnition-xcomp|allow@]_[prep_with@]}	{0.759674,0.759674,0.759674,0.747882,0.499939,0.499939,0.394014,0.394014,0.394014}
SCPDFS_45224.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_45224.pdf_305_305_22_22_10_10_UNSUP	WAGR/HP:0000526|Aniridia	{22}	{10}	{The,ﬂ-subunit,of,follicle-stimulating,hormone,is,deleted,in,patients,with,aniridia,and,Wilms,’,tumor,",",allowing,a,further,definition,of,the,WAGR,locus,.}	{"44 : 486-495 .","GLASER , T. , LEWIS , W. H. , BRUNS , G. A. P. , WATKINS , P. C. , ROGLER , C. E. , SHows , T. B. , POWERS , V. E. , WILLARD , H. F. , GOGUEN , J. M. , SIMOLA , K. O. J. , AND HOUSMAN , D. E. ( 1986 ) ."}	{"Nature ( London ) 321 : 882-887 .","GRAY , K. M. , WHITE , J. W. , CoNsTANzI , C. , GILLESPIE , D. , SCHROEDER , W. T. , CALABRE'I ' I ‘ A , B. , AND SAUNDERS , G. F. ( 1985 ) ."}	0.99	0.27	1	{INV_VERB_DEP_PATH_POS_[delete]_[nn-prep_of|NN-dobj|NN-xcomp|VBG@]_[prep_with@],INV_VERB_DEP_PATH_POS_[allow]_[nn-prep_of|NN-dobj|NN@]_[prep_with@xcomp],INV_DEP_PATH_POS_[nn-prep_of|NN-dobj|NN-xcomp|VBG@prep_with],"INV_POS_SEQ_[CC_NN_CD_NN_,_VBG_DT_JJ_NN_IN_DT]",INV_VERB_DEP_PATH_[allow]_[nn-prep_of|locus-dobj|definition@]_[prep_with@xcomp],INV_VERB_DEP_PATH_[delete]_[nn-prep_of|locus-dobj|definition-xcomp|allow@]_[prep_with@],INV_DEP_PATH_[nn-prep_of|locus-dobj|definition-xcomp|allow@prep_with],"INV_WORD_SEQ_NER_[and PERSON NUMBER tumor , allow a further definition of the]","INV_WORD_SEQ_[and wilm ’ tumor , allow a further definition of the]"}	{0.759674,0.759674,0.759674,0.747882,0.36566,0.36566,0.36566,0.247943,0.247943}
journal.pgen.1001360.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1001360.pdf_260_260_14_14_17_17_UNSUP	p53/HP:0002669|Osteosarcoma	{14}	{17}	{Furthermore,",",a,direct,role,for,p53,in,TLR,gene,expression,was,demonstrated,using,p53,"null",SaOS2,osteosarcoma,cells,that,have,p53,under,the,control,of,a,tetracycline,inducible,promoter,[,27,],.}	{"Thus , all TLR genes are subject to DNA-damage associated transcriptional regulation and most are directly targeted by p53 .","( We also identiﬁed other p53-like sequences in the analyzed regions ; however , these were predicted to be less functional than the sequences examined ) ."}	{"Expression of wild-type",!}	0.96	0.388	0.996	{POS_SEQ_[JJ_NN],"WORD_SEQ_[null saos2]",DEP_PATH_POS_[dobj@nn-tmod|NNS],VERB_DEP_PATH_POS_[use]_[dobj@]_[nn-tmod|NNS@],VERB_DEP_PATH_POS_[have]_[dobj@rcmod-tmod|NNS]_[nn@rcmod],VERB_DEP_PATH_[demonstrate]_[dobj-dep|use@]_[nn-tmod|cell-dep|use@],VERB_DEP_PATH_[be]_[dobj-dep|use@auxpass]_[nn-tmod|cell-dep|use@auxpass],VERB_DEP_PATH_POS_[be]_[dobj-dep|VBG@auxpass]_[nn-tmod|NNS-dep|VBG@auxpass],VERB_DEP_PATH_[use]_[dobj@]_[nn-tmod|cell@],DEP_PATH_[dobj@nn-tmod|cell],VERB_DEP_PATH_[have]_[dobj@rcmod-tmod|cell]_[nn@rcmod],VERB_DEP_PATH_POS_[demonstrate]_[dobj-dep|VBG@]_[nn-tmod|NNS-dep|VBG@]}	{-1.27661,0.375572,0.375572,0.375572,0.375572,0.375572,0.375572,0.375572,0.375572,0.375572,0.375572,0.375572}
SCPDFS_41023.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_41023.pdf_417_417_30_30_28_28_UNSUP	WAGR/HP:0000526|Aniridia	{30}	{28}	{These,have,been,described,either,previously,(,Fantes,et,al.,",",1995a,),or,here,;,WT,denotes,individuals,with,Wilms,tumor,only,;,similarly,",",AN,denotes,aniridia,and,WAGR,denotes,individuals,with,aniridia,and,either,Wilm,’s,tumor,or,gonadal,anomalies,.}	{"The extent of the SeyH deletion was determined in the analyses described here , and the Se ; / De ’ deletion has been described by Glaser et al. ( 1990 ) .","Below the map of human 11p13 the extents of WAGR deletions are shown ."}	{"In addition , some of the individuals have mental retardation .","tation in Pax6 ( Roberts , 1967 ; Hill et al. , 1991 ) are born with no eyes or nose and die soon after birth ."}	0.904	0.012	0.204	{INV_POS_SEQ_[CC],INV_DEP_PATH_[nsubj@nsubj],INV_DEP_PATH_POS_[nsubj@nsubj],INV_VERB_DEP_PATH_[denote]_[nsubj@]_[nsubj@],INV_VERB_DEP_PATH_POS_[have]_[nsubj-ccomp|VBZ-parataxis|VBZ@aux]_[nsubj-ccomp|VBZ-parataxis|VBZ@aux],INV_VERB_DEP_PATH_POS_[denote]_[nsubj-ccomp|VBZ@]_[nsubj-ccomp|VBZ@],INV_VERB_DEP_PATH_[be]_[nsubj-ccomp|denote-parataxis|denote@auxpass]_[nsubj-ccomp|denote-parataxis|denote@auxpass],INV_VERB_DEP_PATH_POS_[describe]_[nsubj-ccomp|VBZ-parataxis|VBZ@]_[nsubj-ccomp|VBZ-parataxis|VBZ@],INV_VERB_DEP_PATH_POS_[denote]_[nsubj@]_[nsubj@],INV_VERB_DEP_PATH_POS_[be]_[nsubj-ccomp|VBZ-parataxis|VBZ@auxpass]_[nsubj-ccomp|VBZ-parataxis|VBZ@auxpass],INV_VERB_DEP_PATH_[describe]_[nsubj-ccomp|denote-parataxis|denote@]_[nsubj-ccomp|denote-parataxis|denote@],INV_VERB_DEP_PATH_POS_[denote]_[nsubj-ccomp|VBZ-parataxis|VBZ@parataxis]_[nsubj-ccomp|VBZ-parataxis|VBZ@parataxis],INV_VERB_DEP_PATH_[have]_[nsubj-ccomp|denote-parataxis|denote@aux]_[nsubj-ccomp|denote-parataxis|denote@aux],INV_VERB_DEP_PATH_[denote]_[nsubj-ccomp|denote@]_[nsubj-ccomp|denote@],INV_VERB_DEP_PATH_[denote]_[nsubj-ccomp|denote-parataxis|denote@parataxis]_[nsubj-ccomp|denote-parataxis|denote@parataxis],INV_WORD_SEQ_[and]}	{-2.39651,-1.68916,-1.68916,0.644259,0.644259,0.644259,0.644259,0.644259,0.644259,0.644259,0.644259,0.644259,0.644259,0.644259,0.644259,0.471703}
journal.pone.0074577.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0074577.pdf_195_195_25_25_19_23_UNSUP	MODY/HP:0004904|Maturity-onset diabetes of the young	{25}	{19,20,23}	{Shields,BM,",",Hicks,S,",",Shepherd,MH,",",Colclough,K,",",Hattersley,AT,et,al.,(,2010,),Maturity-onset,diabetes,of,the,young,(,MODY,),:,how,many,cases,are,we,missing,?}	{References,"1 ."}	{"Diabetologia 53 ( 12 ) : 2504-2508 .","doi :10.1007 / s00125-010-1799-4 ."}	0.938	0.016	0.93	{INV_WORD_SEQ_[(],INV_POS_SEQ_[CD],INV_WORD_SEQ_NER_[NUMBER],INV_DEP_PATH_POS_[dep-prep_of|CD@],INV_DEP_PATH_[dep-prep_of|NUMBER@],INV_VERB_DEP_PATH_POS_[miss]_[dep@xcomp-dep|VBP]_[@xcomp-dep|VBP-prep_of|CD],INV_VERB_DEP_PATH_[miss]_[dep@xcomp-dep|be]_[@xcomp-dep|be-prep_of|NUMBER],INV_VERB_DEP_PATH_POS_[be]_[dep@dep]_[@dep-prep_of|CD],INV_VERB_DEP_PATH_[be]_[dep@dep]_[@dep-prep_of|NUMBER]}	{2.44157,-2.38582,-1.89055,1.46406,1.06552,0.490125,0.490125,0.490125,0.490125}
journal.pone.0068781.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0068781.pdf_29_29_7_7_17_18_UNSUP	GPR56/HP:0007095|Frontoparietal polymicrogyria	{7}	{17,18}	{Mutations,in,one,such,adhesion,GPCR,",",GPR56,",",cause,a,speciﬁc,human,brain,malformation,called,bilateral,frontoparietal,polymicrogyria,(,BFPP,),[,10,],.}	{"Recently , the family of adhesion G proteincoupled receptors ( GPCRs ) was identiﬁed as the third major category of ECM receptors [ 5,6 ] .","Adhesion GPCRs are characterized by the presence of a large extracellular region and a g protein proteolytic gite ( GPS ) domain that cleaves the receptor into N - and C-terminal fragments [ 7 — 9 ] ."}	{"BFPP is a recessively inherited genetic disorder affecting human cerebral cortical development and characterized by disorganized cortical lamination that is most severe in the frontal and parietal lobes [ 10 — 13 ] .","Histological analyses of postmortem human BFPP brain samples and Gpr56 knockout mice indicated that the histopathology of BFPP is a cobblestone-like brain malformation [ 14,15 ] ."}	0.92	0.752	0.992	{VERB_DEP_PATH_[cause]_[appos-prep_in|gpcr-nsubj|mutation@]_[dep-partmod|call-dobj|malformation@],VERB_DEP_PATH_POS_[cause]_[appos-prep_in|NN-nsubj|NNS@]_[dep-partmod|VBN-dobj|NN@],DEP_PATH_POS_[appos-prep_in|NN-nsubj|NNS@dep-partmod|VBN-dobj|NN],"POS_SEQ_[,_VB_DT_NN_JJ_NN_NN_VBN_JJ]","WORD_SEQ_[, cause a speciﬁc human brain malformation call bilateral]",DEP_PATH_[appos-prep_in|gpcr-nsubj|mutation@dep-partmod|call-dobj|malformation]}	{0.408743,0.408743,0.408743,0.408743,0.408743,0.408743}
journal.pone.0029948.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0029948.pdf_583_583_18_18_27_27_UNSUP	endoglin/HP:0001009|Telangiectasia	{18}	{27}	{Llorca,O,",",Trujillo,A,",",Blanco,FJ,",",Bernabeu,C,(,2007,),Structural,model,of,human,endoglin,",",a,transmembrane,receptor,responsible,for,hereditary,hemorrhagic,telangiectasia,.}	{"Nat Cell Biol 4 : 4574461 .",.}	{"J Nlol Biol 365 : 6944705 .",.}	0.934	0.776	1	{"WORD_SEQ_[, a transmembrane receptor responsible for hereditary hemorrhagic]","POS_SEQ_[,_DT_NN_NN_JJ_IN_JJ_JJ]",DEP_PATH_[prep_of-dep|model@prep_for-amod|responsible-appos|receptor],DEP_PATH_POS_[prep_of-dep|NN@prep_for-amod|JJ-appos|NN]}	{0.886315,0.886315,0.554888,0.554888}
SCPDFS_23219.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_23219.pdf_383_383_2_2_8_8_UNSUP	POLG/HP:0000602|Ophthalmoplegia	{2}	{8}	{Mutation,of,POLG,is,associated,with,progressive,extemal,ophthalmoplegia,characterized,by,mtDNA,deletions,.}	{"J .",", Van Broeckhoven , C. , 2001 ."}	{"Nat .","Genet ."}	0.974	0.964	0.986	{VERB_DEP_PATH_[associate]_[prep_of-nsubjpass|mutation@]_[prep_with@],DEP_PATH_[prep_of-nsubjpass|mutation@prep_with],VERB_DEP_PATH_[be]_[prep_of-nsubjpass|mutation@auxpass]_[prep_with@auxpass],VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[prep_with@auxpass],DEP_PATH_POS_[prep_of-nsubjpass|NN@prep_with],POS_SEQ_[VBZ_VBN_IN_JJ_JJ],VERB_DEP_PATH_POS_[associate]_[prep_of-nsubjpass|NN@]_[prep_with@],VERB_DEP_PATH_[characterize]_[prep_of-nsubjpass|mutation@partmod-prep_with|ophthalmoplegium]_[@partmod],"WORD_SEQ_[be associate with progressive extemal]",VERB_DEP_PATH_POS_[characterize]_[prep_of-nsubjpass|NN@partmod-prep_with|NN]_[@partmod]}	{1.68285,1.68285,1.68285,-1.16243,-1.16243,-0.452492,0.339413,0.323259,0.323259,0.323259}
journal.pone.0064966.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0064966.pdf_9_9_27_27_44_44_UNSUP	TBX5/HP:0011675|Arrhythmia	{27}	{44}	{Recent,genome,—,wide,association,studies,found,that,the,sing,|,e,—,nuc,|,eotide,polymorphism,(,SNP,),rs3825214,in,T,—,box,5,(,TBX5,),was,positively,associated,with,PR,interval,",",QRS,duration,",",QT,interval,",",and,common,arrhythmia,disorders,such,as,atrial,fibrillation,(,AF,),and,advanced,atrioventricular,block,.}	{Abstract,"Background : A prolonged PR interval is a sign of increased risk of cardiac arrhythmia ."}	{"However , other independent replication studies are required to validate the result .","This study assessed associations between rs3825214 and ECG parameters , AF , and ventricular tachycardia ( VT ) in a Chinese Han population ."}	0.928	0.056	0.972	{WORD_SEQ_[TOO_FAR_AWAY],DEP_PATH_[nn-nsubjpass|)-conj_and|advance@nn-prep_with|disorder],VERB_DEP_PATH_POS_[find]_[nn-nsubjpass|NN-conj_and|VBD-ccomp|VBN@]_[nn-prep_with|NNS-ccomp|VBN@],VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NN-conj_and|VBD@]_[nn-prep_with|NNS@],VERB_DEP_PATH_[associate]_[nn-nsubjpass|)-conj_and|advance@]_[nn-prep_with|disorder@],VERB_DEP_PATH_POS_[advance]_[nn-nsubjpass|NN@]_[nn-prep_with|NNS@conj_and],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN-conj_and|VBD@auxpass]_[nn-prep_with|NNS@auxpass],VERB_DEP_PATH_[be]_[nn-nsubjpass|)-conj_and|advance@auxpass]_[nn-prep_with|disorder@auxpass],VERB_DEP_PATH_[advance]_[nn-nsubjpass|)@]_[nn-prep_with|disorder@conj_and],DEP_PATH_POS_[nn-nsubjpass|NN-conj_and|VBD@nn-prep_with|NNS],VERB_DEP_PATH_[find]_[nn-nsubjpass|)-conj_and|advance-ccomp|associate@]_[nn-prep_with|disorder-ccomp|associate@]}	{-3.11955,0.571645,0.571645,0.571645,0.571645,0.571645,0.571645,0.571645,0.571645,0.571645,0.571645}
SCPDFS_4871.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_4871.pdf_60_60_15_15_11_11_UNSUP	HHT1/HP:0001009|Telangiectasia	{15}	{11}	{In,humans,",",mutations,of,endoglin,are,associated,with,hereditary,hemorrhagic,telangiectasia,type,1,(,HHT1,),",",a,disease,characterized,by,blood,vessel,malformation,(,Berg,et,al.,",",1996,;,Guttmacher,et,al.,",",1995,;,McAllister,et,al.,",",1994,",",1995,),.}	{"In humans and mice , endoglin expression is present as two isoforms that differ in the amino acid composition of their cytoplasmic tails , i.e. L-endoglin and S-endoglin ( Bellon et al. , 1993 ; Gougos and Letarte , 1990 ; Perez-Gomez et al. , 2005 ) .","Human L-endoglin abrogates the inhibitory action of TGFB in the proliferation of promonocytic cells while S-endoglin partially inhibits proliferation ( Lastres et al. , 1996 ) ."}	{"In mice , endoglin — null mice ( Engi/T ) showed arterio — venous malformation ( HHT phenotype ) and heart defects associated with valve formation and heart septation ( Arthur et al. , 2000 ; Bourdeau et al. , 1999 ; Sorensen et al. , 2003 ) .","Most studies of endoglin are targeted towards its role as a marker of endothelial cell proliferation in angiogenesis ."}	0.962	0.036	1	{"INV_WORD_SEQ_NER_[type NUMBER NUMBER]",INV_DEP_PATH_POS_[nn-dep|NN@nn],INV_DEP_PATH_[nn-dep|)@nn],INV_VERB_DEP_PATH_POS_[be]_[nn-dep|NN-prep_with|NN@auxpass]_[nn-prep_with|NN@auxpass],INV_POS_SEQ_[NN_CD_CD],INV_VERB_DEP_PATH_POS_[characterize]_[nn-dep|NN@partmod-appos|NN]_[nn@partmod-appos|NN],INV_VERB_DEP_PATH_[be]_[nn-dep|)-prep_with|type@auxpass]_[nn-prep_with|type@auxpass],INV_VERB_DEP_PATH_[characterize]_[nn-dep|)@partmod-appos|disease]_[nn@partmod-appos|disease],INV_VERB_DEP_PATH_[associate]_[nn-dep|)-prep_with|type@]_[nn-prep_with|type@],INV_VERB_DEP_PATH_POS_[associate]_[nn-dep|NN-prep_with|NN@]_[nn-prep_with|NN@],"INV_WORD_SEQ_[type 1 (]"}	{3.395,-1.68617,0.842728,0.553181,-0.344507,0.197267,0.0729994,0.0729994,0.0729994,0.0514828,0.0212682}
journal.pone.0023396.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0023396.pdf_42_42_15_15_7_7_UNSUP	MPL/HP:0001873|Thrombocytopenia	{15}	{7}	{p,|,osone.org,negative,patients,with,essential,thrombocytopenia,and,myeloﬁbrosis,have,been,reported,to,have,MPL,mutations,",",primarily,at,codons,515,and,",",to,a,lesser,extent,",",505,[,"5,6,7,8,9,10",],.}	{"This conformational event induces phosphorylation of the intracellular nonreceptor kinase partner of MPL , Janus kinase 2 GAK2 ) , initiating the downstream cascades critical in megakaryocyte and platelet formation @ U ( Although JAKQ mutations at amino acid 617 and nearby positions account for the majority of patients with various forms of","DU ( PLoS ONE | www ."}	{"A lack of experimental structures has hindered understanding of the activation mechanisms of MPL at the atomic level , and the detailed mechanisms of MPL mutational effects remain elusive .","We have demonstrated that modern computational approaches can be used to explore the structures and dynamics of biological molecules , even without experimental structures [ 11,12 ] ."}	0.976	0.978	1	{INV_VERB_DEP_PATH_[have]_[nn-dobj|mutation-xcomp|have@aux]_[prep_with-dep|patient-nsubjpass|p@aux],"INV_WORD_SEQ_[and myeloﬁbrosis have be report to have]",INV_VERB_DEP_PATH_[report]_[nn-dobj|mutation-xcomp|have@]_[prep_with-dep|patient-nsubjpass|p@],INV_VERB_DEP_PATH_POS_[have]_[nn-dobj|NNS@]_[prep_with-dep|NNS-nsubjpass|NN@xcomp],INV_POS_SEQ_[CC_NN_VBP_VBN_VBN_TO_VB],INV_VERB_DEP_PATH_[have]_[nn-dobj|mutation@]_[prep_with-dep|patient-nsubjpass|p@xcomp],INV_DEP_PATH_POS_[nn-dobj|NNS-xcomp|VB@prep_with-dep|NNS-nsubjpass|NN],INV_VERB_DEP_PATH_[be]_[nn-dobj|mutation-xcomp|have@auxpass]_[prep_with-dep|patient-nsubjpass|p@auxpass],INV_VERB_DEP_PATH_POS_[report]_[nn-dobj|NNS-xcomp|VB@]_[prep_with-dep|NNS-nsubjpass|NN@],INV_VERB_DEP_PATH_POS_[have]_[nn-dobj|NNS-xcomp|VB@aux]_[prep_with-dep|NNS-nsubjpass|NN@aux],INV_DEP_PATH_[nn-dobj|mutation-xcomp|have@prep_with-dep|patient-nsubjpass|p],INV_VERB_DEP_PATH_POS_[be]_[nn-dobj|NNS-xcomp|VB@auxpass]_[prep_with-dep|NNS-nsubjpass|NN@auxpass]}	{0.291219,0.291219,0.291219,0.291219,0.291219,0.291219,0.291219,0.291219,0.291219,0.291219,0.291219,0.291219}
journal.pone.0056169.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0056169.pdf_500_500_39_39_33_33_UNSUP	p53/HP:0100242|Sarcoma	{39}	{33}	{Nloneo,V,",",Serelde,BG,",",Fominaya,],",",Leal,],F,",",Blanco-Aparicio,C,",",et,al.,(,2007,),Extreme,sensitivity,to,Yondelis,(,Trabectedin,",",ET-743,),in,low,passaged,sarcoma,cell,lines,correlates,with,mutated,p53,.,]}	{"43 .",.}	{"Cell Biochem 100 : 339 * 348 .",.}	0.916	0.798	0.992	{INV_DEP_PATH_POS_[prep_with@nn-nsubj|NNS],INV_VERB_DEP_PATH_[correlate]_[prep_with@]_[nn-nsubj|line@],INV_POS_SEQ_[NN_NNS_VBZ_IN_VBN],INV_VERB_DEP_PATH_[mutate]_[@amod]_[nn-nsubj|line@amod-prep_with|p53],INV_VERB_DEP_PATH_POS_[correlate]_[prep_with@]_[nn-nsubj|NNS@],INV_VERB_DEP_PATH_POS_[mutate]_[@amod]_[nn-nsubj|NNS@amod-prep_with|NN],"INV_WORD_SEQ_[cell line correlate with mutate]",INV_DEP_PATH_[prep_with@nn-nsubj|line],INV_VERB_DEP_PATH_POS_[passage]_[prep_with-ccomp|VBZ@]_[nn-nsubj|NNS-ccomp|VBZ@],INV_VERB_DEP_PATH_[passage]_[prep_with-ccomp|correlate@]_[nn-nsubj|line-ccomp|correlate@]}	{-0.930657,0.389701,0.389701,0.389701,0.389701,0.389701,0.389701,0.389701,0.389701,0.389701}
journal.pone.0029780.pdf	RELATION_GENEHPOTERM_journal.pone.0029780.pdf_106_106_14_14_24_24	NRGN/HP:0100753|Schizophrenia	{14}	{24}	{Second,",",we,performed,separate,whole,brain,searches,to,explore,the,effect,of,the,NRGN,genotype,on,GM,or,WM,volume,in,patients,with,schizophrenia,and,in,controls,.}	{"Statistical analyses were performed with SPM8 software ( http : / / www.ﬁl.ion.ucl.ac.uk/spm/software/spm8/ ) .","First , we performed whole brain searches to explore the effects of the NRGN genotype and the genotype-diagnosis interaction on GM or \\\\ / V M volume in total subjects ."}	{"The genotype effect on GM or \\\\ / V M volume was assessed statistically using a multiple regression model in SPM8 .","\\\\ / Ve contrasted GM or WM volume between the genotype groups ( coded as the number of rs12807809 risk T alleles : o , 1 , or 2 ) ; GM or WM volumes were correlated with the number of risk T alleles , either positively ( CC < CT < TT ) or negatively ( TT < CT < CC ) ."}	0.928	0.728	0.998	{DEP_PATH_POS_[nn-prep_of|NN-dobj|NN@prep_with-prep_in|NNS],POS_SEQ_[NN_IN_NNP_CC_NNP_NN_IN_NNS_IN],VERB_DEP_PATH_[explore]_[nn-prep_of|genotype-dobj|effect@]_[prep_with-prep_in|patient@],VERB_DEP_PATH_[perform]_[nn-prep_of|genotype-dobj|effect-xcomp|explore@]_[prep_with-prep_in|patient-xcomp|explore@],VERB_DEP_PATH_POS_[perform]_[nn-prep_of|NN-dobj|NN-xcomp|VB@]_[prep_with-prep_in|NNS-xcomp|VB@],"WORD_SEQ_[genotype on GM or WM volume in patient with]",DEP_PATH_[nn-prep_of|genotype-dobj|effect@prep_with-prep_in|patient],"WORD_SEQ_NER_[genotype on ORGANIZATION or WM volume in patient with]",VERB_DEP_PATH_POS_[explore]_[nn-prep_of|NN-dobj|NN@]_[prep_with-prep_in|NNS@]}	{2.52439,0,0,0,0,0,0,0,0}
SCPDFS_19416.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19416.pdf_443_443_5_5_10_10_UNSUP	BRIP1/HP:0001903|Anemia	{5}	{10}	{The,BRCA1,—,interacting,helicase,BRIP1,is,deﬁcient,in,Fanconi,anemia,.}	{"37 , 934-935 .","Levran , o. , et al. , 2005 ."}	{"Nat .","Genet ."}	0.942	0.928	0.994	{POS_SEQ_[VBZ_JJ_IN_JJ],DEP_PATH_[dobj-partmod|interact-nsubj|—@prep_in],VERB_DEP_PATH_POS_[be]_[dobj-partmod|VBG-nsubj|NN@cop]_[prep_in@cop],VERB_DEP_PATH_POS_[interact]_[dobj@]_[prep_in@partmod-nsubj|NN],VERB_DEP_PATH_[interact]_[dobj@]_[prep_in@partmod-nsubj|—],VERB_DEP_PATH_[be]_[dobj-partmod|interact-nsubj|—@cop]_[prep_in@cop],"WORD_SEQ_[be deﬁcient in fanconi]",DEP_PATH_POS_[dobj-partmod|VBG-nsubj|NN@prep_in]}	{0.571197,0.378589,0.378589,0.378589,0.378589,0.378589,0.378589,0.0256653}
journal.pone.0077375.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0077375.pdf_488_488_23_23_31_31_UNSUP	c-Myc/HP:0002665|Lymphoma	{23}	{31}	{Bhatia,K,",",Huppi,K,",",Spangler,G,",",Siwarski,D,",",Iyer,R,et,al.,(,1993,),Point,mutations,in,the,c-Myc,transactivation,domain,are,common,in,Burkitt,'s,lymphoma,and,mouse,plasmacytomas,.}	{"PubMed : 22464321 .",.}	{"Nat Genet 5 : 56-61 .","doi : 10.1038 / ng0993-56 ."}	0.912	0.952	1	{POS_SEQ_[NN_NN_VBP_JJ_IN_NN_POS],DEP_PATH_POS_[nn-prep_in|NN-rcmod|FW-appos|NNP-nsubj|NNP@prep_in],DEP_PATH_[nn-prep_in|domain-rcmod|(-appos|R-nsubj|PERSON@prep_in],"WORD_SEQ_NER_[transactivation domain be common in PERSON 's]","WORD_SEQ_[transactivation domain be common in burkitt 's]"}	{0.665535,0.415439,0.415439,0.415439,0.415439}
journal.pone.0044301.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0044301.pdf_16_16_23_23_12_12_UNSUP	p53/HP:0002861|Melanoma	{23}	{12}	{We,predict,that,Notch,pathway,deregulation,could,be,a,feature,of,uveal,melanoma,",",and,could,be,a,therapeutic,target,",",especially,if,p53,is,concurrently,targeted,.}	{"siRNA ) greatly enhanced apoptosis and cell cycle arrest in vitro as compared to treatment with H101 or siNotch1 alone .","For in vivo treatments , the combined treatment of siNotch1 and H101 showed remarkable tumor growth inhibition and prolonged mouse survival in the OCM1 xenograft model ."}	{"Citation : Huang X , Wang L , Zhang H , Wang H , Zhao X , et al. ( 2012 ) Therapeutic Efﬁcacy by Targeting Correction of Notch1 — lnduced Aberrants in Uveal Tumors .","PLoS ONE 7 ( 8 ) : e44301 ."}	0.956	0.39	0.998	{INV_VERB_DEP_PATH_POS_[target]_[nsubjpass@]_[prep_of-ccomp|NN@dep-conj_and|NN],INV_VERB_DEP_PATH_POS_[predict]_[nsubjpass-dep|VBN-conj_and|NN@]_[prep_of-ccomp|NN@],"INV_POS_SEQ_[,_CC_MD_VB_DT_JJ_NN_,_RB_IN]",INV_VERB_DEP_PATH_[be]_[nsubjpass-dep|target@cop]_[prep_of-ccomp|feature@cop-conj_and|target],INV_VERB_DEP_PATH_[target]_[nsubjpass@]_[prep_of-ccomp|feature@dep-conj_and|target],INV_DEP_PATH_POS_[nsubjpass-dep|VBN-conj_and|NN@prep_of-ccomp|NN],"INV_WORD_SEQ_[, and could be a therapeutic target , especially if]",INV_DEP_PATH_[nsubjpass-dep|target-conj_and|target@prep_of-ccomp|feature],INV_VERB_DEP_PATH_[predict]_[nsubjpass-dep|target-conj_and|target@]_[prep_of-ccomp|feature@],INV_VERB_DEP_PATH_POS_[be]_[nsubjpass-dep|VBN@cop]_[prep_of-ccomp|NN@cop-conj_and|NN]}	{0.303919,0.303919,0.303919,0.303919,0.303919,0.303919,0.303919,0.303919,0.303919,0.303919}
journal.pone.0039656.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0039656.pdf_724_724_17_17_7_9_UNSUP	LPS/HP:0100543|Cognitive impairment	{17}	{7,9}	{Furthermore,",",EX-4,treatment,protected,against,the,impairment,of,cognition,resulting,from,hyperglycemia,and,/,or,intrahippocampal,LPS,injection,.}	{"In conclusion , our results suggest that the activation of the NFKB-related inﬂammatory responses induced cognitive dysfunction in both the hyperglycemia and intrahippocampal LPS injection groups .","However , acute intrahippocampal LPS injection exacerbated the progression of cognitive dysfunction through large increases in astrocytes activation-related responses in the hyperglycemic mice ."}	{"Therefore , these ﬁndings revealed that EX-4 might be considered as a potential adjuvant neuroprotective agent for neurodegenerative diseases .","Materials and Methods"}	0.912	0.394	0.996	{INV_VERB_DEP_PATH_POS_[protect]_[dep-prep_from|NN-xcomp|VBG@]_[prep_against@],INV_DEP_PATH_[dep-prep_from|hyperglycemia-xcomp|result@prep_against],INV_VERB_DEP_PATH_POS_[result]_[dep-prep_from|NN@]_[prep_against@xcomp],INV_VERB_DEP_PATH_[result]_[dep-prep_from|hyperglycemia@]_[prep_against@xcomp],INV_VERB_DEP_PATH_[protect]_[dep-prep_from|hyperglycemia-xcomp|result@]_[prep_against@],INV_DEP_PATH_POS_[dep-prep_from|NN-xcomp|VBG@prep_against],"INV_WORD_SEQ_[result from hyperglycemia and / or intrahippocampal]",INV_POS_SEQ_[VBG_IN_NN_CC_:_CC_JJ]}	{0.329149,0.329149,0.329149,0.329149,0.329149,0.329149,0.329149,0.329149}
journal.pone.0020178.pdf	RELATION_GENEHPOTERM_journal.pone.0020178.pdf_34_34_3_3_14_15	StAR/HP:0008221|Adrenal hyperplasia	{3}	{14,15}	{Mutations,in,the,StAR,gene,were,first,described,in,patients,with,classic,congenital,lipoid,adrenal,hyperplasia,(,CLAH,),in,which,both,the,adrenals,and,the,gonads,seemed,to,completely,lack,steroidogenesis,[,1,],.}	{"f | ueck@dkf.unibe.ch",Introduction}	{"The underlying pathophysiology of CLAH is explained by the defective transport of cholesterol needed for the biosynthesis of steroids , to the inner mitochondrial membrane , and the cytoplasmic accumulation of lipid droplets which would fatally harm the cells of the steroidogenic tissues over time [ 2 ] .","So far , patients described as having the recently described non-classic form of lipoid adrenal hyperplasia ( NCLAH ) presented with"}	0.924	0.804	1	{VERB_DEP_PATH_POS_[describe]_[nn-prep_in|NN-nsubjpass|NNS@]_[amod-prep_with|NN@],VERB_DEP_PATH_[describe]_[nn-prep_in|gene-nsubjpass|mutation@]_[amod-prep_with|)@],VERB_DEP_PATH_POS_[be]_[nn-prep_in|NN-nsubjpass|NNS@auxpass]_[amod-prep_with|NN@auxpass],"WORD_SEQ_[gene be first describe in patient with classic congenital lipoid]","WORD_SEQ_NER_[gene be ORDINAL describe in patient with classic congenital lipoid]",DEP_PATH_[nn-prep_in|gene-nsubjpass|mutation@amod-prep_with|)],DEP_PATH_POS_[nn-prep_in|NN-nsubjpass|NNS@amod-prep_with|NN],VERB_DEP_PATH_[be]_[nn-prep_in|gene-nsubjpass|mutation@auxpass]_[amod-prep_with|)@auxpass],POS_SEQ_[NN_VBD_JJ_VBN_IN_NNS_IN_JJ_JJ_JJ]}	{0.304932,0.304932,0.304932,0.304932,0.304932,0.304932,0.304932,0.304932,0.304932}
SCPDFS_43354.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_43354.pdf_27_27_2_2_17_18_UNSUP	PSACH/HP:0002515|Waddling gait	{2}	{17,18}	{Pseudoachondroplasia,(,PSACH,),is,characterized,by,short,limbs,with,a,normal,trunk,and,head,",",a,waddling,gait,",",lax,joints,",",and,early,onset,osteoarthropathy,(,Maroteaux,and,Lamy,",",1959,;,Taybi,and,Lachman,",",1990,),.}	{"Using a genetic linkage approach , the disease genes for two recessively inherited chondrodysplasias , diastrophic dysplasia ( Hastbacka et al. , 1990 ) and cartilage-hair hypoplasia ( Sulisalo et al. , 1993 ) , have been localized to chromosomes 5 and 9 , respectively .","This latter approach has great promise for deﬁning the chromosomal location of the disease genes for chondrodysplasia phenotypes in which sufficient families can be assembled and for identifying the extent of genetic heterogeneity within this clinically diverse group of conditions ."}	{"The radiographic phenotype shows marked epiphyseal and metaphyseal irregularity in the spine , hands , and long bones .","The radiographic changes in the spine resolve with time , but the epiphyses of the long bones show progressive degeneration and severe osteoarthropathy , frequently leading to hip replacement in the third and fourth decade ."}	0.926	0.008	0.854	{VERB_DEP_PATH_[characterize]_[nn@rcmod]_[appos-prep_with|trunk@],VERB_DEP_PATH_[be]_[nn@auxpass-rcmod|characterize]_[appos-prep_with|trunk@auxpass],"WORD_SEQ_[) be characterize by short limb with a normal trunk and head , a]",DEP_PATH_POS_[nn@appos-prep_with|NN-rcmod|VBN],"POS_SEQ_[NN_VBZ_VBN_IN_JJ_NNS_IN_DT_JJ_NN_CC_NN_,_DT]",VERB_DEP_PATH_POS_[characterize]_[nn@rcmod]_[appos-prep_with|NN@],DEP_PATH_[nn@appos-prep_with|trunk-rcmod|characterize],VERB_DEP_PATH_POS_[be]_[nn@auxpass-rcmod|VBN]_[appos-prep_with|NN@auxpass]}	{0.321265,0.321265,0.321265,0.321265,0.321265,0.321265,0.321265,0.321265}
journal.pone.0080793.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0080793.pdf_839_839_27_27_28_28_UNSUP	DYT1/HP:0001332|Dystonia	{27}	{28}	{Kakazu,Y,",",Koh,JY,",",Ho,KW,",",Gonzalez-Alegre,P,",",Harata,NC,(,2012,),Synaptic,vesicle,recycling,is,enhanced,by,torsinA,that,harbors,the,DYT1,dystonia,mutation,.}	{"doi :10.1016 / j. nbd .2010.04.016 .","PubMed : 20460154 ."}	{"Synapse 66:453 -464 .","doi :10.1002 / syn .21534 ."}	0.938	0.988	0.196	{VERB_DEP_PATH_POS_[enhance]_[nn-dobj|NN-rcmod|VBZ-agent|NN@]_[nn-dobj|NN-rcmod|VBZ-agent|NN@],VERB_DEP_PATH_[enhance]_[nn-dobj|mutation-rcmod|harbor-agent|torsina@]_[nn-dobj|mutation-rcmod|harbor-agent|torsina@],WORD_SEQ_[],POS_SEQ_[],VERB_DEP_PATH_POS_[harbor]_[nn-dobj|NN@]_[nn-dobj|NN@],VERB_DEP_PATH_[harbor]_[nn-dobj|mutation@]_[nn-dobj|mutation@],DEP_PATH_POS_[nn@nn],DEP_PATH_[nn@nn]}	{1.88046,1.88046,-1.47483,-1.46457,0.958792,0.958792,-0.0245278,0.00991182}
journal.pone.0037680.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0037680.pdf_38_38_21_21_35_36_UNSUP	PPARG/HP:0000855|Insulin resistance	{21}	{35,36}	{Finally,",",human,Familial,partial,lipodystrophy,subtype,3,(,FPLD3,",",MIM,604367,),patients,",",harbouring,heterozygous,mutations,in,the,PPARG,gene,",",are,characterized,by,aberrant,fat,distribution,and,metabolic,disturbances,",",including,insulin,resistance,and,dyslipidemia,[,15,],.}	{"Furthermore , PPARY _ / _ mice are severely lipodystrophic , while PPARY + / _ mice have reduced amounts of adipose tissue [ 10,1 l , l2 ,13 ] .","PPARY is also essential for the maintenance of adipose tissue , since conditional knock-out of the Ppalg gene resulted in reduced in viva survival of mature adipocytes [ 14 ] ."}	{"Besides PPARV , other proteins are also essential for adipogenesis , including transcription factors ( eg .","KLF5 [ 16 ] ) , transcriptional co-regulators ( e.g. TRAP220/Medl [ 17 ] , Tip60 [ 18 ] , TLE3 [ 19 ] and TRIP3 [ 20 ] ) and lipid droplet proteins ( e.g. CIDEC/Fsp27 [ 21 ] ) ."}	0.958	0.708	1	{VERB_DEP_PATH_POS_[characterize]_[nn-prep_in|NN-partmod|VBG-nsubjpass|NN@]_[prep_including@],"POS_SEQ_[NN_,_VBP_VBN_IN_JJ_JJ_NN_CC_JJ_NNS_,_VBG]","WORD_SEQ_[gene , be characterize by aberrant fat distribution and metabolic disturbance , include]",VERB_DEP_PATH_[characterize]_[nn-prep_in|gene-partmod|harbour-nsubjpass|fpld3@]_[prep_including@],VERB_DEP_PATH_POS_[harbour]_[nn-prep_in|NN@]_[prep_including@partmod-nsubjpass|NN],DEP_PATH_[nn-prep_in|gene-partmod|harbour-nsubjpass|fpld3@prep_including],VERB_DEP_PATH_[harbour]_[nn-prep_in|gene@]_[prep_including@partmod-nsubjpass|fpld3],DEP_PATH_POS_[nn-prep_in|NN-partmod|VBG-nsubjpass|NN@prep_including]}	{0.406264,0.406264,0.406264,0.406264,0.406264,0.406264,0.406264,0.406264}
journal.pone.0004133.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0004133.pdf_404_404_17_17_8_9_UNSUP	PLN/HP:0001644|Dilated cardiomyopathy	{17}	{8,9}	{Interestingly,",",in,the,MLP,knockout,mouse,with,dilated,cardiomyopathy,(,enhanced,basal,SERCA,activity,),increased,PLN,phosphorylation,is,believed,to,limit,FFR,[,16,],.}	{"In failing ventricular myocardium , the positive FFR disappears and becomes ﬂat or negative [ 1,2 ] .","Multiple alterations in Ca2 + handling determine negative staircase in a cellular heart failure model [ 15 ] ."}	{"In human heart failure reduced expression of SERCA has been demonstrated [ 1,2 ] however in animal studies , there is less consistency [ 1 ] .","PLN expression levels are , however insufficient to evaluate the regulation of SERCA , as the level of inhibition of SERCA by PLN depends on the degree of phosphorylation ."}	0.966	0.818	0.964	{"INV_WORD_SEQ_[( enhance basal serca activity ) increase]",INV_DEP_PATH_[nn-nsubjpass|phosphorylation-ccomp|believe-dep|increase@amod-prep_with|(-prep_in|mouse],INV_VERB_DEP_PATH_POS_[increase]_[nn-nsubjpass|NN-ccomp|VBN@]_[amod-prep_with|NN-prep_in|NN@dep],INV_VERB_DEP_PATH_POS_[enhance]_[nn-nsubjpass|NN-ccomp|VBN-dep|VBD@]_[amod-prep_with|NN-prep_in|NN@],INV_POS_SEQ_[NN_VBD_JJ_NN_NN_CD_VBD],INV_VERB_DEP_PATH_[enhance]_[nn-nsubjpass|phosphorylation-ccomp|believe-dep|increase@]_[amod-prep_with|(-prep_in|mouse@],INV_VERB_DEP_PATH_[increase]_[nn-nsubjpass|phosphorylation-ccomp|believe@]_[amod-prep_with|(-prep_in|mouse@dep],INV_DEP_PATH_POS_[nn-nsubjpass|NN-ccomp|VBN-dep|VBD@amod-prep_with|NN-prep_in|NN],"INV_WORD_SEQ_NER_[( enhance basal serca activity NUMBER increase]"}	{0.318537,0.318537,0.318537,0.318537,0.318537,0.318537,0.318537,0.318537,0.318537}
SCPDFS_25090.pdf	RELATION_GENEHPOTERM_SCPDFS_25090.pdf_994_994_8_8_1_1	IKAP/HP:0002459|Dysautonomia	{8}	{1}	{Familial,dysautonomia,is,caused,by,mutations,of,the,IKAP,gene,.}	{"215 , 403 — 410 .","Anderson , S.L. , Coli , R. , Da1y , I.W. , Kichula , E.A. , Rork , M.J. , Volpi , S.A. , Ekstein , J. , Rubin , B.Y. , 2001 ."}	{"Am .","J. Hum ."}	0.982	0.778	1	{"INV_WORD_SEQ_[be cause by mutation of the]",INV_VERB_DEP_PATH_[be]_[nn-prep_of|gene-agent|mutation@auxpass]_[nsubjpass@auxpass],INV_DEP_PATH_[nn-prep_of|gene-agent|mutation@nsubjpass],INV_VERB_DEP_PATH_[cause]_[nn-prep_of|gene-agent|mutation@]_[nsubjpass@],INV_VERB_DEP_PATH_POS_[cause]_[nn-prep_of|NN-agent|NNS@]_[nsubjpass@],INV_POS_SEQ_[VBZ_VBN_IN_NNS_IN_DT],INV_VERB_DEP_PATH_POS_[be]_[nn-prep_of|NN-agent|NNS@auxpass]_[nsubjpass@auxpass],INV_DEP_PATH_POS_[nn-prep_of|NN-agent|NNS@nsubjpass]}	{1.21132,0.65324,0.65324,0.65324,0.436215,0.431882,0.0442552,0.0442552}
journal.pone.0097720.pdf	RELATION_GENEHPOTERM_journal.pone.0097720.pdf_38_38_46_46_31_31	PFC/HP:0011675|Arrhythmia	{46}	{31}	{Each,of,these,Congenital,long,QT,syndrome,(,LQTS,),is,a,heritable,family,of,arrhythmias,caused,by,mutations,in,13,genes,encoding,ion,features,may,uniquely,predispose,these,cells,to,arrhythmia,Results,I,"\\"",ormation,-,LQT1,and,LQT2,mutations,have,a,mild,phenotype,in,PFC,Mathematical,modeling,has,been,CmP10YCd,to,Simulate,genetic,As,LQT1,and,LQT2,mutations,often,result,in,complete,lossofand,acquired,channelopathies,and,assay,their,effects,on,cardiac,function,of,the,affected,KCNQ1,er,HERG,allele,",",respeetively,nS5uel8,>,9,],-,We,haVe,r,‘,3Cent1Yd,‘,3VC10l3ed,C0mPreh,‘,3n5iV,‘,3,imegratwe,(,through,defective,trafficking,or,biophysical,changes,in,channel}	{"While the majority of the characteriza - manifest their phenotype in a tiSSue_Speeiﬁe manner ’ Several non of arrhythmias in this disorder to date has inwnved the disease-causing mutations are simulated in each cardiac tissue Ventrieular myocyte WM ) = mounting evidenee nnpneates the type \\\\ / Ve demonstrate that arrhythmia formation in LQTS may cardiac specialized conduction system , comprised of the Pl11 ‘ l < 1I1 _ ] 6 depend not only upon the Speeiﬁe mutation and biophysical nher ( PF ) netWOrk = as a parnenlany important trigger of alteration but also upon the tissue of expression , supporting an arrhythmias [ 2 — 6 ] .","PF cells ( PFC ) have distinctive action potential important role for the PFC ( AP ) characteristics , including the property of automaticity , longer APD , and lower plateau membrane potential [ 7 ] ."}	{"PLOS ONE | www .","p | osone.org 1 June 2014 | Volume 9 | Issue 6 | e97720"}	0.938	0.69	1	{INV_VERB_DEP_PATH_POS_[encode]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[encode]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[result]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[result]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[affect]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[affect]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[predispose]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[predispose]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[have]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[have]_[dep@dep]_[dep@dep],INV_DEP_PATH_POS_[dep@dep],INV_DEP_PATH_[dep@dep],INV_VERB_DEP_PATH_POS_[cause]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[cause]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[assay]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[assay]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[simulate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[simulate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[acquire]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[acquire]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[be]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[be]_[dep@dep]_[dep@dep],INV_POS_SEQ_[NNS_PRP_``_NN_:_NN_CC_NN_NNS_VBP_DT_JJ_NN_IN],"INV_WORD_SEQ_[result I \\" ormation - lqt1 and lqt2 mutation have a mild phenotype in]"}	{0.843802,0.843802,0.826395,0.826395,-0.629277,-0.629277,0.540321,0.540321,0.434391,0.418105,-0.366141,-0.339995,0.205891,0.205891,-0.20462,-0.20462,-0.20462,-0.20462,-0.161706,-0.161706,-0.0638204,-0.0453518,0,0}
journal.pone.0002734.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0002734.pdf_170_170_24_24_11_11_UNSUP	MITF/HP:0002861|Melanoma	{24}	{11}	{Notably,",",the,induction,of,BRN2,through,MEK,and,ERK,in,melanoma,cells,appears,to,be,fundamental,to,the,ability,of,VGUOEBRAF,to,regulate,MITF,in,these,cells,(,Figure,3A,),.}	{"Importantly , when introduced into melanocytes , both V \\" mEBRAF and BRN2 can activate the MITF promoter ( Figure 5G ) .","Thus in melanocytes although WTBRAF does not regulate MITF , WOOEBRAF can induce expression of BRN2 , allowing it to induce MITF transcription ."}	{"Thus , we have established that in addition to regulating MITF at the protein level [ 13 ] , oncogenic BRAF also regulates MITF at the level of gene transcription in melanocytic cells .",Discussion}	0.91	0.594	0.994	{INV_POS_SEQ_[NNS_VBZ_TO_VB_JJ_TO_DT_NN_IN_NN_TO_VB],INV_DEP_PATH_[dobj-xcomp|regulate-xcomp|fundamental@nn-prep_in|cell-prep_through|mek-prep_of|brn2-nsubj|induction],"INV_WORD_SEQ_[cell appear to be fundamental to the ability of vguoebraf to regulate]","INV_WORD_SEQ_NER_[cell appear to be fundamental to the ability of ORGANIZATION to regulate]",INV_DEP_PATH_POS_[dobj-xcomp|VB-xcomp|JJ@nn-prep_in|NNS-prep_through|NN-prep_of|NN-nsubj|NN]}	{0.403695,0.403695,0.403695,0.403695,0.403695}
SCPDFS_42733.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_42733.pdf_19_19_1_1_7_7_UNSUP	WAGR/HP:0000526|Aniridia	{1}	{7}	{The,WAGR,syndrome,(,Wilms,tumor,",",aniridia,",",genito-urinary,abnormalities,",",mental,retardation,),is,a,complex,pathology,that,appears,when,the,p13,region,of,human,chromosome,11,is,deleted,.}	{"o 1994 Academic Press , Inc. .",INTRODUCTION}	{"The brain — derived neurotrophic factor ( BDNF ; Leibrock et at , 1989 ) gene maps to this locus , and its deletion is associated with the severity of the mental retardation phenotype ( Hanson et al. , 1993 ) .","The study of the genetic context of the"}	0.966	0.142	0.988	{"POS_SEQ_[NN_CD_NN_NN_,]","WORD_SEQ_NER_[syndrome NUMBER PERSON tumor ,]","WORD_SEQ_[syndrome ( wilm tumor ,]",DEP_PATH_POS_[nn@appos],DEP_PATH_[nn@appos],VERB_DEP_PATH_POS_[appear]_[nn-nsubj|NN@rcmod]_[appos-nsubj|NN@rcmod],VERB_DEP_PATH_POS_[delete]_[nn-nsubj|NN@advcl-rcmod|VBZ]_[appos-nsubj|NN@advcl-rcmod|VBZ],VERB_DEP_PATH_[appear]_[nn-nsubj|tumor@rcmod]_[appos-nsubj|tumor@rcmod],VERB_DEP_PATH_[delete]_[nn-nsubj|tumor@advcl-rcmod|appear]_[appos-nsubj|tumor@advcl-rcmod|appear],VERB_DEP_PATH_[be]_[nn-nsubj|tumor@cop]_[appos-nsubj|tumor@cop],VERB_DEP_PATH_POS_[be]_[nn-nsubj|NN@cop]_[appos-nsubj|NN@cop]}	{1.36863,1.22314,1.22314,-0.737939,-0.737939,0.287525,0.287525,0.287525,0.287525,0.287525,-0.161958}
SCPDFS_40412.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_40412.pdf_347_347_21_21_12_12_UNSUP	CBFA2/HP:0002863|Myelodysplasia	{21}	{12}	{In,translocations,t,(,3,;,21,),in,rare,cases,of,myelodysplasia,and,blast,transformation,of,chronic,myelogenous,leukemia,",",CBFA2,is,fused,with,either,the,EVI1,gene,",",which,encodes,a,zinc,ﬁnger-containing,transcription,factor,",",or,either,of,two,alternative,genes,of,unknown,function,",",EAP,and,MDS1,",",which,are,located,adjacent,to,EVI1,on,3q26,(,Nucifora,et,al.,",",1994,),.}	{"The gene for the a subunit 2 of the core-binding factor with runt domain ( CBFA2 ; MIM 151385 ; also known as the AML1 gene ) is involved in translocations associated with acute myeloid leukemia .","The CBFA2ETO chimeric protein products resulting from translocations t ( 8 ; 21 ) occur in approximately 15 % of cases of acute myeloid leukemia ( Miyoshi et al. , 1991 ) ."}	{"In translocations t ( 12 ; 21 ) in acute lymphocytic leukemias , there is a fusion protein consisting of the N-terminal of TEL gene , which is a member of the Ets-like family of transcription factors , with a nearly complete CBFA2 ( Golub et al. , 1995 ) .","Analysis of a large number of pediatric ALL cases demonstrated expression of the TEL-CBFA2 chimeric transcript in approximately 25 % of cases with a B progenitor immunophenotype , despite the lack of cytogenetic evidence of this translocation in the majority of cases ."}	0.91	0.05	0.886	{"INV_POS_SEQ_[CC_NN_NN_IN_JJ_JJ_NN_,]",INV_DEP_PATH_[nsubjpass@prep_of-prep_in|case-dep|)-prep_in|t],INV_VERB_DEP_PATH_[fuse]_[nsubjpass@]_[prep_of-prep_in|case-dep|)-prep_in|t@],INV_VERB_DEP_PATH_POS_[fuse]_[nsubjpass@]_[prep_of-prep_in|NNS-dep|NN-prep_in|NN@],"INV_WORD_SEQ_[and blast transformation of chronic myelogenous leukemia ,]",INV_DEP_PATH_POS_[nsubjpass@prep_of-prep_in|NNS-dep|NN-prep_in|NN]}	{0.359248,0.359248,0.359248,0.359248,0.359248,0.359248}
SCPDFS_44097.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_44097.pdf_226_226_23_23_12_12_UNSUP	WAGR/HP:0000526|Aniridia	{23}	{12}	{The,beta,—,subunit,of,folliclestimulating,hormone,is,deleted,in,patients,with,aniridia,and,Wilms,’,tumor,allowing,a,further,deﬁnition,of,the,WAGR,locus,.}	{"Science 244 : 1575-1578 .","Glaser , T. , Lewis , W. H. , Bruns , G. A. P. , Watkins , P. C. , Rogler , C. E. , Shows , T. B. , Powers , V. E. , Willard , H. F. , Goguen , J. M. , Simola , K. O. J. , and Housman , D. E. ( 1986 ) ."}	{"Nature 321 : 882-887 .","Hittner , H. M. , Riccardi , V. M. , and Franke , U. ( 1979 ) ."}	0.932	0.266	1	{INV_VERB_DEP_PATH_POS_[allow]_[nn-prep_of|NN-dobj|NN@]_[prep_with-prep_in|NNS@partmod-dobj|NN],"INV_WORD_SEQ_NER_[and PERSON NUMBER tumor allow a further deﬁnition of the]",INV_POS_SEQ_[CC_NN_CD_NN_VBG_DT_JJ_NN_IN_DT],"INV_WORD_SEQ_[and wilm ’ tumor allow a further deﬁnition of the]",INV_DEP_PATH_[nn-prep_of|locus-dobj|deﬁnition-partmod|allow-dobj|tumor@prep_with-prep_in|patient],INV_VERB_DEP_PATH_[allow]_[nn-prep_of|locus-dobj|deﬁnition@]_[prep_with-prep_in|patient@partmod-dobj|tumor],INV_DEP_PATH_POS_[nn-prep_of|NN-dobj|NN-partmod|VBG-dobj|NN@prep_with-prep_in|NNS]}	{0.378308,0.378308,0.378308,0.378308,0.378308,0.378308,0.378308}
journal.pone.0060287.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0060287.pdf_38_38_46_46_40_40_UNSUP	MEF/HP:0011675|Arrhythmia	{46}	{40}	{Stretch-activated,channels,(,SAC,),",",a,type,of,mechanically,activated,ionic,channels,identiﬁed,in,cardiac,tissue,",",have,been,following,a,precordial,thump,p,Abnormal,deformation,associated,with,the,establishment,of,arrhythmia,can,also,affect,the,progression,of,the,arrhythmia,itself,",",this,aspect,of,MEF,has,received,less,attention,in,the,literature,.}	{"Abnormal electrical propagation during arrhythmias also leads to abnormal strain distributions in the heart , which in turn could affect electrical propagation .","The mechanisms that contribute to strain-dependent modulation of electrical wave propagation are termed mechano-electric feedback ( MEF ) mechanisms There are several MEF mechanisms in the heart , including stretch-induced changes in intracellular Ca handling [ 3 ] , depolarization of cardiac ﬁbroblasts by stretch ( via mechano-sensitive ion channels ) affecting the resting potential and action potential duration ( APD ) of the coupled myocyte [ 4 ] , and most importantly , myocyte sarcolemmal channel activation by mechanical stimuli [ 5,6 ] ."}	{"On one hand , opening of SAG has been demonstrated to depolarize the resting membrane and thus cause Na channel inactivation [ lO ,11 ] , which can stabilize scroll waves [ 12 ] , the waves that underlie reentrant arrhythmias .","On the other hand , SAC-induced depolarization and Na channel inactivation have been shown to give rise to scroll wave breakup [ 13 ] that increases electrical instability and leads to turbulent behavior underling the most lethal arrhythmias ."}	0.932	0.198	0.398	{"INV_WORD_SEQ_[itself , this aspect of]","INV_POS_SEQ_[PRP_,_DT_NN_IN]",INV_VERB_DEP_PATH_[follow]_[prep_of-nsubj|aspect@ccomp-ccomp|(]_[prep_of-dobj|progression-rcmod|affect-dobj|p@],INV_VERB_DEP_PATH_POS_[follow]_[prep_of-nsubj|NN@ccomp-ccomp|VBP]_[prep_of-dobj|NN-rcmod|VB-dobj|NN@],INV_DEP_PATH_[prep_of-nsubj|aspect@prep_of-dobj|progression-rcmod|affect-dobj|p-ccomp|follow-ccomp|(],INV_DEP_PATH_POS_[prep_of-nsubj|NN@prep_of-dobj|NN-rcmod|VB-dobj|NN-ccomp|VBG-ccomp|VBP]}	{0.431335,0.431335,0.431335,0.431335,0.431335,0.431335}
SCPDFS_23051.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_23051.pdf_660_660_17_17_20_21_UNSUP	LTBP-4/HP:0002088|Abnormality of the lung	{17}	{20,21}	{Disruption,of,the,gene,encoding,the,latent,transforming,growth,factor,-,[,5,binding,protein,4,(,LTBP-4,),causes,abnormal,lung,development,",",cardiomyopathy,",",and,colorectal,cancer,.}	{"203 , 113-143 .","Sterner-Kock , A. , et al. , 2002 ."}	{"Genes Dev .","16 , 2264-2273 ."}	0.964	0.204	1	{"WORD_SEQ_[) cause]",DEP_PATH_[TOO_FAR_AWAY],POS_SEQ_[NN_VBZ]}	{2.94991,0.889952,-0.797533}
journal.pone.0098317.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0098317.pdf_47_47_0_0_14_15_UNSUP	TAZ/HP:0001644|Dilated cardiomyopathy	{0}	{14,15}	{TAZ,mutations,are,associated,with,a,number,of,clinical,disorders,including,Barth,syndrome,",",dilated,cardiomyopathy,and,endocardial,ﬂbroelastosis,[,"1,2",],.}	{Introduction,"Tafazzin protein ( TAZ ) is encoded by the TAZ gene functions as a phospholipid-lysophospholipid transacylase ."}	{"TAZ is responsible for remodeling of cardiolipin [ 3 ] which stabilizes the assembly of respiratory chain complexes and mediates key steps in apoptosis in mitochondria .","A causative link between mitochondrial dysfunction and pathological disorders has been noted in different disease models ."}	0.95	0.99	0.968	{DEP_PATH_POS_[nn-nsubjpass|NNS@partmod-prep_including|NN-prep_of|NNS-prep_with|NN],DEP_PATH_[nn-nsubjpass|mutation@partmod-prep_including|syndrome-prep_of|disorder-prep_with|number],VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NNS@]_[partmod-prep_including|NN-prep_of|NNS-prep_with|NN@],"WORD_SEQ_[mutation be associate with a number of clinical disorder include Barth syndrome ,]","POS_SEQ_[NNS_VBP_VBN_IN_DT_NN_IN_JJ_NNS_VBG_NNP_NN_,]",VERB_DEP_PATH_[associate]_[nn-nsubjpass|mutation@]_[partmod-prep_including|syndrome-prep_of|disorder-prep_with|number@],"WORD_SEQ_NER_[mutation be associate with a number of clinical disorder include PERSON syndrome ,]"}	{0.381015,0.381015,0.381015,0.381015,0.381015,0.381015,0.381015}
journal.pone.0005877.pdf	RELATION_GENEHPOTERM_journal.pone.0005877.pdf_677_677_2_2_12_14	FASN/HP:0002860|Squamous cell carcinoma	{2}	{12,13,14}	{Overexpression,of,FASN,as,well,as,p63,has,been,previously,demonstrated,in,squamous,cell,carcinomas,from,various,organs,[,"15,18",—,"20,62",],.}	{"OO05877 .",gOO6}	{"In support of the hypothesis that p63 function is mediated by FASN , we observed that the expression of FASN and p63 were positively associated in human HNSCC tissues .","Interestingly , FASN expression levels appeared to be highest in non-keratinizing poorly differentiated tumors with basaloid morphology that also expressed very high p63 levels ."}	0.906	0.992	1	{VERB_DEP_PATH_[be]_[prep_of-nsubjpass|overexpression@auxpass]_[prep_in@auxpass],DEP_PATH_[prep_of-nsubjpass|overexpression@prep_in],VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[prep_in@auxpass],DEP_PATH_POS_[prep_of-nsubjpass|NN@prep_in],VERB_DEP_PATH_[have]_[prep_of-nsubjpass|overexpression@aux]_[prep_in@aux],VERB_DEP_PATH_POS_[have]_[prep_of-nsubjpass|NN@aux]_[prep_in@aux],VERB_DEP_PATH_[demonstrate]_[prep_of-nsubjpass|overexpression@]_[prep_in@],VERB_DEP_PATH_POS_[demonstrate]_[prep_of-nsubjpass|NN@]_[prep_in@],POS_SEQ_[RB_RB_IN_NN_VBZ_VBN_RB_VBN_IN],"WORD_SEQ_[as well as p63 have be previously demonstrate in]","WORD_SEQ_NER_[as well as p63 have be DATE demonstrate in]"}	{0.57491,0.57491,0.410695,0.410695,0.164808,-0.14414,0,0,0,0,0}
journal.pone.0024650.pdf	RELATION_GENEHPOTERM_journal.pone.0024650.pdf_64_64_21_21_12_12	IL-6/HP:0004326|Cachexia	{21}	{12}	{Because,of,the,catabolic,effects,that,may,be,mediated,through,IL-6,during,cachexia,",",several,therapies,have,been,proposed,to,inhibit,IL-6,activity,to,prevent,the,progression,of,cachexia,.}	{"Transgenic mice over-expressing IL-6 have muscle atrophy associated with increased expression of lysosomal and ubiquitin-related mRNA and proteins [ 34,35 ] .","In humans , IL-6 administration can cause a reduction in skeletal muscle protein synthesis [ 36 ] ."}	{"The administration of an IL-6 receptor antibody has effectively countered muscle wasting in tumor bearing mice [ 36,37 ] .","Furthermore , the inhibition of IL-6 activity can reduce both ubiquitin and lysosomal degradation pathways in the gastrocnemius muscle of C-26 tumor bearing mice [ 37 ] ."}	0.946	0.948	0.898	{INV_VERB_DEP_PATH_POS_[inhibit]_[nn-dobj|NN@]_[prep_during-rcmod|VBN-prep_because_of|NNS@xcomp],"INV_WORD_SEQ_[, several therapy have be propose to inhibit]",INV_VERB_DEP_PATH_POS_[be]_[nn-dobj|NN-xcomp|VB@auxpass]_[prep_during-rcmod|VBN-prep_because_of|NNS@auxpass],INV_VERB_DEP_PATH_[inhibit]_[nn-dobj|activity@]_[prep_during-rcmod|mediate-prep_because_of|effect@xcomp],INV_VERB_DEP_PATH_[propose]_[nn-dobj|activity-xcomp|inhibit@]_[prep_during-rcmod|mediate-prep_because_of|effect@],"INV_POS_SEQ_[,_JJ_NNS_VBP_VBN_VBN_TO_VB]",INV_VERB_DEP_PATH_[be]_[nn-dobj|activity-xcomp|inhibit@auxpass]_[prep_during-rcmod|mediate-prep_because_of|effect@auxpass],INV_VERB_DEP_PATH_POS_[propose]_[nn-dobj|NN-xcomp|VB@]_[prep_during-rcmod|VBN-prep_because_of|NNS@],INV_VERB_DEP_PATH_[have]_[nn-dobj|activity-xcomp|inhibit@aux]_[prep_during-rcmod|mediate-prep_because_of|effect@aux],INV_DEP_PATH_POS_[nn-dobj|NN-xcomp|VB@prep_during-rcmod|VBN-prep_because_of|NNS],INV_VERB_DEP_PATH_POS_[have]_[nn-dobj|NN-xcomp|VB@aux]_[prep_during-rcmod|VBN-prep_because_of|NNS@aux],INV_DEP_PATH_[nn-dobj|activity-xcomp|inhibit@prep_during-rcmod|mediate-prep_because_of|effect]}	{0.235644,0.235644,0.235644,0.235644,0.235644,0.235644,0.235644,0.235644,0.235644,0.235644,0.235644,0.235644}
journal.pone.0010985.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0010985.pdf_47_47_12_12_19_20_UNSUP	SCN5A/HP:0001688|Sinus bradycardia	{12}	{19,20}	{Irnportantly,",",reduced,Na,+,channel,expression,in,the,hearts,of,heterozygous,SCN5A,+,/,_,mice,resulted,in,sinus,bradycardia,",",slowed,sinoatrial,conduction,",",and,sinoatrial,exit,block,;,these,phenomena,are,also,observed,in,SSS,patients,[,24,],.}	{"l. 5 mRNA and protein respectively in the human peripheral sinus node was demonstrated recently by Chandler et al. [ 21 ] .","Na + currents were recorded in sinus node pacemaker cells from both mammalian animals [ 14,22 ] and humans [ 23 ] ."}	{"Most of these SSS-related mutant channels have been expressed by different heterologous host cells including mammalian cell lines and Xenopus oocytes , and several loss-of-function features have been identiﬁed [ 22 ] .","However , electrophysiological recordings have not yet been combined with biochemistry techniques that enable quantitative estimation of the localization of mutant channel proteins at the plasma membrane ."}	0.936	0.806	1	{"WORD_SEQ_[+ / _ mouse result in]",VERB_DEP_PATH_POS_[slow]_[prep_of-prep_in|NNS-dobj|NN-ccomp|VBD@]_[prep_in-ccomp|VBD@],VERB_DEP_PATH_[reduce]_[prep_of-prep_in|heart-dobj|expression@]_[prep_in-ccomp|result@ccomp],VERB_DEP_PATH_POS_[reduce]_[prep_of-prep_in|NNS-dobj|NN@]_[prep_in-ccomp|VBD@ccomp],POS_SEQ_[CC_:_NN_NNS_VBD_IN],DEP_PATH_[prep_of-prep_in|heart-dobj|expression-ccomp|reduce@prep_in-ccomp|result],DEP_PATH_POS_[prep_of-prep_in|NNS-dobj|NN-ccomp|VBD@prep_in-ccomp|VBD],VERB_DEP_PATH_[slow]_[prep_of-prep_in|heart-dobj|expression-ccomp|reduce@]_[prep_in-ccomp|result@]}	{0.359971,0.359971,0.359971,0.359971,0.359971,0.359971,0.359971,0.359971}
journal.pgen.1000995.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1000995.pdf_260_260_7_7_26_27_UNSUP	BRCA2/HP:0012125|Prostate cancer	{7}	{26,27}	{A,recent,study,investigating,whether,TP53,and,BRCA2,are,frequently,mutated,together,in,human,prostate,cancer,found,that,TP53,overexpression,could,not,distinguish,BRCA2,carriers,with,prostate,cancer,from,a,control,group,of,prostate,cancer,cases,[,39,],.}	{"The formation of HG PIN lesions in Brca2 ; Trp53 mutant prostates may reﬂect the loss of key regulatory p53-dependent functions in response to DNA damage controlling cell-cycle checkpoints , apoptosis and senescence [ 38 ] .","This demonstrates a co-operative tumour suppressor function of Brca2 and Trp53 in the prostate similar to the mammary gland [ 24 ~ 26 ] ."}	{"A H&E C",TUNEL}	0.962	0.982	1	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_[distinguish]_[nsubjpass@ccomp-rcmod|find-prep_in|cancer]_[prep_with@],DEP_PATH_POS_[nsubjpass@prep_with-ccomp|VB-rcmod|VBD-prep_in|NN],DEP_PATH_[nsubjpass@prep_with-ccomp|distinguish-rcmod|find-prep_in|cancer],VERB_DEP_PATH_POS_[mutate]_[nsubjpass@]_[prep_with-ccomp|VB-rcmod|VBD-prep_in|NN@],VERB_DEP_PATH_POS_[distinguish]_[nsubjpass@ccomp-rcmod|VBD-prep_in|NN]_[prep_with@],VERB_DEP_PATH_[mutate]_[nsubjpass@]_[prep_with-ccomp|distinguish-rcmod|find-prep_in|cancer@],VERB_DEP_PATH_[find]_[nsubjpass@rcmod-prep_in|cancer]_[prep_with-ccomp|distinguish@],VERB_DEP_PATH_POS_[find]_[nsubjpass@rcmod-prep_in|NN]_[prep_with-ccomp|VB@]}	{-3.11955,0.790017,0.790017,0.790017,0.790017,0.790017,0.790017,0.790017,0.790017}
journal.pone.0076774.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0076774.pdf_477_477_23_23_31_32_UNSUP	SEDL/HP:0002655|Spondyloepiphyseal dysplasia	{23}	{31,32}	{Jang,SB,",",Kim,YG,",",Cho,YS,",",Suh,PG,",",Kim,KH,",",et,al.,(,2002,),lrystal,structure,of,SEDL,and,its,implications,for,a,genetic,disease,spondyloepiphyseal,dysplasia,tarda,.}	{"lVIol Cell Biol 11 : 2154 — 2l61 .",.}	{"J Biol Chem 277 : 49863 — 49869 .",.}	0.91	0.104	0.112	{"WORD_SEQ_[and its implication for a genetic disease]",POS_SEQ_[CC_PRP$_NNS_IN_DT_JJ_NN],DEP_PATH_POS_[prep_of-dobj|NN@nn-prep_for|NN],DEP_PATH_[prep_of-dobj|structure@nn-prep_for|tarda]}	{0.663082,0.663082,0.435221,0.435221}
SCPDFS_18784.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_18784.pdf_151_151_7_7_14_14_UNSUP	FGF3/HP:0000691|Microdontia	{7}	{14}	{Homozygous,or,compound,heterozygous,mutation,in,the,FGF3,gene,may,cause,microtia,",",and,microdontia,(,164950,),;,microdeletion,of,FGF3,was,found,in,two,families,",",one,with,otodental,dysplasia,(,166750,),and,one,with,otodental,dysplasia,and,coloboma,(,Gregory,.}	{"Some of their members are key genes for cranial suture development .","FGF19 encodes a ligand exclusive to FGFR4 , is only expressed in muscle and has never been related to any craniofacial malformation ( Xie et al. , 1999 ) ."}	{"— .","Evans et al. , 2007 ) , while ampliﬁcation of FGF3 and FGF4 was found in various kinds of human tumors ."}	0.91	0.924	0.442	{DEP_PATH_POS_[nn-prep_in|NN-conj_or|NN-nsubj|JJ@nn-conj_and|NN-dobj|NN],"WORD_SEQ_[gene may cause microtium , and]","POS_SEQ_[NN_MD_VB_NN_,_CC]",DEP_PATH_[nn-prep_in|gene-conj_or|mutation-nsubj|homozygous@nn-conj_and|)-dobj|microtium],VERB_DEP_PATH_POS_[cause]_[nn-prep_in|NN-conj_or|NN-nsubj|JJ@]_[nn-conj_and|NN-dobj|NN@],VERB_DEP_PATH_[cause]_[nn-prep_in|gene-conj_or|mutation-nsubj|homozygous@]_[nn-conj_and|)-dobj|microtium@]}	{0.410512,0.410512,0.410512,0.410512,0.410512,0.410512}
journal.pone.0019120.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0019120.pdf_45_45_59_59_51_51_UNSUP	CF/HP:0000027|Azoospermia	{59}	{51}	{Interestingly,",",in,a,study,screening,a,panel,of,13,mutations,of,CFTR,in,semen,specimens,from,127,CF-unrelated,healthy,males,attending,infertility,clinics,",",fourteen,(,17.5,%,),of,80,healthy,men,with,infertility,due,to,reduced,sperm,quality,and,two,of,21,men,(,9.5,%,),with,azoospermia,carried,one,CFTR,mutation,",",while,no,CF,TR,mutation,was,detected,in,26,males,who,had,normozoospermia,[,13,],.}	{"R + e PLoS ONE | www .","p | osone.org data were obtained when CFTR mutation screening was performed in infertile patients with defective testicular function , with some reports indicating the association of CFTR mutations and defects in sperm production [ l2 , l3 ,14 , l5 ] , but some others rejecting the association [ l6 , l7 ,18 , l9 ] ."}	{"Another study also shows that a higher proportion of 5 T allele , a common variation of the poly ( T ) in intron 8 of Cftr , which has been associated with low level of CFTR expression and with susceptibility to non-classical CF disease patterns , exists in men with severe oligozoospermia [ 6,20 ] , suggesting that variation in CFTR may be associated with defects in spermatogenesis .","Despite the accumulating evidence indicating possible involvement of CFTR in sperm production , the exact role of CFTR in spermatogenesis has not been elucidated , and thus , the question as to whether CFTR mutations may result in impaired spermatogenesis remains controversial ."}	0.956	0.058	0.944	{INV_DEP_PATH_POS_[nn-nsubjpass|NN-advcl|VBN@prep_with-nsubj|CD],"INV_WORD_SEQ_[carry one cftr mutation , while no]",INV_VERB_DEP_PATH_[detect]_[nn-nsubjpass|mutation@]_[prep_with-nsubj|NUMBER@advcl],INV_VERB_DEP_PATH_POS_[detect]_[nn-nsubjpass|NN@]_[prep_with-nsubj|CD@advcl],INV_VERB_DEP_PATH_POS_[carry]_[nn-nsubjpass|NN-advcl|VBN@]_[prep_with-nsubj|CD@],INV_VERB_DEP_PATH_[be]_[nn-nsubjpass|mutation@auxpass]_[prep_with-nsubj|NUMBER@auxpass-advcl|detect],INV_DEP_PATH_[nn-nsubjpass|mutation-advcl|detect@prep_with-nsubj|NUMBER],"INV_POS_SEQ_[VBD_CD_NN_NN_,_IN_DT]","INV_WORD_SEQ_NER_[carry NUMBER MISC mutation , while no]",INV_VERB_DEP_PATH_[carry]_[nn-nsubjpass|mutation-advcl|detect@]_[prep_with-nsubj|NUMBER@],INV_VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[prep_with-nsubj|CD@auxpass-advcl|VBN]}	{0.250306,0.250306,0.250306,0.250306,0.250306,0.250306,0.250306,0.250306,0.250306,0.250306,0.250306}
journal.pone.0011157.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0011157.pdf_535_535_23_23_28_28_UNSUP	JAK2/HP:0001901|Polycythemia	{23}	{28}	{Scott,Ll,"\\\\",’,I,",",Tong,VV,",",Levine,RL,",",Scott,lVIA,",",Beer,PA,",",et,al.,(,2007,),JAK2,exon,12,mutations,in,polycythemia,vera,and,idiopathic,erythrocytosis,.}	{"Kohlhuber F , Rogers NC , VVatling D , FengJ , Guschin D , et al. ( 1997 ) AJAK1 / JAK2 chimera can sustain alpha and gamma interferon responses .","l \\\\ ’ Iol Cell Biol 17 : 695 — 706 ."}	{"N EnglJ l \\\\ / [ ed 356 : 459 — 468 .","_ s PLoS ONE | www ."}	0.998	0.974	1	{POS_SEQ_[NN_CD_NNS_IN],"WORD_SEQ_NER_[exon NUMBER mutation in]","WORD_SEQ_[exon 12 mutation in]",DEP_PATH_POS_[nn-dep|NN-dobj|CD@nn-prep_in|NN],DEP_PATH_[nn-dep|exon-dobj|DATE@nn-prep_in|vera]}	{1.34484,1.0824,1.0824,0.788682,0.353993}
journal.pone.0057758.pdf	RELATION_GENEHPOTERM_journal.pone.0057758.pdf_484_484_22_22_29_31	SCGB3A2/HP:0100647|Graves disease	{22}	{29,31}	{Song,HD,",",LiangJ,",",ShiJY,",",Zhao,SX,",",Liu,Z,",",et,al.,(,2009,),Functional,SNPs,in,the,SCGB3A2,promoter,are,associated,with,susceptibility,to,Graves,’,disease,.}	{"J Clin Endocrinol Nfetab 86 : 626 — 630 .","10 ."}	{"Human l \\\\ Iolecular Genetics 18 : 1156 — 1170 .","11 ."}	0.906	0.708	1	{VERB_DEP_PATH_POS_[be]_[nn-prep_in|NN-nsubjpass|NNS@auxpass]_[prep_to@auxpass],DEP_PATH_POS_[nn-prep_in|NN-nsubjpass|NNS@prep_to],VERB_DEP_PATH_POS_[associate]_[nn-prep_in|NN-nsubjpass|NNS@]_[prep_to@],"WORD_SEQ_[promoter be associate with susceptibility to]",POS_SEQ_[NN_VBP_VBN_IN_NN_TO],VERB_DEP_PATH_[be]_[nn-prep_in|promoter-nsubjpass|snp@auxpass]_[prep_to@auxpass],VERB_DEP_PATH_[associate]_[nn-prep_in|promoter-nsubjpass|snp@]_[prep_to@],DEP_PATH_[nn-prep_in|promoter-nsubjpass|snp@prep_to]}	{1.07882,1.07882,0.259273,0,0,0,0,0}
journal.pgen.1000541.pdf	RELATION_GENEHPOTERM_journal.pgen.1000541.pdf_664_664_42_42_45_47	COL9A2/HP:0002654|Multiple epiphyseal dysplasia	{42}	{45,46,47}	{Nluragaki,Y,",",1VIariman,EC,",",van,Beersum,SE,",",Perala,IVI,",",van,1,"\\\\",’,Iouri1,<,JB,",",et,al.,(,1996,),A,mutation,in,the,gene,encoding,the,alpha,2,chain,of,the,fibril-associated,collagen,IX,",",COL9A2,",",causes,multiple,epiphyseal,dysplasia,(,EDNI2,),.}	{"Blood 110 : 886 * 893 .",.}	{"Nat Genet 12 : 103 — 105 .",.}	0.918	0.036	1	{"WORD_SEQ_[, cause]","POS_SEQ_[,_VBZ]",DEP_PATH_POS_[appos-nsubj|CD@amod-dobj|NN],VERB_DEP_PATH_[cause]_[appos-nsubj|NUMBER@]_[amod-dobj|)@],VERB_DEP_PATH_[encode]_[appos-nsubj|NUMBER@prepc_in]_[amod-dobj|)@prepc_in],VERB_DEP_PATH_POS_[cause]_[appos-nsubj|CD@]_[amod-dobj|NN@],VERB_DEP_PATH_POS_[encode]_[appos-nsubj|CD@prepc_in]_[amod-dobj|NN@prepc_in],DEP_PATH_[appos-nsubj|NUMBER@amod-dobj|)]}	{1.52516,-0.462072,0.257815,0.257815,0.257815,0.257815,0.257815,0.257815}
journal.pbio.0050325.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pbio.0050325.pdf_552_552_5_5_2_2_UNSUP	PTEN/HP:0001337|Tremor	{5}	{2}	{Tumours,and,tremors,:,how,PTEN,regulation,underlies,both,.}	{.,"Kim RH , Mak TW ( 2006 ) ."}	{"Br _ ] Cancer 94 : 620 — 624 .","Fallon L , Belanger CM , Corera AT , Kontogiannea M , Regan-Klapisz E , et al. ( 2006 ) ."}	0.95	0.718	0.982	{INV_DEP_PATH_[nn-nsubj|regulation-dep|underlie@conj_and],INV_DEP_PATH_POS_[nn-nsubj|NN-dep|VBZ@conj_and],INV_VERB_DEP_PATH_[underlie]_[nn-nsubj|regulation@]_[conj_and@dep],INV_VERB_DEP_PATH_POS_[underlie]_[nn-nsubj|NN@]_[conj_and@dep],"INV_WORD_SEQ_[: how]",INV_POS_SEQ_[:_WRB]}	{0.644468,0.644468,0.644468,0.644468,0.211249,0.211249}
journal.pgen.1004475.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1004475.pdf_545_545_10_10_22_23_UNSUP	RB/HP:0012254|Ewing's sarcoma	{10}	{22,23}	{Esiashvili,N,",",Goodman,IVI,",",l,"\\\\",’,Iarcus,RB,",",Jr.,(,2008,),Changes,in,incidence,and,survival,of,Ewing,sarcoma,patients,over,the,past,3,decades,:,Surveillance,Epidemiology,and,End,Results,data,.}	{"Barker Ll \\\\ ’ I , Pendergrass TVV , Sanders JE , Hawkins DS ( 2005 ) Survival after recurrence of Ewing ’s sarcoma family of tumors .","J Clin Oncol 23 : 435444362 ."}	{"J Pediatr Hematol Oncol 30 : 4254430 .","Delattre O , ZucmanJ , lVIelot T , Garau XS , ZuckerJl \\\\ ’ I , et al. ( 1994 ) The Ewing family of tumors4a subgroup of small-round-cell tumors deﬁned by speciﬁc chimeric transcripts ."}	0.96	0.002	0.998	{"WORD_SEQ_[, Jr. ( 2008 ) change in incidence and survival of]","POS_SEQ_[,_NNP_CD_CD_CD_NNS_IN_NN_CC_NN_IN]",DEP_PATH_[dep-appos|l-dep|ORGANIZATION@nn-prep_of|patient-prep_in|incidence],"WORD_SEQ_NER_[, Jr. NUMBER DATE NUMBER change in incidence and survival of]",DEP_PATH_POS_[dep-appos|NN-dep|NN@nn-prep_of|NNS-prep_in|NN]}	{0.626998,0.626998,0.626998,0.626998,0.626998}
journal.pone.0093439.pdf	RELATION_GENEHPOTERM_journal.pone.0093439.pdf_526_526_21_21_33_34	PTRF/HP:0009064|Generalized lipodystrophy	{21}	{33,34}	{Hayashi,YK,",",Nlatsuda,C,",",Ogawa,NI,",",Goto,K,",",Tominaga,K,",",et,al.,(,2009,),Human,PTRF,mutations,cause,secondary,deﬁciency,of,caveolins,resulting,in,muscular,dystrophy,with,generalized,lipodystrophy,.}	{"Aboulaich N , Ortegren U , Vener AV , Stralfors P ( 2006 ) Association and insulin regulated translocation of hormone-sensitive lipase with PTRF .","Biochem Biophys Res Commun 350 : 657 — 661 ."}	{"J Clin Invest 119 : 262342633 .",.}	0.92	0.988	1	{DEP_PATH_[nn-dep|mutation-nsubj|YK@prepc_with-partmod|result-prep_of|caveolin-dobj|deﬁciency],"WORD_SEQ_[mutation cause secondary deﬁciency of caveolin result in muscular dystrophy with]",POS_SEQ_[NNS_VBP_JJ_NN_IN_NNS_VBG_IN_JJ_NN_IN],VERB_DEP_PATH_POS_[cause]_[nn-dep|NNS-nsubj|NNP@]_[prepc_with-partmod|VBG-prep_of|NNS-dobj|NN@],VERB_DEP_PATH_[cause]_[nn-dep|mutation-nsubj|YK@]_[prepc_with-partmod|result-prep_of|caveolin-dobj|deﬁciency@],DEP_PATH_POS_[nn-dep|NNS-nsubj|NNP@prepc_with-partmod|VBG-prep_of|NNS-dobj|NN]}	{0.433638,0.433638,0.433638,0.433638,0.433638,0.433638}
journal.pone.0068103.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0068103.pdf_359_359_18_18_30_33_UNSUP	RANKL/HP:0011001|Increased bone mineral density	{18}	{30,31,32,33}	{Early,clinical,trials,with,denosumab,",",a,human,monoclonal,antibody,that,neutralises,receptor,activator,of,NF-kappa-B,ligand,(,RANKL,),",",have,shown,promising,results,with,reduced,bone,resorption,",",increased,bone,mineral,density,and,reduced,risk,of,fracture,in,osteoporosis,and,bone,metastasis,patients,[,47,],.}	{"Furthermore bisphosphonate treatments merely maintain bone mass without restoring the bone that has been lost [ 48 ] and patients continue to develop pathologic fractures .","This may be because there is insufﬁcient bone formation activity at the metastatic site to regenerate the bone which has been lost , as suggested by our findings ."}	{"However despite its FDA approval in 2010 , there are ongoing concerns regarding a high incidence of hospitalisations due to infections in denosumab trials [ 48 ] .","RANKL binding is not only required for osteoclast formation but also immunogenesis and therefore denosumab may be producing adverse effects in the differentiation of T and B cells [ 49 ] ."}	0.902	0.064	0.984	{DEP_PATH_[nn-dep|)-prep_of|ligand-dobj|activator-rcmod|neutralise-appos|antibody-nsubj|trial-conj_and|reduce@conj_and],"WORD_SEQ_[) , have show promising result with reduce bone resorption ,]","POS_SEQ_[NN_,_VBP_VBN_JJ_NNS_IN_VBN_NN_NN_,]",DEP_PATH_POS_[nn-dep|NN-prep_of|NN-dobj|NN-rcmod|VBZ-appos|NN-nsubj|NNS-conj_and|VBD@conj_and]}	{0.497763,0.497763,0.497763,0.497763}
journal.pmed.0050120.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pmed.0050120.pdf_315_315_0_0_15_15_UNSUP	MITF/HP:0002861|Melanoma	{0}	{15}	{MITF,is,an,important,transcriptional,regulator,of,pigmentation,that,is,ampliﬁed,in,a,subset,of,melanomas,and,cooperates,with,BRAF,in,transforming,immortalized,human,melanocytes,[,27,],.}	{"p | osmedicine.org the function of a genetic factor .","For example , our observation of increased melanin pigment in the tumor cells in melanomas with BRAF mutations is in line with recent reports of cooperation between BRAF and MITF in melanoma development ."}	{"A link between BRAF and pigmentation is further supported by a recent independent observation that BRAF-mutant melanomas are also more pigmented macroscopically [ 28 ] .","Our study also identiﬁed strong associations between upward scatter of intraepidermal melanocytes and formation of nests and BRAF mutation ."}	0.966	0.668	0.95	{VERB_DEP_PATH_POS_[be]_[nsubj@auxpass-rcmod|VBN]_[prep_of-prep_in|NN@auxpass],VERB_DEP_PATH_POS_[be]_[nsubj@cop]_[prep_of-prep_in|NN-rcmod|VBN@cop],DEP_PATH_POS_[nsubj@prep_of-prep_in|NN-rcmod|VBN],VERB_DEP_PATH_POS_[ampliﬁed]_[nsubj@rcmod]_[prep_of-prep_in|NN@],VERB_DEP_PATH_[be]_[nsubj@cop]_[prep_of-prep_in|subset-rcmod|ampliﬁed@cop],VERB_DEP_PATH_[ampliﬁed]_[nsubj@rcmod]_[prep_of-prep_in|subset@],VERB_DEP_PATH_POS_[cooperate]_[nsubj@rcmod]_[prep_of-prep_in|NN-rcmod|VBN@rcmod],"WORD_SEQ_[be a important transcriptional regulator of pigmentation that be ampliﬁed in a subset of]",VERB_DEP_PATH_[cooperate]_[nsubj@rcmod]_[prep_of-prep_in|subset-rcmod|ampliﬁed@rcmod],VERB_DEP_PATH_[be]_[nsubj@auxpass-rcmod|ampliﬁed]_[prep_of-prep_in|subset@auxpass],DEP_PATH_[nsubj@prep_of-prep_in|subset-rcmod|ampliﬁed],POS_SEQ_[VBZ_DT_JJ_JJ_NN_IN_NN_WDT_VBZ_VBN_IN_DT_NN_IN]}	{0.611139,0.611139,0.611139,0.200766,0.200766,0.200766,0.200766,0.200766,0.200766,0.200766,0.200766,0.200766}
journal.pone.0042644.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0042644.pdf_69_69_34_34_22_22_UNSUP	DYT1/HP:0001332|Dystonia	{34}	{22}	{To,test,this,hypothesis,",",we,administered,the,irreversible,complexII,inhibitor,3-nitroproprionic,acid,(,3-NP,),",",a,toxin,known,to,cause,dystonia,in,rodents,",",primates,and,humans,[,19,],",",to,DYT1,/,mac,/,"{",in,(,KI,),mice,.}	{"Collectively , these reports suggest that challenges to the neuronal energy/redox states could be a trigger for the pathogenic cascade in DYT1 .","Based on this information , we hypothesized that the mammalian DYT1 brain is sensitized to the effects of energy depletion and oxidative stress caused by disruption of the mitochondrial respiratory chain , which would trigger the disease phenotype ."}	{"Materials and Methods","Ethics Statement This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health ."}	0.934	0.518	0.996	{"INV_WORD_SEQ_[in rodent , primate and human [ 19 ] , to]",INV_VERB_DEP_PATH_POS_[know]_[prep_to@partmod-nsubj|NN]_[dobj-xcomp|VB@],"INV_WORD_SEQ_NER_[in rodent , primate and human [ NUMBER NUMBER , to]","INV_POS_SEQ_[IN_NNS_,_NNS_CC_NNS_VBP_CD_CD_,_TO]",INV_DEP_PATH_[prep_to@dobj-xcomp|cause-partmod|know-nsubj|toxin],INV_VERB_DEP_PATH_[cause]_[prep_to@xcomp-partmod|know-nsubj|toxin]_[dobj@],INV_VERB_DEP_PATH_POS_[cause]_[prep_to@xcomp-partmod|VBN-nsubj|NN]_[dobj@],INV_VERB_DEP_PATH_[know]_[prep_to@partmod-nsubj|toxin]_[dobj-xcomp|cause@],INV_DEP_PATH_POS_[prep_to@dobj-xcomp|VB-partmod|VBN-nsubj|NN]}	{0.294946,0.294946,0.294946,0.294946,0.294946,0.294946,0.294946,0.294946,0.294946}
SCPDFS_19876.pdf	RELATION_GENEHPOTERM_SCPDFS_19876.pdf_252_252_3_3_15_17	IL-13/HP:0005584|Renal cell carcinoma	{3}	{15,16,17}	{Polymorphisms,in,the,IL-13,and,IL,—,4R,genes,are,associated,with,the,development,of,renal,cell,carcinoma,.}	{"Rep. 39 , 5349-5357 .","Chu , H. , et al. , 2011b ."}	{"Ann .","Oncol ."}	0.984	0.968	1	{VERB_DEP_PATH_POS_[be]_[prep_in-nsubjpass|NNS@auxpass]_[prep_of-prep_with|NN@auxpass],DEP_PATH_POS_[prep_in-nsubjpass|NNS@prep_of-prep_with|NN],VERB_DEP_PATH_POS_[associate]_[prep_in-nsubjpass|NNS@]_[prep_of-prep_with|NN@],"WORD_SEQ_NER_[and il NUMBER 4r gene be associate with the development of]",POS_SEQ_[CC_NN_CD_NN_NNS_VBP_VBN_IN_DT_NN_IN],"WORD_SEQ_[and il — 4r gene be associate with the development of]",VERB_DEP_PATH_[associate]_[prep_in-nsubjpass|polymorphism@]_[prep_of-prep_with|development@],VERB_DEP_PATH_[be]_[prep_in-nsubjpass|polymorphism@auxpass]_[prep_of-prep_with|development@auxpass],DEP_PATH_[prep_in-nsubjpass|polymorphism@prep_of-prep_with|development]}	{1.31143,1.31143,0.86815,0,0,0,0,0,0}
SCPDFS_45289.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_45289.pdf_41_41_16_16_21_21_UNSUP	WAGR/HP:0000526|Aniridia	{16}	{21}	{These,studies,have,located,WAGR,between,CAT,and,F,SHB,and,suggest,that,",",within,the,WAGR,gene,complex,",",the,aniridia,determinant,(,AN2,),is,telomeric,to,the,Wilms,tumor,gene,(,WT,),:,CENCA,T,-,WT,.}	{"POLYMORPHIC LoCUs AT A WAGR DELETION BREAKPOINT 881","and Junien , 1987 ) ."}	{"— .","AN2 ."}	0.956	0.512	0.07	{VERB_DEP_PATH_POS_[suggest]_[nn-prep_within|NN-ccomp|JJ@]_[nn-nsubj|NN-ccomp|JJ@],VERB_DEP_PATH_[have]_[nn-prep_within|complex-ccomp|telomeric-conj_and|suggest@]_[nn-nsubj|)-ccomp|telomeric-conj_and|suggest@],VERB_DEP_PATH_[suggest]_[nn-prep_within|complex-ccomp|telomeric@]_[nn-nsubj|)-ccomp|telomeric@],DEP_PATH_[nn-prep_within|complex@nn-nsubj|)],VERB_DEP_PATH_[be]_[nn-prep_within|complex@cop]_[nn-nsubj|)@cop],VERB_DEP_PATH_POS_[be]_[nn-prep_within|NN@cop]_[nn-nsubj|NN@cop],"WORD_SEQ_[gene complex , the]",DEP_PATH_POS_[nn-prep_within|NN@nn-nsubj|NN],VERB_DEP_PATH_POS_[have]_[nn-prep_within|NN-ccomp|JJ-conj_and|VBP@]_[nn-nsubj|NN-ccomp|JJ-conj_and|VBP@],"POS_SEQ_[NN_NN_,_DT]"}	{0.327281,0.327281,0.327281,0.327281,0.327281,0.327281,0.327281,0.327281,0.327281,-0.0334645}
journal.pone.0021720.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0021720.pdf_515_515_30_30_34_35_UNSUP	alpha-synuclein/HP:0100315|Lewy bodies	{30}	{34,35}	{Zarranz,J,],",",Alegre,J,",",Gomez-Estel,),an,JC,",",Lezcano,E,",",Ros,R,",",et,al.,(,2004,),The,new,mutation,",",E46K,",",of,alpha-synuclein,causes,Parkinson,and,Lewy,body,dementia,.}	{"Spillantini IVIG , Schmidt IVIL , Lee V ' l \\\\ ’ I , Trojanowski Jakes R , et al. ( 1997 ) Alpha-synuclein in Lewy bodies .","Nature 388 : 839-840 ."}	{"Ann Neurol 55 : 164-173 .","Sato S , Chiba T , Sakata E , Kato K , Mizuno Y , et al. ( 2006 ) 14-3-3eta is a novel regulator of parkin ubiquitin ligase ."}	0.98	0.456	1	{"WORD_SEQ_[cause Parkinson and]",POS_SEQ_[VBZ_NNP_CC],VERB_DEP_PATH_POS_[cause]_[prep_of-appos|NNP-nsubj|NNP@]_[nn-dobj|NN@],DEP_PATH_POS_[prep_of-appos|NNP-nsubj|NNP@nn-dobj|NN],DEP_PATH_[prep_of-appos|PERSON-nsubj|JC@nn-dobj|dementia],VERB_DEP_PATH_[cause]_[prep_of-appos|PERSON-nsubj|JC@]_[nn-dobj|dementia@]}	{2.51126,1.70298,-0.325378,-0.325378,-0.0429787,-0.0429787}
journal.pone.0027720.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0027720.pdf_3_3_13_13_2_3_UNSUP	ERK/HP:0012125|Prostate cancer	{13}	{2,3}	{LIV-1,Promotes,Prostate,Cancer,EpithelialtoMesenchymal,Transition,and,Metastasis,through,HB-EGF,Shedding,and,EGFR-Mediated,ERK,Signaling}	{"1 ‘ @ \\" ' PL0S one","OPEN 8 ACCESS Freely available online"}	{"Hui-Wen Lue ‘ , Xiaojian Yang2 ' 9 , Ruoxiang Wangz , Weiping Qian3 , Roy Z. H. Xu4 , Robert Ly | es4 , Adeboye O. Osunkoyas , Binhua P. Zhou ° , Robert L. Vesse | | a7 , Majd Zayzafoons , Zhi-Ren Liu ' , Haiyen E. Zhau2 * , Leland W. K. Chung2 * 1 Department of Biology , Georgia State University , Atlanta , Georgia , United States of America , 2 Department of Medicine , Samuel Oschin Comprehensive Cancer Institute , Cedars .","— ."}	0.958	0.768	0.878	{INV_DEP_PATH_POS_[nn-prep_through|NN@nn],INV_DEP_PATH_[nn-prep_through|signaling@nn],"INV_WORD_SEQ_[EpithelialtoMesenchymal transition and metastasis through hb-egf shedding and egfr-mediated]",INV_VERB_DEP_PATH_[promote]_[nn-prep_through|signaling-dobj|transition@]_[nn-dobj|transition@],INV_VERB_DEP_PATH_POS_[promote]_[nn-prep_through|NN-dobj|NN@]_[nn-dobj|NN@],INV_POS_SEQ_[NNP_NN_CC_NN_IN_NN_NN_CC_JJ]}	{1.45282,0.319244,0.319244,0.319244,0.319244,0.319244}
SCPDFS_4232.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_4232.pdf_655_655_0_0_11_11_UNSUP	PAX6/HP:0000526|Aniridia	{0}	{11}	{PAX6,gene,dosage,effect,in,a,family,with,congenital,cataracts,",",aniridia,",",anophthalmia,and,central,nervous,system,defects,.}	{"282 , 5973-5983 .","Glaser , T. , Jepeal , L. , Edwards , J.G. , Young , S.R. , Favor , J. , Maas , R.L. , 1994 ."}	{"Nat .","Genet ."}	0.99	0.868	1	{"WORD_SEQ_[gene dosage effect in a family with congenital cataract ,]","POS_SEQ_[NN_NN_NN_IN_DT_NN_IN_JJ_NNS_,]",DEP_PATH_POS_[nn@nn-nn|NN-appos|NNS-prep_with|NNS],DEP_PATH_[nn@nn-nn|anophthalmium-appos|defect-prep_with|cataract]}	{2.16722,1.95334,0.0776574,0.0776574}
SCPDFS_44671.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_44671.pdf_18_18_24_24_27_27_UNSUP	WAGR/HP:0000526|Aniridia	{24}	{27}	{While,most,tumors,are,sporadic,and,occur,in,children,with,normal,karyotypes,and,no,congenital,anomalies,",",WT,does,occur,as,part,of,the,WAGR,syndrome,(,aniridia,",",genitourinary,abnormalities,",",and,mental,retardation,),attributable,to,a,constitutional,chromosomal,deletion,at,11p13,(,Francke,et,al.,",",1979,;,Narahara,et,al.,",",1984,),.}	{INTRODUCTION,"Wilms tumor ( WT ) or nephroblastoma occurs at a rate of 1 per 10,000 live-born children , making it one of the more common childhood cancers ( Innis , 1973 ; Stukonis , 1978 ) ."}	{"In addition , some spo ‘","To whom correspondence should be addressed at Molecular Genetics Laboratory , Greenwood Genetic Center , One Gregor Mendel Circle , Greenwood , SC 29646 ."}	0.944	0.11	0.974	{POS_SEQ_[NN_CD],"WORD_SEQ_[syndrome (]","WORD_SEQ_NER_[syndrome NUMBER]",VERB_DEP_PATH_[occur]_[nn-prep_of|syndrome-prep_as|part@]_[dobj@],VERB_DEP_PATH_POS_[occur]_[nn-prep_of|NN-prep_as|NN@]_[dobj@],VERB_DEP_PATH_POS_[do]_[nn-prep_of|NN-prep_as|NN@aux]_[dobj@aux],DEP_PATH_[nn-prep_of|syndrome-prep_as|part@dobj],VERB_DEP_PATH_[occur]_[nn-prep_of|syndrome-prep_as|part@advcl]_[dobj@advcl],VERB_DEP_PATH_POS_[occur]_[nn-prep_of|NN-prep_as|NN@advcl]_[dobj@advcl],VERB_DEP_PATH_[do]_[nn-prep_of|syndrome-prep_as|part@aux]_[dobj@aux],DEP_PATH_POS_[nn-prep_of|NN-prep_as|NN@dobj]}	{-2.92118,1.48593,1.43132,0.382277,0.382277,0.382277,0.382277,0.382277,0.382277,0.382277,-0.00387441}
journal.pone.0068063.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0068063.pdf_781_781_27_27_28_28_UNSUP	DYT1/HP:0001332|Dystonia	{27}	{28}	{Kakazu,Y,",",Koh,JY,",",Ho,KW,",",Gonzalez-Alegre,P,",",Harata,NC,(,2012,),Synaptic,vesicle,recycling,is,enhanced,by,torsinA,that,harbors,the,DYT1,dystonia,mutation,.}	{"2010.285 .","PubMed : 21102408 ."}	{"Synapse 66 : 453-464 .","doi :10.1002 / syn .21534 ."}	0.942	0.98	0.202	{VERB_DEP_PATH_POS_[enhance]_[nn-dobj|NN-rcmod|VBZ-agent|NN@]_[nn-dobj|NN-rcmod|VBZ-agent|NN@],VERB_DEP_PATH_[enhance]_[nn-dobj|mutation-rcmod|harbor-agent|torsina@]_[nn-dobj|mutation-rcmod|harbor-agent|torsina@],WORD_SEQ_[],POS_SEQ_[],VERB_DEP_PATH_[harbor]_[nn-dobj|mutation@]_[nn-dobj|mutation@],VERB_DEP_PATH_POS_[harbor]_[nn-dobj|NN@]_[nn-dobj|NN@],DEP_PATH_POS_[nn@nn],DEP_PATH_[nn@nn]}	{1.88046,1.88046,-1.47483,-1.46457,0.958792,0.958792,-0.0245278,0.00991182}
SCPDFS_3276.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_3276.pdf_955_955_2_2_10_10_UNSUP	PAX6/HP:0000526|Aniridia	{2}	{10}	{The,human,PAX6,gene,is,mutated,in,two,patients,with,aniridia,.}	{"29 , 27-43 .","Jordan , T. , Hanson , I. , Zaletayev , D. , Hodgson , 5. , Prosser , J. , Seawright , A. , Hastie , N. , van Heyningen , V. , 1992 ."}	{"Nat .","Genet ."}	0.998	0.888	1	{DEP_PATH_[nn-nsubjpass|gene@prep_with-prep_in|patient],VERB_DEP_PATH_[be]_[nn-nsubjpass|gene@auxpass]_[prep_with-prep_in|patient@auxpass],"WORD_SEQ_NER_[gene be mutate in NUMBER patient with]",POS_SEQ_[NN_VBZ_VBN_IN_CD_NNS_IN],"WORD_SEQ_[gene be mutate in two patient with]",VERB_DEP_PATH_[mutate]_[nn-nsubjpass|gene@]_[prep_with-prep_in|patient@],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[prep_with-prep_in|NNS@auxpass],DEP_PATH_POS_[nn-nsubjpass|NN@prep_with-prep_in|NNS],VERB_DEP_PATH_POS_[mutate]_[nn-nsubjpass|NN@]_[prep_with-prep_in|NNS@]}	{1.13618,1.13618,1.1073,1.1073,1.1073,0.943145,-0.0584279,-0.0584279,-0.00449092}
SCPDFS_45289.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_45289.pdf_41_41_4_4_21_21_UNSUP	WAGR/HP:0000526|Aniridia	{4}	{21}	{These,studies,have,located,WAGR,between,CAT,and,F,SHB,and,suggest,that,",",within,the,WAGR,gene,complex,",",the,aniridia,determinant,(,AN2,),is,telomeric,to,the,Wilms,tumor,gene,(,WT,),:,CENCA,T,-,WT,.}	{"POLYMORPHIC LoCUs AT A WAGR DELETION BREAKPOINT 881","and Junien , 1987 ) ."}	{"— .","AN2 ."}	0.922	0.018	0.07	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_[suggest]_[dobj@conj_and]_[nn-nsubj|)-ccomp|telomeric@],DEP_PATH_POS_[dobj@nn-nsubj|NN-ccomp|JJ-conj_and|VBP],VERB_DEP_PATH_POS_[suggest]_[dobj@conj_and]_[nn-nsubj|NN-ccomp|JJ@],DEP_PATH_[dobj@nn-nsubj|)-ccomp|telomeric-conj_and|suggest],VERB_DEP_PATH_[be]_[dobj@cop-ccomp|telomeric-conj_and|suggest]_[nn-nsubj|)@cop],VERB_DEP_PATH_[have]_[dobj@]_[nn-nsubj|)-ccomp|telomeric-conj_and|suggest@],VERB_DEP_PATH_POS_[be]_[dobj@cop-ccomp|JJ-conj_and|VBP]_[nn-nsubj|NN@cop],VERB_DEP_PATH_POS_[have]_[dobj@]_[nn-nsubj|NN-ccomp|JJ-conj_and|VBP@]}	{-3.11955,0.678115,0.678115,0.678115,0.678115,0.678115,0.678115,0.678115,0.678115}
journal.pone.0042504.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0042504.pdf_560_560_22_22_27_27_UNSUP	PTEN/HP:0000717|Autism	{22}	{27}	{BuxbaumJD,",",Cai,G,",",Chaste,P,",",Nygren,G,",",Go1dsmithJ,",",et,al.,(,2007,),Nlutation,screening,of,the,PTEN,gene,in,patients,with,autism,spectrum,disorders,and,macrocephaly,.}	{"Cell 149 : 49432 .","9 ."}	{"AmJ 1VIed Genet B Neuropsychiatr Genet 144B : 484 — 491 .","Fombonne E , Roge B , Claverie J , Courty S , FremolleJ ( 1999 ) 1VIicrocephaly and macrocephaly in autism ."}	0.906	0.294	1	{"WORD_SEQ_[gene in patient with]",POS_SEQ_[NN_IN_NNS_IN],DEP_PATH_[nn-prep_of|gene-dobj|screening@nn-pobj|disorder-dep|with-prep_in|patient],DEP_PATH_POS_[nn-prep_of|NN-dobj|NN@nn-pobj|NNS-dep|IN-prep_in|NNS]}	{2.85222,-1.30547,0.350115,0.350115}
journal.pone.0079933.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0079933.pdf_4_4_13_13_5_9_UNSUP	MODY2/HP:0004904|Maturity-onset diabetes of the young	{13}	{5,6,9}	{Identification,of,Candidate,Children,for,Maturity-Onset,Diabetes,of,the,Young,Type,2,(,MODY2,),Gene,Testing,:,A,Seven-Item,Clinical,Flowchart,(,7-iF,)}	{.,": l ° ” E"}	{"Michele Pinelli ” , Fabio Acquaviva ” , Fabrizio Barbettiz , Elisabetta Caredda3 , Sergio Cocozza ‘ , Maurizio Delvecchio4 , Enza Mozzillos , Daniele Pirozzi \\" 6 , Francesco Prisco3 , lvana Rabbone7 , Lucia Sacchetti \\" ° , Nadia Tinto \\" ° , Sonia Toni “ , Stefano Zucchini9 , Dario lafusco3 * , Italian Study Group on Diabetes of the Italian Society of Pediatric Endocrinology and Diabetology ( lSPED ) ' ” 1Department of Molecular Medicine and Medical Biotechnologies , University of Naples ” Federico II ” , Naples , Italy , 2Laboratory of Molecular Endocrinology and Metabolism , Bambino Gesu Children 's Hospital , Scientiﬁc Institute - Laboratory of Mendelian Diabetes , Rome , Italy , 3 Department of Pediatrics , Second University of Naples , Naples , Italy , 4Pediatrics Unit , IRCCS Casa Sollievo della Sofferenza Hospital , 5 .","Giovanni Rotondo ( FG ) , Italy , 5 Department of Pediatrics , University of Naples \\" Federico II ” , Naples , Italy , 6CE | NGE — Advanced Biotechnologies S. C. a R. L. , Naples , Italy , 7Department of Pediatrics , University of Turin , Turin , Italy , 8Pediatric Diabetologic Unit , Meyer Children Hospital , Florence , Italy , 9Department of Pediatrics , University of Bologna , Bologna , Italy"}	0.998	0.014	1	{"INV_WORD_SEQ_NER_[type NUMBER NUMBER]","INV_WORD_SEQ_[type 2 (]",INV_POS_SEQ_[NN_CD_CD],INV_DEP_PATH_POS_[nn-dep|NNP-dep|CD@prep_for-prep_of|NNP],INV_DEP_PATH_[nn-dep|Testing-dep|NUMBER@prep_for-prep_of|Children]}	{3.395,1.84683,-0.344507,0.0277215,0.0277215}
SCPDFS_18980.pdf	RELATION_GENEHPOTERM_SCPDFS_18980.pdf_464_464_2_2_7_8	CAPN10/HP:0000147|Polycystic ovaries	{2}	{7,8}	{Comment,:,CAPN10,alleles,are,associated,with,polycystic,ovary,syndrome,.}	{"Online 7 , 602-605 .","Gonzalez , A. , et al. , 2002 ."}	{"J. Clin .","Endocrinol ."}	0.938	0.784	1	{VERB_DEP_PATH_[be]_[nn-nsubjpass|allele@auxpass]_[amod-prep_with|syndrome@auxpass],"WORD_SEQ_[allele be associate with]",VERB_DEP_PATH_[associate]_[nn-nsubjpass|allele@]_[amod-prep_with|syndrome@],DEP_PATH_[nn-nsubjpass|allele@amod-prep_with|syndrome],POS_SEQ_[NNS_VBP_VBN_IN],VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NNS@]_[amod-prep_with|NN@],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NNS@auxpass]_[amod-prep_with|NN@auxpass],DEP_PATH_POS_[nn-nsubjpass|NNS@amod-prep_with|NN]}	{0.58578,0.58578,0.58578,0.58578,0.553668,-0.372782,0.0380447,0.0380447}
journal.pone.0097720.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0097720.pdf_105_105_23_23_34_34_UNSUP	SCN5A/HP:0001662|Bradycardia	{23}	{34}	{S1904L,mutation,in,SCNSA,confers,a,more,severe,phenotype,in,PFC,than,VM,through,a,different,channel,gating,mechanism,In,contrast,to,typical,SCN5A,LQT3,mutations,",",for,which,the,phenotype,is,exacerbated,by,bradycardia,and,rest,",",the,SCNSA,Sl904L,LQTS,mutation,was,described,in,a,young,patient,with,only,a,mildly,prolonged,QT,interval,who,developed,palpitations,with,mild,exercise,[,9,],.}	{"For PFC at 40 BPM , there is a single EAD in every other beat ( AP alternans , seen in panel D ) , while at 30 BPM APs with an EAD alternate with shorter APs .","These ﬁndings clearly establish an arrhythmogenic substrate within PFC for the Fl473C mutation ."}	{"\\\\ / Ve have recently characterized these mutant channels , which exhibit late current as a result of late channel reopenings without a bursting component .","This channel behavior is recapitulated by reducing the inactivation rate constant and reducing the rate constant of entry into deeper buried inactivated states by a factor of 5 and 6 , respectively , generating 0.28 % late current ( as seen experimentally [ 9 ] ) ."}	0.97	0.994	0.994	{DEP_PATH_[nn@agent-rcmod|exacerbate],VERB_DEP_PATH_POS_[exacerbate]_[nn@rcmod]_[agent@],VERB_DEP_PATH_POS_[gate]_[nn-prep_to|NNS@]_[agent-rcmod|VBN-prep_to|NNS@],VERB_DEP_PATH_[be]_[nn@auxpass-rcmod|exacerbate]_[agent@auxpass],VERB_DEP_PATH_[exacerbate]_[nn@rcmod]_[agent@],VERB_DEP_PATH_[gate]_[nn-prep_to|mutation@]_[agent-rcmod|exacerbate-prep_to|mutation@],"POS_SEQ_[NN_NNS_,_IN_WDT_DT_NN_VBZ_VBN_IN]","WORD_SEQ_[lqt3 mutation , for which the phenotype be exacerbate by]",VERB_DEP_PATH_POS_[be]_[nn@auxpass-rcmod|VBN]_[agent@auxpass],DEP_PATH_POS_[nn@agent-rcmod|VBN]}	{0.41338,0.41338,0.41338,0.41338,0.41338,0.41338,0.230973,0.230973,0.0402794,0.0402794}
journal.pone.0005762.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0005762.pdf_429_429_24_24_35_36_UNSUP	GJB2/HP:0000365|Hearing impairment	{24}	{35,36}	{Tang,HY,",",Fang,P,",",VVard,PA,",",Schmitt,E,",",Darilek,S,",",et,al.,(,2006,),DNA,sequence,analysis,of,GJB2,",",encoding,connexin,26,:,observations,from,a,population,of,hearing,impaired,cases,and,variable,carrier,rates,",",complex,genotypes,",",and,ethnic,stratification,of,alleles,among,controls,.}	{"JAMA 281 : 2211 — 2216 .","25 ."}	{"AmJ 1\\\\/Ied Genet A 140 : 2401 ~ 2415 .","26 ."}	0.946	0.08	0.99	{DEP_PATH_[prep_of-dep|analysis-appos|et@amod-prep_of|case-prep_from|population-conj_and|observation-dobj|connexin-partmod|encode],"WORD_SEQ_NER_[, encode connexin NUMBER : observation from a population of]","WORD_SEQ_[, encode connexin 26 : observation from a population of]","POS_SEQ_[,_VBG_NN_CD_:_NNS_IN_DT_NN_IN]",DEP_PATH_POS_[prep_of-dep|NN-appos|FW@amod-prep_of|NNS-prep_from|NN-conj_and|NNS-dobj|NN-partmod|VBG]}	{0.592372,0.592372,0.592372,0.592372,0.592372}
SCPDFS_39050.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_39050.pdf_606_606_2_2_17_18_UNSUP	DYT1/HP:0001304|Torsion dystonia	{2}	{17,18}	{Mutations,in,DYT1,(,formerly,TORIA,),",",which,encodes,torsin,A,",",lead,to,early,onset,torsion,dystonia,",",an,autosomaldominant,movement,disorder,which,begins,in,childhood,and,results,in,contracted,",",twisted,postures,throughout,life,[,"30,38,43,47,48",],.}	{"It is possible that the ADIR2 protein , which lacks the box IV motif ( thought to hydrogen bond with ATP [ 31 ] ) , may assume a different function and / or interacts with different cellular components than ADIR1 .","The human and mouse ADIR genes encode conserved ATP binding proteins with deduced molecular weights of 46 and 44 kDa , respectively , which exhibit a high degree of homology with the torsin A and torsin B proteins [ 30,38 ] ."}	{"Most cases of typical early onset torsion dystonia have a common mutation that results in an in-frame GAG deletion with a loss of a single glutamic acid residue in the C-terminal region of the protein .","This and other related forms of early onset dystonia are thought to be caused by defects in dopamine neurotransmission in the basal ganglia ."}	0.962	0.894	1	{DEP_PATH_POS_[prep_in-nsubj|NNS@prep_to],DEP_PATH_[prep_in-nsubj|mutation@prep_to],VERB_DEP_PATH_POS_[lead]_[prep_in-nsubj|NNS@]_[prep_to@],"POS_SEQ_[CD_RB_NN_CD_,_WDT_VBZ_NN_NN_,_VBP_TO_JJ_NN]","WORD_SEQ_[( formerly torium ) , which encode torsin a , lead to early onset]",VERB_DEP_PATH_[twist]_[prep_in-nsubj|mutation@partmod-prep_to|dystonium]_[@partmod],VERB_DEP_PATH_POS_[twist]_[prep_in-nsubj|NNS@partmod-prep_to|NN]_[@partmod],VERB_DEP_PATH_POS_[encode]_[prep_in@rcmod]_[prep_to@rcmod-nsubj|NNS],VERB_DEP_PATH_[encode]_[prep_in@rcmod]_[prep_to@rcmod-nsubj|mutation],"WORD_SEQ_NER_[NUMBER formerly torium NUMBER , which encode torsin a , lead to early onset]",VERB_DEP_PATH_[lead]_[prep_in-nsubj|mutation@]_[prep_to@]}	{1.04277,0.530288,0.274863,0.191753,0.191753,0.191753,0.191753,0.191753,0.191753,0.191753,-0.0890537}
journal.pone.0084849.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0084849.pdf_503_503_21_23_29_30_UNSUP	microtubule-associated_protein_tau/HP:0002185|Neurofibrillary tangles	{21,22,23}	{29,30}	{Goedert,M,",",Spillantini,MG,",",Jakes,R,",",Rutherford,D,",",Crowther,RA,(,1989,),Multiple,isoforms,of,human,microtubule-associated,protein,tau,:,sequences,and,localization,in,neurofibrillary,tangles,of,Alzheimer,'s,disease,.}	{References,"1 ."}	{"Neuron 3 : 519-526 .","doi :10.1016 / 0896-6273 ( 89 ) 90210-9 ."}	0.976	1	0.998	{POS_SEQ_[:_NNS_CC_NN_IN],"WORD_SEQ_[: sequence and localization in]",DEP_PATH_POS_[@pobj-dep|IN-dep|NNS],DEP_PATH_[@pobj-dep|in-dep|sequence]}	{1.12341,1.12341,0.851047,0.468664}
journal.pone.0057120.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0057120.pdf_376_376_20_20_31_31_UNSUP	APP/HP:0000726|Dementia	{20}	{31}	{Tamayev,R,",",l,"\\\\",’,Iatsuda,S,",",Giliberto,L,",",Arancio,O,",",D’Adamio,L,(,2011,),APP,heterozygosity,averts,memory,deficit,in,knockin,mice,expressing,the,Danish,dementia,BRI2,mutant,.}	{"Tamayev R , lVIatsuda S , Fa l \\\\ ’ I , Arancio O , D’Adamio L ( 2010 ) Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits .","Proc Natl Acad Sci U S A 107 : 20822 * 20827 ."}	{"ENIBOJ 30 : 2501 * 2509 .","Nlatsuda S , Tamayev R , D’Adamio L ( 2011 ) Increased AbetaPP processing in familial Danish dementia patients ."}	0.968	0.574	0.806	{DEP_PATH_POS_[nn-nsubj|NN@nn-dobj|NN-partmod|VBG-prep_in|NNS],"WORD_SEQ_NER_[heterozygosity avert memory deficit in knockin mouse express the MISC]",DEP_PATH_[nn-nsubj|heterozygosity@nn-dobj|mutant-partmod|express-prep_in|mouse],POS_SEQ_[NN_VBZ_NN_NN_IN_JJ_NNS_VBG_DT_JJ],VERB_DEP_PATH_POS_[express]_[nn-nsubj|NN@partmod-prep_in|NNS]_[nn-dobj|NN@],VERB_DEP_PATH_[avert]_[nn-nsubj|heterozygosity@]_[nn-dobj|mutant-partmod|express-prep_in|mouse@],VERB_DEP_PATH_[express]_[nn-nsubj|heterozygosity@partmod-prep_in|mouse]_[nn-dobj|mutant@],VERB_DEP_PATH_POS_[avert]_[nn-nsubj|NN@]_[nn-dobj|NN-partmod|VBG-prep_in|NNS@],"WORD_SEQ_[heterozygosity avert memory deficit in knockin mouse express the danish]"}	{0.416862,0.416862,0.416862,0.416862,0.416862,0.416862,0.416862,0.416862,0.416862}
SCPDFS_19273.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19273.pdf_473_473_9_9_12_12_UNSUP	FMO3/HP:0003614|Trimethylaminuria	{9}	{12}	{Mutations,of,the,ﬂavin,—,containing,monooxygenase,gene,(,FMO3,),cause,trimethylaminuria,",",a,defect,in,detoxiﬁcation,.}	{"Treacy , E.P. .","et al. , 1998 ."}	{"Hum .","Mol ."}	0.948	0.01	0.978	{"WORD_SEQ_[) cause]",POS_SEQ_[CD_NN],"WORD_SEQ_NER_[NUMBER cause]",VERB_DEP_PATH_[contain]_[nn-tmod|trimethylaminurium@]_[tmod@],VERB_DEP_PATH_POS_[contain]_[nn-tmod|NN@]_[tmod@],DEP_PATH_[nn@],DEP_PATH_POS_[nn@]}	{2.94991,-2.24436,1.54683,0.4995,0.4995,-0.105105,-0.0901411}
journal.pone.0065187.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0065187.pdf_277_277_10_10_1_2_UNSUP	PI3K/HP:0002637|Cerebral ischemia	{10}	{1,2}	{The,cerebral,ischemia,/,reperfusion,injury,inhibited,the,activity,of,PI3K,at,day,l,post,MCAO,as,compared,with,that,of,sham,—,operated,group,(,68.4,i4,.5,%,vs.,l00,.0,i4,.3,%,",",P,<,o.,ol,),",",whereas,at,day,14,and,28,;,it,enhanced,the,PI3K,activity,(,l09,.5,i6,.4,%,",",P,<,o.,ol,at,day,l4,;}	{"The average volume of the ipsilateral DG was similar for all groups , independent of the drug usage or cerebral ischemia ( Figure 2C ) .","P | 3K Activity PI3K activity was shown in Figure 3 ."}	{"111.2 i5 .3 % , P = 0.03 at day 28 vs. sham-operated group , respectively ) .","Propofol post-conditioning increased PI3K activity at day 1 as compared with that of I/R group ( 187.0 i15 .2 % vs. 68.4:4.5 % , P < o. ol ) ."}	0.944	0.632	0.96	{INV_POS_SEQ_[:_NN_NN_VBD_DT_NN_IN],INV_VERB_DEP_PATH_[inhibit]_[prep_of-dobj|activity@]_[@dep],INV_VERB_DEP_PATH_POS_[operate]_[prep_of-dobj|NN-dep|VBD@dep]_[@dep],"INV_WORD_SEQ_[/ reperfusion injury inhibit the activity of]",INV_VERB_DEP_PATH_POS_[inhibit]_[prep_of-dobj|NN@]_[@dep],INV_DEP_PATH_[prep_of-dobj|activity-dep|inhibit@],INV_VERB_DEP_PATH_[operate]_[prep_of-dobj|activity-dep|inhibit@dep]_[@dep],INV_DEP_PATH_POS_[prep_of-dobj|NN-dep|VBD@]}	{0.3588,0.3588,0.3588,0.3588,0.3588,0.3588,0.3588,0.271582}
journal.pgen.1004309.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1004309.pdf_406_406_27_27_34_34_UNSUP	p53/HP:0002861|Melanoma	{27}	{34}	{This,is,expected,to,be,of,signiﬁcant,impact,",",since,one,attractive,strategy,for,cancer,therapy,is,based,on,p53,reactivation,in,cancers,encoding,normal,but,inactivated,p53,protein,",",as,observed,frequently,in,melanomas,[,5l,",52,53",],.}	{"These observations indicate that USF1 may act through more than one route to increase p53 levels according to cell type .","In skin and in response to UV-induced DNA damage USF1 controls the p53 protein stability ."}	{"Our evidence that USF1 stabilizes the p53 protein suggests that it may have functions independent of its well-deﬁned role as a transcriptional regulator .","Indeed , USF1 regulates gene expression"}	0.974	0.276	0.926	{DEP_PATH_POS_[nn-dobj|NN@prep_in-advcl|VBN],VERB_DEP_PATH_POS_[observe]_[nn-dobj|NN@advcl]_[prep_in@],VERB_DEP_PATH_POS_[be]_[nn-dobj|NN@auxpass-dep|VBN]_[prep_in-advcl|VBN@auxpass-dep|VBN],VERB_DEP_PATH_POS_[be]_[nn-dobj|NN@xcomp-dep|VBN]_[prep_in-advcl|VBN@xcomp-dep|VBN],VERB_DEP_PATH_POS_[expect]_[nn-dobj|NN@dep]_[prep_in-advcl|VBN@dep],VERB_DEP_PATH_[be]_[nn-dobj|protein@xcomp-dep|expect]_[prep_in-advcl|observe@xcomp-dep|expect],VERB_DEP_PATH_[inactivate]_[nn-dobj|protein@]_[prep_in-advcl|observe@],VERB_DEP_PATH_[be]_[nn-dobj|protein@auxpass-dep|expect]_[prep_in-advcl|observe@auxpass-dep|expect],VERB_DEP_PATH_[expect]_[nn-dobj|protein@dep]_[prep_in-advcl|observe@dep],"WORD_SEQ_[protein , as observe frequently in]",VERB_DEP_PATH_[observe]_[nn-dobj|protein@advcl]_[prep_in@],DEP_PATH_[nn-dobj|protein@prep_in-advcl|observe],VERB_DEP_PATH_POS_[inactivate]_[nn-dobj|NN@]_[prep_in-advcl|VBN@],"POS_SEQ_[NN_,_IN_VBN_RB_IN]"}	{0.926051,0.213837,0.213837,0.213837,0.213837,0.213837,0.213837,0.213837,0.213837,0.213837,0.213837,0.213837,0.213837,0.213837}
journal.pone.0013451.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0013451.pdf_80_80_105_105_101_101	BCL2/HP:0001909|Leukemia	{105}	{101}	{Genes,related,to,apoptosis,:,p,=,0.02,BIN1,bridging,integrator,1,CDK2AP1,CDK2,—,associated,protein,1,CDKN1A,cyclin,—,dependent,kinase,inhibitor,1A,(,p21,",",Cip1,),CFLAR,CASP8,and,FADD,—,|,ike,apoptosis,regulator,CROP,cisplatin,resistance,»,associated,overexpressed,protein,DAPK1,death,—,associated,protein,kinase,1,DUSP5,",6",dual,specificity,phosphatase,"5,6",GLRX,glutaredoxin,(,thioltransferase,),HTRA2,HtrA,serine,peptidase,2,|,ER2,immediate,early,response,2,IER3,immediate,early,response,3,IGFBP3,insulin,—,like,growth,factor,binding,protein,3,MBD4,methy,|,»,CpG,binding,domain,protein,4,MCL1,myeloid,cell,leukemia,sequence,1,(,BCL2,—,re,|,ated,),NDRG1,N,—,myc,downstream,regulated,gene,1,SFN,stratifin,THBD,thrombomodulin}	{"Table 1 .","Genes differentially expressed in cells exposed to albumin ."}	{"Cell growth and proliferation : p = 0.03 ADFP adipose differentiation — re | ated protein CCL20 chemokine ( C » C motif ) ligand 20 DNAJC9 DnaJ ( Hsp40 ) homolog , subfamily C , member 9","HSPB8 heat shock 22kDa protein 8 | RF8 interferon regulatory factor 8 SEMA4D sema domain , immunoglobulin domain ( lg ) , transmembrane domain ( TM ) and short cytoplasmic domain , ( semaphorin ) 4D"}	0.944	0.642	1	{"INV_WORD_SEQ_[sequence 1 (]","INV_WORD_SEQ_NER_[sequence NUMBER NUMBER]",INV_VERB_DEP_PATH_[ate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[ate]_[dep@dep]_[dep@dep],INV_DEP_PATH_POS_[dep@dep],INV_POS_SEQ_[NN_CD_CD],INV_DEP_PATH_[dep@dep],INV_VERB_DEP_PATH_POS_[associate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[associate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[relate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[relate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[regulate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[regulate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[bridge]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[bridge]_[dep@dep]_[dep@dep]}	{1.40422,1.40422,0.433069,0.433069,-0.366141,-0.344507,-0.339995,0.301241,0.301241,-0.16209,-0.16209,0.0907256,0.0907256,0,0}
journal.pone.0018257.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0018257.pdf_596_596_14_14_35_35_UNSUP	p16/HP:0002861|Melanoma	{14}	{35}	{Straume,O,",",Sviland,L,",",Akslen,LA,(,2000,),Loss,of,nuclear,p16,protein,expression,correlates,with,increased,tumor,cell,proliferation,(,Ki-67,),and,poor,prognosis,in,patients,with,vertical,growth,phase,melanoma,.}	{"Grover R , ChanaJS , \\\\ Vilson GD , Richman PI , Sanders R ( 1998 ) An analysis of p16 protein expression in sporadic malignant melanoma .","Nlelanoma Res 1998 Jun ; 8 ( 3 ) : 267 — 72 ."}	{"Clin Cancer Res 2000 lVIay ; 6 ( 5 ) : l845 — 53 .","Rizos H , Darmanian AP , Holland EA , 1 \\\\ ’ Iann GJ , Keflord RF ( 2001 ) 1 \\\\ ’ Iutations in the INK4a/ARF melanoma susceptibility locus functionally impair pl4ARF ."}	0.922	0.92	0.996	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_[correlate]_[nn-prep_of|expression-nsubj|loss@]_[prep_with-prep_in|patient-dobj|prognosis@],VERB_DEP_PATH_POS_[correlate]_[nn-prep_of|NN-nsubj|NN@]_[prep_with-prep_in|NNS-dobj|NN@],DEP_PATH_POS_[nn-prep_of|NN-nsubj|NN@prep_with-prep_in|NNS-dobj|NN],DEP_PATH_[nn-prep_of|expression-nsubj|loss@prep_with-prep_in|patient-dobj|prognosis]}	{-3.11955,1.32662,1.32662,1.32662,1.32662}
journal.pone.0055049.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0055049.pdf_43_43_45_45_18_18_UNSUP	CF/HP:0002090|Pneumonia	{45}	{18}	{In,this,paper,",",we,report,the,construction,of,new,plasmids,that,expand,the,tools,available,for,S.,pneumoniae,cell,biology,studies,by,allowing,the,expression,of,N,-,or,C,-,terminal,protein,fusions,to,different,ﬂuorescent,reporters,",",namely,mCherry,",",Citrine,",",CF,P,and,GFP,.}	{"Since then , other proteins involved in processes such as cell division [ lo , l 1 ] , cell wall synthesis [ 12 ] and capsular polysaccharide synthesis [ 13,14 ] have been localized in live pneumococcal cells .","However , the variety of tools available for these studies is still limited ."}	{"For this purpose we have improved the expression of the various ﬂuorescent proteins in S. pneumoniae , by introducing an upstream tag , named “ i-tag ” , which increases protein translation .","The availability of these plasmids should greatly facilitate studies of protein localization in this important clinical pathogen ."}	0.918	0.126	0.948	{INV_WORD_SEQ_[TOO_FAR_AWAY],INV_VERB_DEP_PATH_POS_[report]_[nn-dep|NN-dobj|NN@]_[nn-dobj|NN-rcmod|VBP-dobj|NN@],INV_VERB_DEP_PATH_POS_[allow]_[nn-dep|NN@prepc_by-rcmod|VBP]_[nn-dobj|NN@prepc_by],INV_VERB_DEP_PATH_[report]_[nn-dep|p-dobj|construction@]_[nn-dobj|biology-rcmod|expand-dobj|construction@],INV_VERB_DEP_PATH_[expand]_[nn-dep|p@rcmod]_[nn-dobj|biology@],INV_VERB_DEP_PATH_POS_[expand]_[nn-dep|NN@rcmod]_[nn-dobj|NN@],INV_DEP_PATH_POS_[nn-dep|NN@nn-dobj|NN-rcmod|VBP],INV_VERB_DEP_PATH_[allow]_[nn-dep|p@prepc_by-rcmod|expand]_[nn-dobj|biology@prepc_by],INV_DEP_PATH_[nn-dep|p@nn-dobj|biology-rcmod|expand]}	{-2.7069,0.627888,0.627888,0.627888,0.627888,0.627888,0.627888,0.627888,0.627888}
SCPDFS_19488.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19488.pdf_209_209_47_47_54_54_UNSUP	CPT2/HP:0003326|Myalgia	{47}	{54}	{Deschauer,et,al.,(,2003,),have,revealed,the,common,S113L,mutation,on,one,allele,while,a,novel,mutation,at,the,splice,donor,junction,in,intron,3,on,the,other,allele,(,resulting,in,skipping,of,exon,3,),in,a,25-year-old,patient,with,biochemical,evidence,of,CPT2,deﬁciency,and,suffered,from,attacks,of,myalgia,and,muscle,weakness,in,early,adult,life,.}	{"common polymorphisms of CPT2 , V3681 and M647V , have been reported to be strikingly overrepresented in the myopathic patients ; they may signiﬁcantly inﬂuence the manifestation of clinical disease and could therefore potentially be considered as susceptibility variants ( Olpin et al. , 2003 ) .","Vladutiu et al. ( 2000 ) have presented biochemical and molecular evidence for vertical transmission of a variable myopathy caused by heterozygosity for a single mutation , R503C , in the CPT2 gene ."}	{"Taggart et al. ( 1999 ) have proposed that heterozygosity for certain CPT2 mutations , S113L and R503C is sufﬁcient to render individuals at risk of clinical symptoms .","We did not ﬁnd any statistical difference in the frequencies of various genotypes of the variants of CPT1B and CPT2 genes , between AMI patients and controls ( Table 3 ) ."}	0.926	0.778	1	{DEP_PATH_[TOO_FAR_AWAY],"WORD_SEQ_[deﬁciency and suffer from attack of]",POS_SEQ_[NN_CC_VBN_IN_NNS_IN]}	{0.889952,0.665536,0.665536}
journal.pone.0006867.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0006867.pdf_396_396_30_30_21_21_UNSUP	OPA1/HP:0000602|Ophthalmoplegia	{30}	{21}	{Together,",",this,suggests,that,OPA1,mutations,cause,multiple,organ,abnormalities,",",including,auditory,neuropathy,",",peripheral,neuropathy,(,apoptosis,and,ophthalmoplegia,),",",cardiomyopathy,and,myopathy,",",suggesting,that,OPA1,could,be,a,common,target,for,treatment,of,mitochondriarelated,disorders,.}	{"Moreover , mutation of OPA1 causes mitochondrial dysfunction , including fragmentation , decreased ATP production , increased ROS production and decreased mitochondrial membrane potentials [ 10 ] .","Abnormalities of mitochondrial fusion and ﬁssion have been reported in several mitochondrial disorders [ 43,44 ] ."}	{"Materials and Methods","Drosophila stocks y [ d2 ] w [ 1118 ] P { ry [ + t7 .2 ] = 92-FLP ."}	0.94	0.806	1	{INV_VERB_DEP_PATH_[cause]_[nsubj-ccomp|target-partmod|suggest@]_[nn-prep_including|)@],INV_VERB_DEP_PATH_[suggest]_[nsubj-ccomp|target@]_[nn-prep_including|)@partmod],INV_VERB_DEP_PATH_POS_[suggest]_[nsubj-ccomp|NN-partmod|VBG-ccomp|VBP@]_[nn-prep_including|NN-ccomp|VBP@],"INV_POS_SEQ_[NN_,_NN_CC_NN_,_VBG_IN]",INV_VERB_DEP_PATH_POS_[cause]_[nsubj-ccomp|NN-partmod|VBG@]_[nn-prep_including|NN@],"INV_WORD_SEQ_[) , cardiomyopathy and myopathy , suggest that]",INV_VERB_DEP_PATH_[suggest]_[nsubj-ccomp|target-partmod|suggest-ccomp|cause@]_[nn-prep_including|)-ccomp|cause@],INV_DEP_PATH_POS_[nsubj-ccomp|NN-partmod|VBG@nn-prep_including|NN],INV_VERB_DEP_PATH_POS_[suggest]_[nsubj-ccomp|NN@]_[nn-prep_including|NN@partmod],INV_DEP_PATH_[nsubj-ccomp|target-partmod|suggest@nn-prep_including|)]}	{0.293826,0.293826,0.293826,0.293826,0.293826,0.293826,0.293826,0.293826,0.293826,0.293826}
SCPDFS_37927.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_37927.pdf_442_442_24_24_35_36_UNSUP	APC/HP:0003003|Colon cancer	{24}	{35,36}	{Y.,Miki,",",I.,Nishisho,",",A.,Horii,",",Y.,Miyoshi,",",J.,Utsunomiya,",",K.W.,Kinzler,",",et,al.,",",Disruption,of,the,APC,gene,by,a,retrotransposal,insertion,of,L1,sequence,in,a,colon,cancer,",",Cancer,Res,.}	{"A. Coquelle , E. Pipiras , F. Toledo , G. Buttin , M. Debatisse , Expression of fragile sites triggers intrachromosomal mammalian gene ampliﬁcation and sets boundaries to early amplicons , Cell 89 ( 1997 ) 215-225 .","B. Morse , P.G. Rotherg , V.J. South , J.M. Spandorfer , S.M. Astrin , Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma , Nature 333 ( 1988 ) 87-90 ."}	{"52 ( 1992 ) 643-645 .","H. Inoue , H. Ishii , H. Alder , E. Snyder , T. Druck , K. Huebner , eta1. , Sequence of the FRA3B common fragile region : implications for the mechanism of FHIT deletion , Proc ."}	0.994	0.328	0.992	{"WORD_SEQ_[gene by a retrotransposal insertion of l1 sequence in a]",POS_SEQ_[NN_IN_DT_JJ_NN_IN_NN_NN_IN_DT],DEP_PATH_[nn@prep_in-prep_of|sequence-prep_by|insertion],DEP_PATH_POS_[nn@prep_in-prep_of|NN-prep_by|NN]}	{1.19665,1.19665,0.821341,0.821341}
SCPDFS_46000.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46000.pdf_496_496_12_12_16_17_UNSUP	AHI1/HP:0000556|Retinal dystrophy	{12}	{16,17}	{75,",",979-987,70,Parisi,",",M.A.,et,al.,(,2006,),AHI1,mutations,cause,both,retinal,dystrophy,and,renal,cystic,disease,in,Joubert,syndrome,.}	{"Hum .","Genet ."}	{"J. Med .","Genet ."}	0.946	0.99	0.996	{VERB_DEP_PATH_POS_[cause]_[nn-nsubj|NNS@]_[dobj@],DEP_PATH_POS_[nn-nsubj|NNS@dobj],DEP_PATH_[nn-nsubj|mutation@dobj],"WORD_SEQ_[mutation cause both]",POS_SEQ_[NNS_VBP_CC],VERB_DEP_PATH_[cause]_[nn-nsubj|mutation@]_[dobj@]}	{3.00607,-2.09121,1.21768,0.685407,0.685407,-0.465917}
journal.pone.0069083.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0069083.pdf_668_668_18_18_28_28_UNSUP	AML1/HP:0001909|Leukemia	{18}	{28}	{Okuda,T,",",van,Deursen,J,",",Hiebert,SW,",",Grosveld,G,",",Downing,JR,(,1996,),AML1,",",the,target,of,multiple,chromosomal,translocations,in,human,leukemia,",",is,essential,for,normal,fetal,liver,hematopoiesis,.}	{"PubMed : 19129762 .","6 ."}	{"Cell 84 : 321-330 .","doi :10.1016 / S0092-8674 ( 00 ) 80986-1 ."}	0.988	0.114	0.958	{"WORD_SEQ_[, the target of multiple chromosomal translocation in human]","POS_SEQ_[,_DT_NN_IN_JJ_JJ_NNS_IN_JJ]",DEP_PATH_POS_[dep-appos|NNP@prep_in-prep_of|NNS-appos|NN],DEP_PATH_[dep-appos|JR@prep_in-prep_of|translocation-appos|target]}	{1.95084,1.95084,0.337266,0.337266}
journal.pone.0035048.pdf	RELATION_GENEHPOTERM_journal.pone.0035048.pdf_216_216_5_5_13_14	SCHAD/HP:0001984|Intolerance to protein	{5}	{13,14}	{Kapoor,et,al.,described,novel,SCHAD,mutations,in,a,patient,with,severe,dietary,protein,intolerance,[,24,],.}	{"The increase in the insulin secretion in response to various metabolites such as L-carnitine and 3-hydroxybutyrate was also affected [ 22 ] .","In our earlier study we were able to demonstrate that GDH activity was up regulated in the absence of SCHAD in a fashion similar to that seen in hyperinsulinism due to gainoffunction mutations in GDH [ 23 ] , and this provides a paradigm that may be relevant across additional SCHAD protein-protein interactions ."}	{"\\\\ Ne have analyzed plasma amino acids in the SCHAD-deﬁcient mouse to see if the interactions with proteins that are responsible for amino acid and urea cycle pathways provide clues to other regulatory roles of SCHAD in associated pathways or to the protein sensitivity .","We could not ﬁnd any obvious changes in pathways involving ammonia removal through the measurement of urea cycle intermediates or glutamine or to known post-prandial elevations including leucine and the other branched-chain amino acids ."}	0.99	0.986	0.172	{DEP_PATH_[nn-dobj|mutation@prep_with],DEP_PATH_POS_[nn-dobj|NNS@prep_with],POS_SEQ_[NNS_IN_DT_NN_IN_JJ_JJ],VERB_DEP_PATH_POS_[describe]_[nn-dobj|NNS@]_[prep_with@],VERB_DEP_PATH_[describe]_[nn-dobj|mutation@]_[prep_with@],"WORD_SEQ_[mutation in a patient with severe dietary]"}	{2.91848,0.907306,0.808317,0,0,0}
SCPDFS_19373.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19373.pdf_891_891_5_5_12_13_UNSUP	p53/HP:0012125|Prostate cancer	{5}	{12,13}	{Evidence,that,transfer,of,functional,p53,protein,results,in,increased,apoptosis,in,prostate,cancer,.}	{"17 , 1019-1026 .","Pisters , L.L. , et al. , 2004 ."}	{"Clin .","Cancer Res ."}	0.938	0.522	1	{DEP_PATH_[nn-prep_of|protein-nsubj|transfer-rcmod|result@prep_in-prep_in|apoptosis],VERB_DEP_PATH_POS_[result]_[nn-prep_of|NN-nsubj|NN@]_[prep_in-prep_in|NN@rcmod],DEP_PATH_POS_[nn-prep_of|NN-nsubj|NN-rcmod|VBZ@prep_in-prep_in|NN],"WORD_SEQ_[protein result in increase apoptosis in]",POS_SEQ_[NN_VBZ_IN_VBN_NN_IN],VERB_DEP_PATH_[result]_[nn-prep_of|protein-nsubj|transfer@]_[prep_in-prep_in|apoptosis@rcmod]}	{0.439029,0.439029,0.439029,0.439029,0.439029,0.439029}
journal.pone.0103563.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0103563.pdf_45_45_13_13_17_18_UNSUP	BMP15/HP:0000147|Polycystic ovaries	{13}	{17,18}	{Furthermore,",",in,humans,",",rare,mutations,and,genetic,variance,of,GDF9,and,BMP15,are,associated,with,polycystic,ovary,syndrome,[,23,],",",dizygotic,twinning,[,24,],and,premature,ovarian,failure,[,25,—,27,],.}	{"CrossMark Llldlanlpdalas sterile [ 17,18 ] .","Interestingly , sheep heterozygous for these mutant forms of GDF 9 or BMP15 have an increased ovulation rate and incidence of mutiple pregnancies due to increased LH sensitivity in secondary follicles that leads to a rise in the number of antral follicles [ l7 ,18,22 ] ."}	{"Like other members of the TGFI3 superfamily , the pro-proteins ( un-processed proteins ) of GDF9 and BMP15 are composed of a pro-region and a mature region [ 28 ] .","The pro-regions of these proteins can only be dissociated from the corresponding mature regions after processing at their protease processing site , after which they form a pro-mature complex held together by noncovalent interactions [ 29 ] ."}	0.978	0.686	1	{"WORD_SEQ_[be associate with]",POS_SEQ_[VBP_VBN_IN],VERB_DEP_PATH_[be]_[conj_and-prep_of|gdf9-nsubjpass|variance@auxpass]_[amod-prep_with|syndrome@auxpass],VERB_DEP_PATH_POS_[be]_[conj_and-prep_of|NN-nsubjpass|NN@auxpass]_[amod-prep_with|NN@auxpass],DEP_PATH_POS_[conj_and-prep_of|NN-nsubjpass|NN@amod-prep_with|NN],VERB_DEP_PATH_[associate]_[conj_and-prep_of|gdf9-nsubjpass|variance@]_[amod-prep_with|syndrome@],DEP_PATH_[conj_and-prep_of|gdf9-nsubjpass|variance@amod-prep_with|syndrome],VERB_DEP_PATH_POS_[associate]_[conj_and-prep_of|NN-nsubjpass|NN@]_[amod-prep_with|NN@]}	{2.44981,-0.2401,0.211026,0.211026,0.211026,0.211026,0.211026,0.211026}
journal.pcbi.1000658.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pcbi.1000658.pdf_307_307_13_13_19_19_UNSUP	LQT/HP:0011675|Arrhythmia	{13}	{19}	{Hence,",",we,performed,a,series,of,simulations,to,investigate,pause,—,dependent,LQT,syndrome,and,its,association,with,arrhythmia,susceptibility,in,the,presence,of,male,and,female,hormones,.}	{"The pseudo ECG ( 5B — lower traces ) shows that QT interval is substantially longer in the late follicular phase ( case i ) than with testosterone treatment ( case ii ) .","Effects of female hormones on pause — dependent LQT — associated arrhythmias with E — 4031 The exact mechanism of TdP induction is unclear , but it is thought that pause-induced early afterdepolarizations ( EADs ) can underlie TdP initiation [ 38,39 ] ."}	{"Single M cells were paced for 10 beats of BCL at 1000 ms ( s1 ) followed by a premature beat ( 52 ) with varying sl — s2 intervals and then a long pause of varying duration as indicated .","Our simulations show no EADs ( APD > 450 ms ) occurred during the late follicular phase with no drug application ( Figure 6A — left panel ) or with the application of E-4031 in the presence of testosterone 3 nM ( middle ) during a short-long pacing"}	0.966	0.48	1	{POS_SEQ_[NN_CC_PRP$_NN_IN],DEP_PATH_POS_[nn-dep|NN-dobj|NN@nn-prep_with|NN-dobj|NN],VERB_DEP_PATH_[investigate]_[nn-dep|syndrome-dobj|—@]_[nn-prep_with|susceptibility-dobj|association@],DEP_PATH_[nn-dep|syndrome-dobj|—@nn-prep_with|susceptibility-dobj|association],VERB_DEP_PATH_POS_[perform]_[nn-dep|NN-dobj|NN-xcomp|VB@]_[nn-prep_with|NN-dobj|NN-xcomp|VB@],VERB_DEP_PATH_[perform]_[nn-dep|syndrome-dobj|—-xcomp|investigate@]_[nn-prep_with|susceptibility-dobj|association-xcomp|investigate@],VERB_DEP_PATH_POS_[investigate]_[nn-dep|NN-dobj|NN@]_[nn-prep_with|NN-dobj|NN@],"WORD_SEQ_[syndrome and its association with]"}	{1.26066,0.262221,0.262221,0.262221,0.262221,0.262221,0.262221,0.262221}
journal.pone.0088140.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0088140.pdf_91_91_0_0_3_3_UNSUP	ATM/HP:0001009|Telangiectasia	{0}	{3}	{ATM,(,Ataxia,telangiectasia,mutated,),and,ATR,(,Ataxia,telangiectasia,and,Rad3,related,),",",two,important,transducer,proteins,",",play,critical,roles,in,DNA,damage,response,by,controlling,the,damage,response,through,phosphorylation,of,effector,proteins,[,"19,20",],.}	{"the oxidative injury of DNA [ 16 ] , which can via checkpoint activation induce cell cycle arrest [ 17 ] .","In the DNA damage response , activation of DNA damage checkpoints is ﬁrstly recognized by sensors proteins , followed by activation of a series effector kinases which target the major cell cycle control machinery [ 18 ] ."}	{"Following their activation and phosphorylation , the downstream effectors such as Chkl , Chk2 , p53 were phosphorylated and activated , leading to further transmission of the checkpoint signals [ 21,22 ] .","By the interaction between the cyclin-dependent kinases ( Cdks ) and the cyclins , cells transit between different phases of cycle ."}	0.966	0.602	0.97	{"WORD_SEQ_[( Ataxia]",POS_SEQ_[NNP_NNP],DEP_PATH_POS_[nn@nsubj-rcmod|VBP],VERB_DEP_PATH_POS_[play]_[nn@rcmod]_[nsubj@],VERB_DEP_PATH_[play]_[nn@rcmod]_[nsubj@],VERB_DEP_PATH_POS_[mutate]_[nn@partmod-nsubj|NN-rcmod|VBP]_[@partmod],VERB_DEP_PATH_[mutate]_[nn@partmod-nsubj|telangiectasium-rcmod|play]_[@partmod],VERB_DEP_PATH_POS_[control]_[nn@prepc_by-rcmod|VBP]_[nsubj@prepc_by],DEP_PATH_[nn@nsubj-rcmod|play],VERB_DEP_PATH_[control]_[nn@prepc_by-rcmod|play]_[nsubj@prepc_by]}	{3.08576,-2.47331,-0.453345,0.405183,0.405183,0.405183,0.405183,0.405183,0.405183,0.405183}
SCPDFS_46428.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46428.pdf_189_189_7_7_15_16_UNSUP	APP/HP:0001342|Cerebral hemorrhage	{7}	{15,16}	{APPD.,",",",",ch,:,Mice,express,APP,with,the,Dutch,mutation,that,causes,hereditary,cerebral,hemorrhage,with,amy,|,oidosis,.}	{"— .","A246E + APPSWE [ 8 ] ) : Bigenic transgenic mice , addition of the mutant PSEN1 transgene markedly accelerated amyloid pathology compared with singly transgenic mutant APP mice , demonstrating that the PSEN1 — driven elevation of AB42 enhances plaque pathology ."}	{"— .","Dutch type in humans ."}	0.936	0.904	1	{VERB_DEP_PATH_POS_[cause]_[dobj-parataxis|VBP@]_[dobj@],POS_SEQ_[IN_DT_JJ_NN_WDT_VBZ_JJ],VERB_DEP_PATH_[cause]_[dobj-parataxis|express@]_[dobj@],DEP_PATH_[dobj-parataxis|express@dobj],VERB_DEP_PATH_POS_[express]_[dobj@]_[dobj@parataxis],"WORD_SEQ_NER_[with the MISC mutation that cause hereditary]",VERB_DEP_PATH_[express]_[dobj@]_[dobj@parataxis],"WORD_SEQ_[with the dutch mutation that cause hereditary]",DEP_PATH_POS_[dobj-parataxis|VBP@dobj]}	{0.321797,0.321797,0.321797,0.321797,0.321797,0.321797,0.321797,0.321797,0.24152}
SCPDFS_2931.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_2931.pdf_208_208_3_3_7_8_UNSUP	FMR1/HP:0000478|Abnormality of the eye	{3}	{7,8}	{A.,Injection,of,FMR1,Mo,led,to,abnormal,eye,development,(,white,and,black,arrows,),in,a,dose,—,dependent,manner,as,judged,by,the,RPE,.}	{"1 .","Downregulation of FMR1 results in defects during eye as well as cranial cartilage development ."}	{"Control MO injection did not interfere with eye development .","Vibratome sections showed disorganized layers of the retina as well as missing ventral RPE ( black arrowheads ) ."}	0.966	0.528	0.992	{VERB_DEP_PATH_POS_[lead]_[nn-prep_of|NN-nsubj|NN@]_[amod-prep_to|NN@],DEP_PATH_POS_[nn-prep_of|NN-nsubj|NN@amod-prep_to|NN],DEP_PATH_[nn-prep_of|DURATION-nsubj|injection@amod-prep_to|development],"WORD_SEQ_[mo lead to]","WORD_SEQ_NER_[DURATION lead to]",VERB_DEP_PATH_[lead]_[nn-prep_of|DURATION-nsubj|injection@]_[amod-prep_to|development@],POS_SEQ_[NN_VBD_TO]}	{0.662999,0.662999,0.347115,0.347115,0.347115,0.347115,0.0581112}
journal.pone.0060177.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0060177.pdf_70_70_19_19_8_8_UNSUP	WT1/HP:0000093|Proteinuria	{19}	{8}	{Interestingly,",",50,%,of,diabetic,patients,without,proteinuria,(,15,out,of,30,),were,detected,positive,for,WT1,(,Figure,1B,),.}	{"Therefore , we divided diabetic population based on urine albumin-to-creatinine ratio ( ACR ) into Proteinuria ( ACR > 30 mg / g creatinine ) and Non-Proteinuria ( ACR < 30 mg / g creatinine ) groups .","WT1 was detected in all the patients in Proteinuria group ( 100 % ) ."}	{"Furthermore , Proteinuria group had signiﬁcantly higher levels of WT1 compared to Non-Proteinuria and control groups ( p < 0.001 , Figure 1D ) .","Expression of \\\\ / \\\\ / T1 protein in Urinary exosomes of Diabetic patient ’s associates with increase in urine protein excretion Higher levels of \\\\ / VTl observed in Proteinuria group led us to determine its relation with urine protein excretion in diabetic patients ."}	0.942	0.21	0.998	{"INV_WORD_SEQ_NER_[NUMBER NUMBER out of NUMBER NUMBER be detect positive for]",INV_DEP_PATH_[nn-prep_for|1b-amod|positive-dobj|)@prep_without-prep_of|patient-nsubjpass|PERCENT],INV_POS_SEQ_[CD_CD_IN_IN_CD_CD_VBD_VBN_JJ_IN],"INV_WORD_SEQ_[( 15 out of 30 ) be detect positive for]",INV_DEP_PATH_POS_[nn-prep_for|NN-amod|JJ-dobj|NN@prep_without-prep_of|NNS-nsubjpass|NN],INV_VERB_DEP_PATH_POS_[detect]_[nn-prep_for|NN-amod|JJ-dobj|NN@]_[prep_without-prep_of|NNS-nsubjpass|NN@],INV_VERB_DEP_PATH_[detect]_[nn-prep_for|1b-amod|positive-dobj|)@]_[prep_without-prep_of|patient-nsubjpass|PERCENT@]}	{0.389665,0.389665,0.389665,0.389665,0.389665,0.389665,0.389665}
journal.pmed.0040172.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pmed.0040172.pdf_956_956_22_22_25_25_UNSUP	CBFA2/HP:0001873|Thrombocytopenia	{22}	{25}	{Song,WJ,",",Sullivan,MG,",",Legare,RD,",",Hutchings,S,",",Tan,X,",",et,al.,(,1999,),Haploinsufﬁciency,of,CBFA2,causes,familial,thrombocytopenia,with,propensity,to,develop,acute,myelogenous,leukaemia,.}	{"Blood 96 : 3154 — ?","> 160 ."}	{"Nat Genet 23 : 166 — 175 .","Ling KW , Ottersbach K , van HamburgJP , Oziemlak A , Tsai FY , et al. ( 2004 ) GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells ."}	0.996	0.56	0.994	{"WORD_SEQ_[cause familial]",VERB_DEP_PATH_POS_[cause]_[prep_of-nsubj|NN@]_[dobj@],VERB_DEP_PATH_POS_[develop]_[prep_of-nsubj|NN@xcomp]_[dobj@xcomp],POS_SEQ_[VBZ_JJ],DEP_PATH_POS_[prep_of-nsubj|NN@dobj],VERB_DEP_PATH_[develop]_[prep_of-nsubj|haploinsufﬁciency@xcomp]_[dobj@xcomp],DEP_PATH_[prep_of-nsubj|haploinsufﬁciency@dobj],VERB_DEP_PATH_[cause]_[prep_of-nsubj|haploinsufﬁciency@]_[dobj@]}	{2.24998,1.56131,1.10457,-0.99968,-0.981214,0.721557,0.677698,0.677698}
journal.pone.0058830.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0058830.pdf_238_238_42_42_32_34_UNSUP	FREM1/HP:0000776|Congenital diaphragmatic hernia	{42}	{32,33,34}	{Frem1,and,Gata4,Interact,Genetically,in,the,Development,of,Lung,Lobulation,Defects,Galas,”,/,A,"\\"",X2,mice,",",which,harbor,a,deletion,in,exon,2,of,Gata4,",",have,anterior,congenital,diaphragmatic,hernias,that,are,similar,to,those,seen,in,FREM1,—,deﬁcient,mice,[,"12,26",],.}	{"— .","P30 wild-type and FremI \\" \\" \\" “ 2 / \\" W2 mice on this background are not signiﬁcantly different ( 14.4 g vs. 15.5 g , p = 0.58 ; 14.8 cm vs. 14.9 cm , p = 0.6 ) ."}	{"Defects in Game ‘ also cause lung lobulation defects .","Speciﬁcally , embryos that are homozygous for the V238G missense mutation in Gataé ‘ ( Gata4ki / k ) , which die between E11 .5 and 1313.5 , have abnormal lung lobulation with failure of accessory lobe development being evident in cultured lungs harvested at E1 1.5 and E12 .5 [ 28 ] ."}	0.924	0.24	0.872	{INV_VERB_DEP_PATH_POS_[see]_[prep_in@]_[@partmod-prep_to|DT-rcmod|JJ],INV_DEP_PATH_[prep_in-partmod|see-prep_to|those-rcmod|similar@],INV_VERB_DEP_PATH_POS_[be]_[prep_in-partmod|VBN-prep_to|DT@cop]_[@cop-rcmod|JJ],"INV_WORD_SEQ_[that be similar to those see in]",INV_POS_SEQ_[WDT_VBP_JJ_TO_DT_VBN_IN],INV_VERB_DEP_PATH_[see]_[prep_in@]_[@partmod-prep_to|those-rcmod|similar],INV_VERB_DEP_PATH_[be]_[prep_in-partmod|see-prep_to|those@cop]_[@cop-rcmod|similar],INV_DEP_PATH_POS_[prep_in-partmod|VBN-prep_to|DT-rcmod|JJ@]}	{0.304773,0.304773,0.304773,0.304773,0.304773,0.304773,0.304773,0.304773}
SCPDFS_21702.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_21702.pdf_721_721_6_6_16_16_UNSUP	TOR1A/HP:0001332|Dystonia	{6}	{16}	{In,addition,",",the,expression,of,TOR1A,argues,for,using,the,pig,as,model,organism,for,dystonia,.}	{"Furthermore , transcript analysis , SNP analysis and identiﬁcation of regulatory elements have provided information of use for the knowledge for gene function in vivo .","The obtained data on porcine TOR1A could aid the development of gene constructs to recapitulate the human disease models ."}	{"The information provided by this study and earlier observations of cellular localization and function of TorsinA , and the impact of the GAG deletion on protein function will generate valuable knowledge regarding the pathophysiology of dystonia .","To date , models of an early — onset dystonia have been created in C. elegans ( Caldwell et al. , 2003 ) , Drosophila ( Koh et al. , 2004 ) and mouse ( Dang et al. , 2005 ; Sharma et al. , 2005 ; Shashidharan et al. , 2005 ; Balcioglu et al. , 2007 ) ."}	0.948	0.622	0.628	{VERB_DEP_PATH_POS_[use]_[prep_of-nsubj|NN@prepc_for]_[prep_for-prep_as|NN@],VERB_DEP_PATH_POS_[argue]_[prep_of-nsubj|NN@]_[prep_for-prep_as|NN-prepc_for|VBG@],VERB_DEP_PATH_[argue]_[prep_of-nsubj|expression@]_[prep_for-prep_as|organism-prepc_for|use@],VERB_DEP_PATH_[use]_[prep_of-nsubj|expression@prepc_for]_[prep_for-prep_as|organism@],DEP_PATH_POS_[prep_of-nsubj|NN@prep_for-prep_as|NN-prepc_for|VBG],POS_SEQ_[VBZ_IN_VBG_DT_NN_IN_NN_NN_IN],"WORD_SEQ_[argue for use the pig as model organism for]",DEP_PATH_[prep_of-nsubj|expression@prep_for-prep_as|organism-prepc_for|use]}	{0.319084,0.319084,0.319084,0.319084,0.319084,0.319084,0.319084,0.319084}
journal.pgen.1003040.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1003040.pdf_383_383_28_28_32_33_UNSUP	RP11/HP:0000510|Retinitis pigmentosa	{28}	{32,33}	{NIcGee,TL,",",Devoto,1,"\\\\",’,I,",",Ott,J,",",Berson,EL,",",Dryja,TP,(,1997,),Evidence,that,the,penetrance,of,mutations,at,the,RP11,locus,causing,dominant,retinitis,pigmentosa,is,influenced,l,),y,a,gene,linked,to,the,homologous,RP11,allele,.}	{"Invest Ophthalmol V is Sci 44 : 4204 — 4209 .","19 ."}	{"AmJ Hum Genet 61 : 1059 — 1066 .","20 ."}	0.952	0.734	0.998	{DEP_PATH_POS_[nn@dobj-partmod|VBG],VERB_DEP_PATH_[cause]_[nn@partmod]_[dobj@],VERB_DEP_PATH_POS_[cause]_[nn@partmod]_[dobj@],DEP_PATH_[nn@dobj-partmod|cause],POS_SEQ_[NN_VBG_JJ],"WORD_SEQ_[locus cause dominant]",VERB_DEP_PATH_POS_[influence]_[nn@rcmod-dobj|NN-partmod|VBG]_[@rcmod],VERB_DEP_PATH_[influence]_[nn@rcmod-dobj|pigmentosa-partmod|cause]_[@rcmod]}	{-1.79746,1.05663,1.05663,1.05663,0.864039,0.386968,0.184376,0.184376}
SCPDFS_20798.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_20798.pdf_166_166_2_2_10_11_UNSUP	COL10A1/HP:0005871|Metaphyseal chondrodysplasia	{2}	{10,11}	{Mutations,in,COL10A1,have,been,described,to,cause,Schmid,type,metaphyseal,chondrodysplasia,.}	{"However , the contribution of each deletion as well as the partial gene deletion to the phenotype remains open .","COL10A1 is involved in the mosaic aberration of patient 7 whose medical history includes frequent bone fractures in early childhood and a syndromic dysmorphic phenotype including hyperlaxity , blue sclerae and hearing deﬁcit compatible with connective tissue disease as part of the syndrome ."}	{"Interestingly , the array result suggested mosaic duplication of the region and FISH analysis conﬁrmed an interstitial duplication in about 2/3 and an interstitial deletion in about 1/3 of examined cells , compatible with the overall dosage result obtained by array analysis .","Friedman et al. ( 2009 ) report on a patient ( 3160 ) with a larger deletion of 9.5 Mb containing the region , but clinical features of connective tissue disease are not speciﬁcally described ."}	0.974	0.888	0.966	{VERB_DEP_PATH_[describe]_[prep_in-nsubjpass|mutation@]_[dobj-xcomp|cause@],"WORD_SEQ_[have be describe to cause Schmid type]",VERB_DEP_PATH_POS_[cause]_[prep_in-nsubjpass|NNS@xcomp]_[dobj@],VERB_DEP_PATH_[cause]_[prep_in-nsubjpass|mutation@xcomp]_[dobj@],"WORD_SEQ_NER_[have be describe to cause PERSON type]",VERB_DEP_PATH_POS_[have]_[prep_in-nsubjpass|NNS@aux]_[dobj-xcomp|VB@aux],DEP_PATH_[prep_in-nsubjpass|mutation@dobj-xcomp|cause],VERB_DEP_PATH_[be]_[prep_in-nsubjpass|mutation@auxpass]_[dobj-xcomp|cause@auxpass],VERB_DEP_PATH_POS_[be]_[prep_in-nsubjpass|NNS@auxpass]_[dobj-xcomp|VB@auxpass],DEP_PATH_POS_[prep_in-nsubjpass|NNS@dobj-xcomp|VB],POS_SEQ_[VBP_VBN_VBN_TO_VB_NNP_NN],VERB_DEP_PATH_[have]_[prep_in-nsubjpass|mutation@aux]_[dobj-xcomp|cause@aux],VERB_DEP_PATH_POS_[describe]_[prep_in-nsubjpass|NNS@]_[dobj-xcomp|VB@]}	{0.256751,0.256751,0.256751,0.256751,0.256751,0.256751,0.256751,0.256751,0.256751,0.256751,0.256751,0.256751,0.256751}
SCPDFS_48020.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_48020.pdf_116_116_3_3_7_7_UNSUP	DAZ/HP:0000027|Azoospermia	{3}	{7}	{Another,gene,",",DAZ,(,deleted,in,azoospermia,),",",has,been,identified,in,a,different,part,of,the,AZF,region27,.}	{"Of 100 men with seriously impaired spermatogenesis , eight had microdeletions in the sequence — tagged site ( STS ) intervals corresponding to these two genes .","Of 80 fertile men , including relatives of the patients , none carried a microdeletion36 ."}	{"15 % of azoospermic and some oligospermic men had microdeletions in DAZ , while an STS — based mapping strategy detected AZF microdeletions in 11/60 ( 18 % ) infertile men , four overlapping with DAZ , four outside and three both in and outside DAZ ( Ref .","28 ) ."}	0.958	0.624	0.992	{POS_SEQ_[CD_VBN_IN],"WORD_SEQ_[( delete in]",VERB_DEP_PATH_[delete]_[@partmod]_[nn-prep_in|)@],DEP_PATH_[@nn-prep_in|)-partmod|delete],"WORD_SEQ_NER_[NUMBER delete in]",VERB_DEP_PATH_POS_[delete]_[@partmod]_[nn-prep_in|NN@],DEP_PATH_POS_[@nn-prep_in|NN-partmod|VBN]}	{1.33288,0.597602,0.501968,0.501968,-0.35894,0.270307,0.180253}
journal.pone.0096168.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0096168.pdf_331_331_21_21_10_12_UNSUP	p53/HP:0005584|Renal cell carcinoma	{21}	{10,11,12}	{"\\\\",/,Ve,conﬁrmed,the,cell,cycle,status,of,the,renal,cell,carcinoma,cells,by,performing,immunoblots,for,RBI,and,S15-phosphorylated,p53,.}	{"The differences of cell cycle molecules in two types of renal cell carcinomas under glucose deprivation The expression of mitotic kinase genes associated with the G2 / M transition was examined by qRT-PCR in renal carcinoma cells under glucose deprivation .","Our results show that these genes were suppressed to the same extent in both cell types associated with NGlcNAc2-modiﬁed proteins ( data not shown ) ."}	{"In the two types of cells with or without production of N-GlcNAc2-modiﬁed proteins , total RBI and phosphorylated RBI ( pRBl ) slowly decreased 15 h after the start of glucose deprivation .","However , no significant differences were observed between the two cell types ( Figure 3A , Figure SBA and S3B ) ."}	0.956	0.166	1	{"INV_WORD_SEQ_NER_[cell by perform immunoblot for MISC and s15-phosphorylated]","INV_WORD_SEQ_[cell by perform immunoblot for rbus and s15-phosphorylated]",INV_VERB_DEP_PATH_[perform]_[prep_for@]_[amod-prep_of|cell-dobj|status@prepc_by],INV_POS_SEQ_[NNS_IN_VBG_NNS_IN_NN_CC_JJ],INV_DEP_PATH_POS_[prep_for-prepc_by|VBG@amod-prep_of|NNS-dobj|NN],INV_VERB_DEP_PATH_[conﬁrmed]_[prep_for-prepc_by|perform@]_[amod-prep_of|cell-dobj|status@],INV_VERB_DEP_PATH_POS_[perform]_[prep_for@]_[amod-prep_of|NNS-dobj|NN@prepc_by],INV_VERB_DEP_PATH_POS_[conﬁrmed]_[prep_for-prepc_by|VBG@]_[amod-prep_of|NNS-dobj|NN@],INV_DEP_PATH_[prep_for-prepc_by|perform@amod-prep_of|cell-dobj|status]}	{0.334925,0.334925,0.334925,0.334925,0.334925,0.334925,0.334925,0.334925,0.334925}
SCPDFS_19792.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19792.pdf_317_317_7_7_4_4_UNSUP	PAX6/HP:0000526|Aniridia	{7}	{4}	{3,’,deletions,cause,aniridia,by,preventing,PAX6,gene,expression,.}	{"15 , 563-581 .","Lauderdale , J.D. , Wilensky , J.S. , Oliver , E.R. , Walton , D.S. , Glaser , T. , 2000 ."}	{"Proc .","Natl. Acad ."}	0.972	0.842	0.996	{"INV_WORD_SEQ_[by prevent]",INV_VERB_DEP_PATH_POS_[cause]_[nn-dobj|NN-prepc_by|VBG@]_[dobj@],INV_POS_SEQ_[IN_VBG],INV_VERB_DEP_PATH_[prevent]_[nn-dobj|expression@]_[dobj@prepc_by],INV_DEP_PATH_[nn-dobj|expression-prepc_by|prevent@dobj],INV_VERB_DEP_PATH_POS_[prevent]_[nn-dobj|NN@]_[dobj@prepc_by],INV_VERB_DEP_PATH_[cause]_[nn-dobj|expression-prepc_by|prevent@]_[dobj@],INV_DEP_PATH_POS_[nn-dobj|NN-prepc_by|VBG@dobj]}	{1.60105,0.854661,-0.524562,0.438294,0.438294,0.438294,0.438294,-0.287478}
journal.pone.0010462.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0010462.pdf_726_726_20_20_23_23_UNSUP	ATDC/HP:0001009|Telangiectasia	{20}	{23}	{Laderoute,KR,",",Knapp,"Al\\\\/I",",",Green,CJ,",",Sutherland,RNI,",",Kapp,LN,(,1996,),Expression,of,the,ATDC,(,ataxia,telangiectasia,group,D,~,complementing,),gene,in,A431,human,squamous,carcinoma,cells,.}	{"Proc Natl Acad Sci U S A 92 : 782447828 .",.}	{"IntJ Cancer 66 : 7724778 .",.}	0.95	0.436	0.926	{"WORD_SEQ_NER_[NUMBER ataxia]","WORD_SEQ_[( ataxia]",POS_SEQ_[CD_NN],DEP_PATH_POS_[prep_of-dep|NN@nn-dep|NN],VERB_DEP_PATH_POS_[complement]_[prep_of-dep|NN@dep-dep|NN]_[nn@dep],DEP_PATH_[prep_of-dep|expression@nn-dep|~],VERB_DEP_PATH_[complement]_[prep_of-dep|expression@dep-dep|~]_[nn@dep]}	{2.68377,2.68377,-2.24436,-0.128392,-0.0565851,-0.0565851,-0.0565851}
journal.pntd.0002004.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pntd.0002004.pdf_134_134_15_15_0_1_UNSUP	AST/HP:0001392|Abnormality of the liver	{15}	{0,1}	{Abnormal,liver,function,(,ALT,>,45,International,Unit,per,Litre,(,IU/L,),and,AST,>,35,IU/L,),was,found,in,14,%,and,28,%,respectively,.}	{"Biological presentation at inclusion Lymphopenia was frequent at inclusion ( 94 % of cases with a value < 1.5 Giga per Litre ( G/L ) ; 79.6 % with a value < 1 G/L ) .","Thrombocytopenia ( < 150 G / L ) was noted in 24 % of cases and neutropenia ( < 2.5 G / L , but always > 1 G / L ) in 33 % of cases ."}	{"C Reactive Protein ( GRP ) was > 15 mg / L in 82 % of cases , > 50 mg/L in 33 % and > 100 mg/L in 12 % ( Table 1 ) .","There was no leukocytosis ( > 10 G / L ) ."}	0.93	0.014	0.242	{INV_VERB_DEP_PATH_[find]_[conj_and-dep|)-dep|>@]_[dep-dep|Unit-dep|)-dep|>@],"INV_WORD_SEQ_NER_[function NUMBER ALT > NUMBER International Unit per Litre NUMBER iu/l ) and]",INV_VERB_DEP_PATH_POS_[find]_[conj_and-dep|NN-dep|JJR@]_[dep-dep|NNP-dep|NN-dep|JJR@],INV_DEP_PATH_POS_[conj_and@dep-dep|NNP],INV_DEP_PATH_[conj_and@dep-dep|Unit],INV_POS_SEQ_[NN_CD_NNP_JJR_CD_NNP_NNP_IN_NNP_CD_NN_NN_CC],"INV_WORD_SEQ_[function ( ALT > 45 International Unit per Litre ( iu/l ) and]"}	{0.34671,0.34671,0.34671,0.34671,0.34671,0.34671,0.34671}
journal.pone.0002396.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0002396.pdf_282_282_10_10_14_14_UNSUP	XLHED/HP:0000668|Hypodontia	{10}	{14}	{Affected,members,in,this,Mongolian,family,did,not,show,other,XLHED,characteristics,",",except,hypodontia,.}	{"So far , only two articles reported that mutations in the EDA gene resulted in unique hypodontia phenotype rather than the full XLHED phenotype [ 28 — 29 ] .","In that study the test group one was a Mongolian family with a missense mutation ( p. R65G ) in the juxtamembrane region of EDA [ 28 ] ."}	{"The patterns of missing teeth","Family A"}	0.912	0.002	0.958	{"POS_SEQ_[NNS_,_IN]",VERB_DEP_PATH_POS_[affect]_[nn-dobj|NNS@csubj]_[prep_except@csubj],VERB_DEP_PATH_[show]_[nn-dobj|characteristic@]_[prep_except@],VERB_DEP_PATH_[affect]_[nn-dobj|characteristic@csubj]_[prep_except@csubj],VERB_DEP_PATH_POS_[do]_[nn-dobj|NNS@aux]_[prep_except@aux],DEP_PATH_[nn-dobj|characteristic@prep_except],"WORD_SEQ_[characteristic , except]",VERB_DEP_PATH_[do]_[nn-dobj|characteristic@aux]_[prep_except@aux],DEP_PATH_POS_[nn-dobj|NNS@prep_except],VERB_DEP_PATH_POS_[show]_[nn-dobj|NNS@]_[prep_except@]}	{-0.889761,0.394088,0.394088,0.394088,0.394088,0.394088,0.394088,0.394088,0.394088,0.394088}
